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Abstract 
        Availability of genome sequences for numerous bacterial species comprising of different 
bacterial strains allows elucidation of species and strain specific adaptations that facilitate their 
survival in widely fluctuating micro-environments and enhance their pathogenic potential. 
Different bacterial species use different strategies in their pathogenesis and the pathogenic 
potential of a bacterial species is dependent on its genomic complement of virulence factors. A 
bacterial virulence factor, within the context of this study, is defined as any endogenous protein 
product encoded by a gene that aids in the adhesion, invasion, colonization, persistence and 
pathogenesis of a bacterium within a host. Anecdotal evidence suggests that bacterial virulence 
genes are undergoing diversifying evolution to counteract the rapid adaptability of its host’s 
immune defences. Genome sequences of pathogenic bacterial species and strains provide unique 
opportunities to study the action of diversifying selection operating on different classes of 
bacterial genes.  
        A computational pipeline was developed to assay for strain specific genes undergoing 
diversifying selection between Helicobacter pylori 26695 and J99, Neisseria meningitidis Z2491 
and MC58 as well as Vibrio cholerae N16961 and O395. Existing databases housing collections 
of virulence genes curated from literature were mined for known bacterial virulence genes. 
Characterisation of functional biological processes for genes under positive selection using Gene 
Ontology (GO), Clusters of Orthologous Proteins (COG), sub-cellular localisation prediction 
and metabolic pathways was undertaken to determine common and unique processes under 
positive selection within the three bacterial species. Functional characterisation of H. pylori, N. 
meningitidis and V. cholerae known bacterial virulence genes was performed to elucidate shared 
and species unique modes of bacterial pathogenicity. Comparisons between genes under positive 
selection and known bacterial virulence genes were conducted to discover whether known 
virulence genes and the biological processes they are involved in are enriched for diversifying 
selection. 
        Apart from N. meningitidis, no statistically significant intersection could be established 
when genes under positive selection and known virulence genes are examined as separate 
entities, suggesting positive selection and bacterial virulence operate in a parallel, unrelated 
manner. However, a substantial overlap between the biological processes and functional 
annotations of genes under positive selection and known virulence genes was found. Four 
common bacterial virulence metabolic pathways were also found to contain genes under positive 
selection and known virulence genes within all three bacterial species, one of them (Lysine 
Biosynthesis I) is currently being investigated as an anti-bacterial target, thereby demonstrating 
a link between nucleotide diversity and bacterial pathogenesis.  
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Chapter 1 : Microbial Genomes, Positive Selection and 
Bacterial Virulence 
Introduction 
        Advances in genome sequencing technologies, assembly and annotation have driven the 
explosion of publicly available genomes for a myriad of microbial organisms. At present, there 
are 1,136 completed genome projects listed in the Genomes Online Database as of 12th 
November 2009, 83% (945 of 1,136 complete genomes) are from the Bacterial domain and are 
pre-dominantly human pathogens of medical importance•. The plethora of microbial genomes 
offers unprecedented opportunities to investigate bacterial genome evolution, identify virulent 
determinants, characterize microbial gene content and metabolic pathways while concurrently 
creating avenues for novel diagnostic and anti-microbial therapies 1-6. The glut of genomic 
information has actuated development of numerous in silico tools for storage, annotation, 
dissemination and analysis of biological data and given rise to comparative genomics, an 
integral approach in the annotation, analysis and contextualisation of sequenced genomes 1,2,4-9.  
        A major goal in the study of microbial pathogens is the identification and characterization 
of microbial genes that facilitate invasion and colonization of a host species 2,5,6,9-12. Systematic 
explorations of microbial genomic diversity and the dynamics shaping adaptations ensuing the 
survival and success of bacterial pathogens is now possible at the genome level 1,2,6,9,12-17. 
Development of sophisticated computational tools and rigorous models of evolution coupled 
with the availability of microbial genomes provides unique opportunities to investigate the effect 
of evolutionary selective forces on microbial virulence determinants 2,6,9,12,15,17,18. The 
cornucopia of available microbial genomes is being leveraged by researchers around the world 
to understand the impact of evolutionary selective pressures on microbial virulence determinants 
that enable the continued success of a microbial pathogen 13,15,17-19. 
        One of the fastest evolving gene classes in mammalian genomes are immune response 
related genes due to the dynamic inimical interplay between bacterial infection and host 
immunity 20-22. Within this “biological arms race”, microbial pathogens are under strong 
selective pressure to rapidly alter their genomic complement to ensure continued survival within 
their hosts and in widely fluctuating micro-environments 5,6,11. Elucidating these signatures of 
rapid evolution from microbial genomes will provide glimpses to the origins of pathogenicity in 
response to selective pressures exerted by a bacteria’s host environment, thereby establishing a 
relationship between microbial genome sequence diversity and pathogenesis  5-7,13. 
                                                
•
 http://www.genomesonline.org/gold.cgi?want=Published+Complete+Genomes 
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Microbial Genomes – Knowledge, Applications, Limitations 
        Our understanding of microbial genomes has greatly advanced to a point where a bacterial 
species is no longer defined by its genome, but by its pan-genome 4,23,24. Different strains of the 
same bacterial species have been sequenced to identify genotypic variations resulting in 
phenotypic traits that define those bacterial strains 4,23,24. Intra-species bacterial genome 
sequencing and comparisons have identified genes unique to different strains that collectively 
form a bacterial species’ genomic repertoire, this combined repertoire of bacterial genes from 
different bacterial strains represents a bacterial species’ pan-genome 4,23,24. Genes present in all 
bacterial strains within that bacterial species form its core genome, genes unique to two or more 
bacterial strains constitute its dispensable genome 4,23,24. Bacterial genome sequencing and 
comparative genomics show the plasticity of microbial genomes is far greater then first 
envisioned with microbial gene pools and diversity being grossly underestimated 5,9,25. The 
flexibility of bacterial genomes is underlined by three Escherichia coli strains (K12, O157:H7 
and CFT073) having only 39.2% genes in common 26. Compared to E. coli K12, E. coli 
O157:H7 was found to contain ~1,300 strain specific genes, many of which are associated with 
metabolic and virulence processes 26,27. 
        In addition to a revised definition of a bacterial species and diversity, microbial genomics is 
redefining our concept of microbial genome architecture 3,5,13. Microbial genomes vary in size 
from 0.5 to 10 megabases with the majority of bacterial species containing a singular round 
chromosome 3,5,13. Certain species such as Borrelia burgdoferi have linear chromosomes while 
pathogenic bacteria such as Brucella and Vibrio species contain two or more chromosomes 3,28. 
Exogenous chromosomal genetic material carried by bacterial cells include plasmids that can 
vary both in size and number and encode factors such as antibiotic resistance genes 3,5,13. In 
certain cases like in Vibrio, the second chromosome is postulated to be a mega-plasmid acquired 
by an ancestral Vibrio species causing the distinction between a second chromosome and a 
mega-plasmid to be blurred 3,28. Similar to genome size, the guanine-cytosine percentage (%GC) 
content between microbial species also ranges widely from approximately 75% in various 
Micrococcus species to 25% in Mycoplasma species 3,5,13.                
        Genome analysis of a number of microbes has enabled the design of specific growth media 
for previously uncultivable bacteria and provided a basis for understanding resistance to anti-
microbials by some bacterial species 3,10. In silico metabolic pathway analysis suggested the 
inability of the causative agent of Whipple’s disease, Tropheryma whipplei, to synthesis nine 
amino acids 10,29,30. Incorporation of these nine amino acids to the growth media enabled T. 
whipplei to be axenically cultured for the very first time 10,29,30. Similarly, resistance to 
fluoroquinolones by T whipplei was predicted by genome analysis which identified mutations 
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producing alanine instead of serine residues in the parC and gyrA genes which was subsequently 
confirmed experimentally 29,31. Microbial genomic data is now being used in reverse 
vaccinology whereby the complete proteome of a micro-organism is screened for potential 
vaccine candidates opposed to the conventional empirical testing of antigens 10,32,33. Potential 
vaccine targets using reverse vaccinology have been identified in species such as Neisseria 
meningitidis and Streptococcus agalactiae amongst others 10,32,33.   
        However, despite advancements in our understanding and leveraging of microbial genomes 
and the prodigious efforts of numerous research groups globally, functional knowledge for all 
genes within a given bacterial genome is far from complete. For example, only 66% of 4,460 
genes from the laboratory work horse E. coli K-12, whose genome was sequenced in 1997, have 
experimental evidence for their function 34,35. Compared to other sequenced genomes from all 
Kingdoms, E. coli K-12 represents the most complete genome annotation to date in both 
absolute and relative terms 35. Clearly technological advances enable the rapid generation of 
genomic data at a greater rate then our ability to identify, characterise and decipher each 
individual component and how interactions between those components relate to an organism’s 
phenotype. 
        In terms of genomic characterisation, Reed et al postulate four dimensions of genome 
annotation 36. One-dimensional annotation comprises of genomic sequences demarcated with 
genes and their functions (where known) and is accomplished by gene finding algorithms, 
comparative genomics and controlled vocabularies (ontologies) 36. Two-dimensional genome 
annotation utilizes literature mining and functional genomic studies to reconstruct metabolic and 
regulatory networks contained within a sequenced genome 35-37. The spatial configurations of 
chromosomes and their genes during varying expression states within a cell constitutes the third-
dimension of genome annotation 36. Comparisons of bacterial genome sequences to decipher 
microbial genome diversity and architecture as well as identify evolutionary events that mould a 
genome represent the fourth-dimension of genome annotation 36.  
        Investigation of evolutionary events that shape genomic landscapes of bacterial pathogens 
will provide insights to the adaptations undergone by those pathogens that enable their 
successful infection and colonization of a host 5,6,11,13. Such insights will facilitate a better 
understanding of virulence determinants encoded within a pathogen’s genome and influence our 
strategies for combating bacterial pathogens using novel approaches, a fundamental aim of 
pathogen informatics. 
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Forces Shaping Microbial Genome Evolution 
        Gene content and genome size variation between microbial species is attributed to 
evolutionary processes driven by a bacterial species’ interactions within widely fluctuating 
environments 13,38-40. Gene loss and decay is observed when some micro-organisms shift from 
free living to being symbiotic or parasitic 13,38-40. The host provides many of the metabolites and 
co-factors needed for growth and replication resulting in redundancy of some of the genetic 
machinery contained by the micro-organism 13,38-40. Rather then expending energy maintaining 
and replicating the redundant genetic machinery, gene loss or inactivation is preferred resulting 
in reduced genome sizes or genomes with numerous pseudogenes 13,38-40. The observed reduced 
genome sizes for endosymbionts such as Buchnera aphidicola and obligate intracellular 
pathogens like Rickettsia prowazekii are directly attributed to their niche adaptations 13,40,41. 
Extensive genome decay is also observed in Mycobacterium leprae where only 49.5% of protein 
coding genes are functional and 27% of the genome is characterised as pseudogenes 16,42. When 
compared to Mycobacterium tuberculosis, an estimated 2,000 genes have been lost in M. leprae 
since divergence from their last common mycobacterial ancestor 16,42. Conversely, free living 
micro-organisms need to synthesis and scavenge essential metabolites and co-factors for their 
growth and replication in their fluctuating micro-environments resulting in large, diverse gene 
pools and consequently the maintenance of large genome sizes 13,38-40.  
        Just as gene loss may result in niche adaptation, gene gain enables colonization of new host 
species and altered pathogenesis by bacterial species 43. Gene gain may occur via duplications of 
existing gene families or by the horizontal transfer of mobile genetic elements between bacterial 
species 5,13,43. Horizontal (lateral) gene transfer is responsible for antibiotic resistance in 
previously susceptible bacteria and a shift from avirulence to virulence by some bacterial species 
within their host 5,13,43. Genetic material transferred laterally between bacterial species include 
prophages, plasmids and larger mobile genetic elements such as pathogenicity islands 5,43. 
Prophages are bacterial viruses whose genomes have been integrated into their bacterial host and 
can confer a virulence phenotype in some bacterial species like Vibrio cholerae or 
Corynebacterium diphtheriae where chromosomally integrated prophages CTXphi and 
corynephage beta encode for the cholera and diphtheria toxins respectively 44-46. Integration of 
prophages into a micro-organism’s genome propels sequence diversity between bacterial species 
and strains as prophages can constitute anywhere between 10-20% of a microbial genome 47. 
        Pathogenicity islands are larger horizontally transferred genomic elements which integrate 
into bacterial genomes and generally encode complete virulence systems such as type III 
secretion systems associated with pathogenic gram-negative bacteria like enterohaemorrhagic 
and enteropathogenic E. coli or the Cag pathogenicity island in Helicobacter pylori 5,43. 
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Increased virulence in Type I H. pylori strains is linked directly with the genomic integration of 
the Cag pathogenicity island and as such, marks an important evolutionary shift in the 
pathogenicity of H. pylori as avirulent Type II H. pylori do not contain the 40Kb Cag 
pathogenicity island 48,49. Pathogenicity islands can be delineated from other mobile genetic 
elements as they have differing mean %GC contents in relation to the bacterial %GC genome 
mean and form clusters of adjoining genes which bestow distinctive virulent phenotypes in 
carrier bacterial strains compared to non-carrier bacterial strains 5,43,48,49. 
        Other forces driving microbial genome evolution include gene duplications, point 
mutations and recombination events. Gene duplication is essential for gene innovation and 
creation of novel functionality within an organism 50,51. In bacteria, gene duplication mainly 
arises as an adaptable response to evolutionary selection pressures such as temperature 
fluctuations and nutrient unavailability 50,51. Duplicated bacterial genes come under strong 
selective pressure and in most cases are expunged, in some cases they may undergo neo-
functionalization to attain altered functions from their parent gene 50,51. In M. tuberculosis, 
approximately 51% of genes contained within its genome are estimated to have arisen via gene 
duplication 16,52. Point mutations can increase microbial diversity, promote survival and lead to 
an increased prevalence of some bacterial clones as in the case of H. pylori where point 
mutations within the 23SrRNA gene is responsible for resistance to the anti-microbial agent 
clarithromycin 53,54. Recombination in certain bacteria like Neisseria meningitidis allows for the 
novel generation of antigenic variants for certain apparatus like pili which facilitates adhesion of 
N. meningitidis to host endothelial and epithelial cells 55. Cell surface exposed pili that mediate 
host epithelial cell adhesion are subjected to host immune surveillance which exerts selection 
pressure for recombinant variants of pili genes like PilE from N. meningitidis, thus causing 
propagation of sequence diversity within a bacterial species 55.    
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Positive Selection: Theory and Implementation 
        The advent of complete genome sequence information facilitates empirical testing of 
orthologous aligned nucleotide sequences for elevated signs of sequence divergence based on 
Kimura’s neutral evolutionary theory 56-58. Generally, two closely related genomes will differ 
from their common ancestor due to evolutionary forces acting upon random mutations occurring 
in those genomes 56-58. Most of these mutations occur due to random genetic drift which has 
little or no effect on an organism’s fitness and as these changes do not alter any amino acids, 
they are classified as neutral 56-58. A small subset of mutations that occur by random genetic drift 
may either be detrimental or beneficial to an organism within its given environmental niche. 
Mutations that prove detrimental to an organism’s fitness come under strong purifying selection 
to be expunged from an organism’s genome 56-58. Mutations which confer a selective advantage 
to an organism within its environmental niche come under strong positive (diversifying) 
pressure to be fixed within an organism’s genome 56-58.  
        Molecular evolutionary theory has been developed and constantly refined over the years 
using various methods and approaches to produce a rigorous, statistical framework for the 
detection of positive selection 58,59. The common goal of all the various approaches involve 
determination of the parameter omega (ω) which is obtained by dividing the number of non-
synonymous substitutions (amino acid altering; dN) by the number of synonymous substitutions 
(non amino acid altering; dS) 58-60. As synonymous substitutions do not involve an amino acid 
change, their rate of substitution is considered to be neutral, non-synonymous substitutions are 
non-neutral as they involve an amino acid change and are considered to be a function of 
selective pressure acting on a gene product. Hence, ω = dN/dS and if ω > 1 then positive 
selection is inferred, if ω = 1 neutral evolution is inferred while ω < 1 is indicative of purifying  
selection 58-61. 
        Methods that calculate ω from nucleotide sequence data can be classified as approximate 
(counting) and maximum likelihood methods 58,60,61. Most approximate methods involve 
counting and calculating differences between synonymous and non-synonymous sites in an 
aligned nucleotide sequence making corrections for multiple substitutions at a site 58,60,61. Many 
of the approximate methods use simplified mutational models of nucleotide substitutions with 
relatively few parameters that do not take into account unequal transition / transversion rates and 
differing organism specific nucleotide frequencies 58,61,62. Depending on which nucleotide 
substitution model is employed, under-estimation and over estimation of synonymous and non-
synonymous substitutions is possible as in the case of the JC69 model due to synonymous 
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transversions being less likely to occur at the third nucleotide position in a codon compared to 
transitions 58,61,62.  
        More biologically relevant models using codon substitutions were developed by Goldman 
and Yang incorporating a Markov process between codon substitutions within a Maximum 
Likelihood framework 61-63. Codon based methods use the organism’s genetic code to filter out 
stochastic noise and derive biologically realistic substitution models from the underlying 
sequence data enabling codon based models to fit sequence data better then nucleotide based 
models 61-63. Codon based models also have more power to detect positive selection compared to 
approximate methods which in effect, averages ω over the whole length of a sequence alignment 
due to the assumption that all sites within an alignment are under equal selective pressure 60,63,64. 
Usually, only a few amino acid sites within a protein might be under adaptive evolution as most 
sites are conserved to retain protein structure and function, codon based models take into 
account the paucity of sites under positive selection by allowing ω to vary amongst different 
codon sites thereby providing increased power in detecting positive selection 63-65. The greater 
flexibility and accuracy of codon based models as well as their use of a rigorous statistical 
testing framework centred on Maximum Likelihood theory has made programs implementing 
such methods like PAML, the de facto standard when assaying for positive selection.  
        Maximum Likelihood is a statistical method which makes inferences about dataset 
parameters such as the transition / transversion rate and ω and from the underlying probability 
distribution of the dataset and assigns log-likelihood ratios to each codon model test used 58,64-67. 
When assaying for positive selection using PAML, there are two models universally employed; 
M1a and M2a 15,18,58,61,65. The M1a or nearly neutral model forms the null hypothesis within 
which near neutral evolution is assumed and permits variation of dN/dS (ω) amongst sites as 
opposed to the whole alignment 58,61,65,68. Within the M1a model, ω is fixed with ω1 = 1 or ω0 < 
1 for neutral evolution. The M2a or positive selection model enables for an additional proportion 
(p2) of sites where ω2 > 1 and is derived from the sequence data, hence allowing for a model of 
positive selection 58,61,65,68. The log-likelihood ratio derived from the M1a model is compared to 
the log-likelihood ratio obtained from the M2a model. A log-likelihood ratio test (LRT) is 
preformed between M1a and M2a log-likelihood ratios and results are compared against a Chi-
Square table of critical values using 2 degrees of freedom 58,61,65,68. If the M1a model is rejected 
in favour of the M2a model, then positive selection can be inferred and vice versa 58,61,65,68.   
        Although methods for detecting positive selection have increased in sophistication, they 
still do have some drawbacks. Results obtained from any method assaying for positive selection 
are only as good as the input sequence alignment and even though a gene may be found to be 
under positive selection, no information as to the origin of the selection pressure is provided. 
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Bacterial Pathogens and Virulence 
        Multi-cellular organisms have been described as “a multitude of microbiomes” 69. Varying 
degrees of relationships between microbial communities and their multi-cellular hosts exist 
ranging from mutualism, commensalism, parasitism to virulent 69. Pathogenicity by a micro-
organism is often associated with disease and morbidity occurring to a host caused by the 
presence as well as relative abundance of a micro-organism within a host 69-71. However, in 
certain cases, disease and morbidity within a host may be caused by an absence of a microbial 
organism, hence the broad definition of a pathogen by Ehrlich et al. as a microbial organism 
“that results in a disruption of homeostasis” 69. Historically, Robert Koch laid the basis for 
bacterial pathogens to be identified as the primary etiological factor for a disease only when four 
criteria can be met in what is termed Koch’s postulates 5,72,73. These criteria stipulate: 
 
1) The bacterial organisms should be present in people with the disease and absent from 
people without the disease. 
2) The bacterial organism should be isolated and maintained in a pure culture form. 
3) The bacterial organism should be capable of causing an infection when re-inoculated into 
a host from its culture form. 
4) The bacterial organism should be able to be re-isolated and cultured from its host after 
re-inoculation. 
 
        The advent of molecular biology resulted in a further refinement of Koch’s postulates by 
Stanley Falkow to what are known as molecular Koch’s postulates. Molecular Koch’s postulates 
were developed to reflect our increased sophistication in isolating and manipulating bacterial 
genetic elements responsible for pathogenesis and attempt to provide a systematic framework for 
identification of a virulence factor 5,72,73. These molecular Koch’s postulates stipulate: 
 
1) The proposed virulence determinant should be absent in non-pathogenic bacterial strains 
and only present in pathogenic bacterial strains. 
2) Attenuation of a pathogenic bacterial strain should be observed with inactivation of the 
proposed virulence determinant / genes. 
3) An attenuated bacterial strain should revert back to its wildtype pathogenic form upon re-
introduction of the inactivated virulent determinant / genes. 
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        Micro-organisms cause disease and morbidity within their host through a gamut of 
interactions mediated by virulence factors or determinants 70,71,74. A virulence factor can 
describe bacterial products that directly cause detrimental damage to host cells e.g. toxins, or use 
of mechanisms for survival of the micro-organism within a host e.g. iron acquisition 
siderophores 70,71,74. The term “virulence factor” is a biological concept and like many biological 
concepts, its use is context driven resulting in blurred definitional boundaries 71.  
        Attempts have been made to categorise known virulence factors into different classes based 
upon biological functions, however most of these groupings of bacterial virulence factors were 
determined in the pre-genomic era 6,12,19. Many of the classically known virulence factors were 
derived using molecular biological approaches such as adhesion and colonization assays, In vitro 
Expression Technology (IVET) or transposon mutagenesis 6. Such molecular techniques only 
allow certain classes of bacterial virulence determinants to be identified such as toxins or 
adhesive outer membrane proteins through quantification of what can be measured 6,70,74.  
        Application of high throughput novel genomic, transcriptomic and proteomic technologies 
has resulted in a further distortion of the definition of a bacterial virulence factor. Genes 
identified by homology, genes whose expression is up-regulated during specific infection 
periods, transcriptional regulators controlling the expression of virulence associated genes and 
post transcriptionally modified proteins are being added to the ever growing list of bacterial 
virulence factors 4,6,9,11,17. With refinement and increased usage, high throughput technologies 
will no doubt contribute towards the debate in defining what constitutes a virulence factor and 
may possibly incorporate a systems based approach, whereby bacterial virulence will be defined 
on the basis of biological processes. Until such a time, the broad working definition of a 
virulence factor employed for the purpose of this study is; any endogenous bacterial gene 
product which aids in the adhesion, invasion, infection, colonization, persistence and 
pathogenesis of a microbial organism within its host. 
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Determination of Bacterial Genes Subject to Diversifying Selection 
        The plethora of bacterial species and strains sequenced coupled with the parallel 
development of molecular evolutionary theory facilitates the scanning of bacterial genomes for 
traces of genes undergoing rapid diversification 6,9,15,18,57,64. There are number of reasons why 
one would scan closely related genomes to identify genes undergoing rapid evolution which 
include; 
 
1) Discovery of nucleotide changes that may affect the fitness of an organism. 
2) Identification of evolutionary changes which may provide insights into mechanisms 
contributing to the continued success of a pathogen. 
3) Ascertain what biological processes are undergoing adaptation enabling a bacterial 
species to flourish within its environmental niche. 
4) A better understanding of the dynamic interface between infection and immunity by 
identification of rapid evolutionary changes between bacterial strains. 
5) Contribute to a better rationale in management and development of novel therapeutics to 
combat bacterial pathogens. 
 
        To date, several groups have focused on determining which genes are under positive 
selection within a single bacterial species and grouping these genes according to their known 
functional roles in bacterial virulence 15,18. A limiting factor for many of these studies and 
indeed for this study, is the lack of functional information for the majority of genes within a 
bacterial genome. E. coli was used in previous studies partly due to the relatively high 
proportion of genes with functional annotation 15,18. The approach undertaken in this study is to 
use a variety of microbial species opposed to a single bacterial species in order to: 
 
1) Determine whether there are any universal classes of genes and common biological 
processes that maybe under positive selection across bacterial species. 
2) Determine if there are any classes of genes and biological processes undergoing positive 
selection that are unique to each of the bacterial species under study. 
3) Determine if there are any classes of genes under positive selection that have a 
substantial enrichment of known virulence genes characterised within those bacterial 
species.  
4) Determine whether there are shared or unique biological processes between virulence 
genes within each bacterial species. 
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5) Determine whether there are shared or unique biological processes between genes under 
positive selection and virulence genes within each bacterial species. 
 
        The three bacterial species used in this study are Helicobacter pylori, Neisseria 
meningitidis and Vibrio cholerae with each bacterial species comprising of two strains 
summarised below in Table 1.1. 
Bacterial 
Species 
(Strain) 
Accession 
Genome 
Size 
(Mbp) 
No of 
Genes 
Morphology  
(Gram 
Stain) 
Habitat Pathogenesis 
H. pylori 
(26695) 
 
NC_000915 1.66787 1630 
Spiral, 
motile 
(Gram 
Negative) 
Host associated 
mucosal layer of 
gastrointestinal 
tract 
Gastric 
inflammation 
and peptic 
ulcer disease 
H. pylori 
(J99) 
 
NC_000921 1.6 1535 
Spiral, 
motile 
(Gram 
Negative) 
Host associated 
mucosal layer of 
gastrointestinal 
tract 
Gastric 
inflammation 
and peptic 
ulcer disease 
N. meningitidis 
(MC58) 
 
NC_003112 2.3 2225 Cocci (Gram Negative) 
Host associated 
– usually 
pharynx 
Septicaemia, 
meningitis 
N. meningitidis 
(Z2491) 
 
NC_003116 2.2 2208 Cocci (Gram Negative) 
Host associated 
– usually 
pharynx 
Septicaemia, 
meningitis 
V. cholerae 
(N16961) 
 
NC_002505 
NC_002506 4.03 
4008 
Curved 
bacillus 
(Gram 
Negative) 
Aquatic Cholera 
V. cholerae 
(O395) 
 
NC_009456 
NC_009457 4.1 
3998 
Curved 
bacillus 
(Gram 
Negative) 
Aquatic Cholera 
 Table 1.1: GenBank genome accession numbers, genome size, number of genes, morphology, 
habitat and pathogenesis of bacterial strains used for determining classes of genes under positive 
selection. 
 
        H. pylori is estimated to colonize approximately half the world’s population and is a 
leading global cause of peptic ulcers, stomach cancer and chronic active gastritis with infection 
durations ranging from a couple of years to decades 75-77.  H. pylori causes 5.5% of annual 
human cancer incidences and is one of the first bacterial pathogens to be recognized and 
classified as a Class I carcinogen by the World Health Organisation as it is a major risk factor in 
the development of gastric cancers 75-78. H. pylori has no known natural reservoir outside of its 
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human host and because of a persistent chronic infection which if untreated results in a fatal 
outcome, H. pylori is considered an obligate pathogen. H. pylori is acquired orally from related 
family members and its origins have been traced to East Africa with its subsequent global spread 
linked to human population migrations out of Africa approximately 60,000 years ago 75,79. 
Taxonomically, H. pylori belongs to the epsilon sub-division of proteobacteria and can further 
be broken down into gastric and non-gastric species 76,80. Production of urease and high motility 
are characteristics of all known gastric H. pylori species with both factors considered essential 
for H. pylori survival and colonization within the hostile gastric environment 76,80. Urease 
production helps neutralize the low pH of gastric acid and is vital for H. pylori motility towards 
more neutral pH gradients like the gastric mucosal layer within which the bacterium may 
replicate 76,80,81. Approximately 6-7% of H. pylori genes are strain specific with 89 and 117 
genes specific to H. pylori J99 and 26695 respectively, both H. pylori strains harbour the Cag 
pathogenicity island 14,77,82,83. The pan-genome of H. pylori consists of the core genome 
calculated to comprise of 1,111 genes with an additional 400 genes making up the dispensable 
genome 78,84. Variation between H. pylori strains operates primarily at the nucleotide level 
opposed to the amino acid level as many of the nucleotide differences are silent with respect to 
the protein product, indicating strong selective pressure to maintain functional conservation of 
the proteome 14,82,83. 
        N. meningitidis is usually part of the nasopharynx commensal flora and colonizes 
approximately 10% of the healthy human population, N. meningitidis is also an opportunistic 
pathogen which causes epidemic outbreaks of bacterial meningitis and septicaemia for reasons 
largely unknown 85-87. Taxonomically, N. meningitidis belongs to the beta-proteobacterial 
subdivisions and different strains of N. meningitidis are divided into serogroups A, B, C, W135 
and Y based on typing of their polysaccharide capsular structures 86,88,89. N. meningitidis Z2491 
belongs to serogroup A and is responsible for epidemic meningitis outbreaks within mainly 
developing countries while N. meningitidis MC58 belongs to serogroup B and is the etiological 
agent in sporadic meningitis outbreaks within developed countries that are characterized as 
being invasive 86. The pan-genome of N. meningitidis is estimated to have 3,290 genes and is 
predicted to be open with the continual addition of 43 genes per a genome sequenced while the 
core genome is calculated to contain 1,337 genes at minimum 87,90.  
        V. cholerae, the causative agent of cholera, is a facultative pathogen mainly found in 
aquatic and estuarine environments associated with poor water quality and has been responsible 
for seven cholera pandemics 28,91,92. V. cholerae is motile and belongs to the gamma-
proteobacterial sub-division. Of the estimated 200 or so V. cholerae serotypes identified, V. 
cholerae serotype O1 is responsible for the seven cholera pandemics 28,91,92. The O1 V. cholerae 
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serotype is further divided into two biotypes; the El Tor biotype which includes V, cholerae 
N16961 and the classical biotype which includes V. cholerae O395 28,91,92. The two O1 V. 
cholerae serotypes are differentiated based on biochemical properties with the El Tor biotype 
being Voges Proskaur reaction positive and haemolytic 28,91,92. The El Tor biotype arose as the 
causative agent for the 7th cholera pandemic replacing the classical biotype responsible for the 
6th cholera pandemic in prevalence 28,91,92. V. cholerae N16961 was responsible for the 7th 
cholera pandemic in 1971 while strain O395 was isolated as the aetiological agent for the 6th 
cholera pandemic in 1965 28,91,92. There is conflicting evidence to the origin of the El Tor cholera 
strains with some studies showing both O1 classical and El Tor biotypes are part of a single 
epidemic clonal complex with intermediate strains between the two biotypes identified 93,94. In 
contrast, some studies imply V. cholerae N16961 is more closely related to environmental 
isolates then to the V. cholerae O395 strain indicating that the 7th cholera pandemic originated 
independently from the 6th cholera pandemic 91,92. The core genome of V cholerae is estimated to 
contain 2,787 genes while the dispensable genome comprises of 447 genes 95. 
        The three bacterial species comprising of two strains each (Table 1.1, page 16) were 
specifically chosen for this study due to their wide range of host-pathogen interactions and 
lifestyles which should exert different types of selection pressures upon their existing gene 
complement and the maturity of their sequenced genomes. H. pylori is an obligate pathogen with 
no known environmental reservoir other then humans and hence, is postulated to be undergoing 
host restriction 78. N. meningitidis does not survive for long within the environment and is a 
commensal which in certain cases turns into an opportunistic pathogen within its host 90,96,97. V 
cholerae is a free-living environmental bacterial species that is not part of the normal human 
microbial flora, but causes severe diarrheal disease when contracted and therefore is a facultative 
pathogen 6,71. Although all three bacterial species have different lifestyles and interactions with a 
human host, they share a common element in that they are detrimental to their human host. 
Assaying for genes under positive selection within the three bacterial species should enable 
elucidation any common biological processes contributing to the pathogenesis of these micro-
organisms and whether genes under positive selection within these bacterial species represent 
known virulence factors. Differences in gene classes under positive selection may provide 
insights into diversification undergone by these three bacterial species to facilitate their niche 
adaptations and possibly enhance their virulence potential which is reflected by their differing 
modes of pathogenicity.  
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Chapter 2 : Methods and Materials 
Introduction 
        The following methods chapter is structured into twelve sections. Each section provides a 
description of the various aspects of data acquisition, handling, positive selection detection, 
functional annotation, metabolic pathway determination and statistical analysis conducted. The 
twelve sections presented in this method’s chapter are: 
 
1) Description of bacterial genome sequences used. 
2)  Pre-processing of bacterial GenBank genome sequence files for use in the pipeline 
approach employed to determine positive selection. 
3) Description of the pipeline approach used to scan for positive selection which is divided 
into four subsections: 
a) Orthologue identification. 
b) Generation of orthologous in-frame codon alignments 
c) Assay for positive selection 
d) Annotation of bacterial genes under positive selection using GenBank submitted 
genome annotation files. 
4) Curation of alignments for orthologous genes identified as being under positive selection. 
5) Data mining of bacterial virulence genes.  
6) Description of bacterial gene lists used in subsequent analyses (6 to 12). 
7) Gene length and %GC content distribution analysis of the bacterial gene lists. 
8) Gene Ontology annotation and enrichment analysis of the bacterial gene lists. 
9) Clusters of Orthologous Proteins annotation and analysis of the bacterial gene lists.  
10)  Sub-cellular localization determination of protein products and analysis for the bacterial 
gene lists. 
11)  Metabolic pathway analysis of the bacterial gene lists. 
12)  Statistical methods and graphical packages used for data analyses and visualisation.  
 
        All the PERL programmes, UNIX commands, positive selection detection pipeline 
documentation, parsers used for data mining and R code for statistical analysis relevant to each 
of the above mentioned sections are presented in the appropriate Appendices referenced within 
the text.   
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Bacterial Sequences 
        RefSeq records for six bacterial strains belonging to three Proteobacterial species; H. pylori 
(strains 26695 and J99), N. meningitidis (strains Z2491 and MC58) and V. cholerae (strains 
N16961 and O395) together with their submitted annotation files were obtained from NCBI’s 
bacterial genome repository via ftp in June 2007 •. Genome sequence information pertaining to 
the six bacterial strains are summarised below in Table 2.1. 
 
Bacterial 
Strain 
 
Accession 
Genome 
Size 
(Mbp) 
No of 
Genes 
Sequencing 
Centre 
(Year Released) 
PubMed ID 
H. pylori 
26695 NC_000915 1.66787 
1630 TIGR (1997) PMID : 9252185 
H. pylori 
J99 NC_000921 1.6 
1535 ASTRA 
(1999) PMID : 9923682 
N. meningitidis 
MC58 NC_003112 2.3 
2225 TIGR 
(2000) PMID : 10710307 
N. meningitidis 
Z2491 NC_003116 2.2 
2208 Sanger (2000) PMID : 10761919 
V. cholerae 
N16961 
NC_002505 
NC_002506 4.03 
4008 TIGR (2000) PMID : 10952301 
V. cholerae 
O395 
NC_009456 
NC_009457 4.1 
3998 TIGR (2007) PMID : 19115014 
Table 2.1: Bacterial strains, RefSeq accessions, sequencing centres, year of public data release 
and PubMed IDs of the primary genome project publications for the bacterial strains obtained 
from NCBI’s ftp repository. 
Pre-Processing of GenBank Bacterial Sequence Files 
        Nucleotide sequences of bacterial genes in Fasta format were attained using the European 
Molecular Biology Open Software Suite’s (EMBOSS, Version 3.0.0) ExtractFeat utility 98. In 
the instance of V. cholerae, extracted nucleotide gene sequences for chromosomes I and II were 
concatenated to form a single Fasta formatted file. Stream editor (sed) regular expressions were 
used to alter bacterial Fasta headers to remove special characters which interfere with 
downstream bioinformatics programmes, to contain less then 10 characters as required by the 
Phylip sequence format and facilitate accession parsing for subsequent analyses. Nucleotide 
gene sequences for each of the six bacterial strains (Table 2.1) were translated to their amino 
acid equivalents using GenBank’s bacterial genetic code 11 by EMBOSS’s TranSeq. Details of 
                                                
•
 ftp://ftp.ncbi.nih.gov/genomes/Bacteria/ 
 
 
 
 
 21 
quality control checks to ensure fidelity of the extracted sequences after processing by EMBOSS 
tools and sed regular expressions are presented in Appendix A2 (Pipeline Documentation). Steps 
followed for the pre-processing of bacterial GenBank files are presented below in Figure 2.1. 
 
Figure 2.1: Schematic representation of the steps performed for the pre-processing of bacterial 
GenBank files before use in the positive selection detection pipeline. 
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Positive Selection Detection Pipeline 
        The pipeline approach used for detection of positive selection was originally conceived by 
Dr. Junaid Gamieldien. I have used the pipeline after making a number of changes that include 
pre-processing steps of bacterial GenBank files, incorporation of new bioinformatics tools, 
orthologous gene determination, better methods and models for detecting positive selection and 
a curation step to remove false positives. The pipeline comprises of PERL scripts (Appendix 
A1) that utilise established bioinformatics software modules in a sequential manner (Appendix 
A2). A workflow of the positive selection detection pipeline is presented overleaf in Figure 2.2.  
Orthologue Identification 
        Translated amino acid sequences were used for putative orthologue identification as the 
amino acid alphabet consists of more characters (20 amino acids) then the nucleotide alphabet (4 
deoxyribonucleic acids), thereby providing greater sensitivity 99-102. Processed amino acid 
sequence files for each bacterial strain were formatted to create BLAST databases (see 
Appendix A2 for details) in separate directories. The Fasta_split.pl PERL script, originally 
written by Dr. Alan Christoffels, was used to split a multi-sequence Fasta formatted file into 
individual sequence Fasta files for bacterial strains A and B (Figure 2.2, page 23, Appendix A1). 
The individual amino acid sequence files form the query for BLASTP searches. BLASTP 
(Version 2.2.6) searches of the query against the BLAST databases were done by the 
ortho_BLAST.pl PERL script (Figure 2.2, page 23, Appendix A1). Parameters used for the 
BLASTP searches are ≥ 50 % identity and coverage, an expectation score of 1e-10 and a 
BLOSUM 62 matrix. Orthologous genes between bacterial strains A and B were identified using 
the Reciprocal Best Hits (RBH) method 99-102. Strain A is used as the BLASTP query against 
strain B, generating a list of “best BLASTP hits 99-102. The procedure is repeated with strain B 
forming the query against strain A, also generating a list of “best BLASTP hits” 99-102. The 
intersection between the two lists of best BLASTP hits forms the reciprocal best BLASTP hit 
(RBH) of a given gene between strains A and B, allowing putative orthology to be inferred 99-102. 
The PERL script, reciprocal_gene_ID.pl, was used to parse paired accession lists of top 
BLASTP hits for strain A against strain B and vice versa to obtain an intersection list of paired 
orthologous gene accessions between bacterial strains A and B (Figure 2.2, page 23, Appendix 
A1). 
        A major assumption of all positive selection detection methodologies is the input gene 
sequences are orthologous in nature and have arisen through vertical descent as opposed to 
duplication, horizontal gene transfer or recombination 58,103,104. Therefore, identification of 
orthologous genes between bacterial strains is vital for any positive selection analysis because 
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paralogous genes arising from gene duplications are under different selection pressures from the 
parent gene and will provide erroneous results 51,104.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Graphical summary of workflow used for determination of positive selection. Green 
boxes represent each sequential pipeline step performed and yellow eclipses represent PERL 
scripts used for each sequential pipeline step. 
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Generation of In – Frame Codon Aligned Sequences 
        Paired accession gene lists obtained from RBH were used by the accession_to_gene.pl 
PERL script to extract orthologous amino acid and nucleotide sequences from the concatenated 
amino acid and nucleotide files created during the pre-processing of bacterial GenBank files 
(Figure 2.1, page 21, Appendix A1 and A2). Each identified orthologous gene pair between 
bacterial strains A and B will have two files, one containing amino acid sequences and the other 
nucleotide sequences in Table format (Figure 2.2, page 23). These two types of orthologous 
sequence files are used to generate in-frame codon alignments (Figure 2.2, page 23). 
        The PERL script In_frame_codon_align.pl uses the Table formatted orthologous amino 
acid and counterpart nucleotide sequence files as input to ClustalW (Version 1.83) creating 
global alignments for each sequence file type (Appendix A1) 105. A ClustalW aligned amino acid 
file and an aligned nucleotide file are written out which can be viewed for quality control 
checking with any sequence viewing software such as BioEdit. Both the ClustalW aligned 
nucleotide and amino acid file are concatenated into a single file, from which in-frame codon 
alignments are created using EMBOSS’s TranAlign utility (Figure 2.2, page 23, Appendix A1). 
The output is an in-frame, codon aligned, orthologous nucleotide gene pair which is converted to 
Phylip format for use by the CODEML module from the PAML package (Figure 2.2, page 23, 
Appendices A1 and A2) 58,61,106. 
Assay for Positive Selection 
        The PERL script codeML.pl is used to call CODEML from the PAML package (Version 
3.15) to screen each orthologous in-frame, codon aligned gene pair using a pre-specified control 
file (Appendix A2) designating the parameters and models to use by CODEML (Figure 2.2, 
page 23, Appendix A1). The codeML.pl PERL script writes out the CODEML results into a pre-
specified file within the subdirectories those files are read from. On average, it takes 3 minutes 
for CODEML to calculate log likelihoods for the M1a and M2a specified models of neutral and 
positive selection. For H. pylori, N. meningitidis and V. cholerae which have 1,382, 1,707 and 
3,431 putative orthologous gene pairs identified, it takes CODEML approximately 69.1, 85.4 
and 171.6 hours respectively to generate results on a 2 x 2.4 GHz Intel Pentium 4 Xeon server 
with 4 GB of RAM.   
        CODEML results are parsed using the parse_codeML_LRT.pl PERL (Appendix A1) script 
which performs a Likelihood Ratio Test (LRT) between the log-likelihood results for the M1a 
and M2a tests 58,61,67,106. The formula used for the LRT is presented below: 
LRT = 2*(lnL1 - lnL2) 
  lnL1 = Log likelihood ratio; M1a model              lnL2 = Log likelihood ratio; M2a model 
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Results of the LRT are compared to a Chi-Square critical value of 5.99 with two degrees of 
freedom which corresponds to P = 0.05, genes that reject the null hypothesis (M1a) in favour of 
the selection hypothesis (M2a) are written out into a new, user specified directory.  
Annotation of Bacterial Genes under Positive Selection 
        Bacterial gene accessions of genes surpassing the LRT at P = 0.05 are used by the 
gene_annotation.pl PERL script to parse against their respective GenBank bacterial annotation 
files to create a file containing the cluster ID, gene accession and annotation for genes under 
positive selection in bacterial strain A (Figure 2.2, page 23). The procedure is repeated using 
bacterial strain B’s annotation file to obtain annotations for genes under positive selection in 
bacterial strain B (Figure 2.2, page 23, Appendix A1). The two resulting files are opened in 
MicroSoft (MS) Excel, sorted by cluster ID number and merged to form a single MS Excel file 
containing the cluster ID number for tracking / reference, orthologous paired gene accessions for 
bacterial genes under positive selection between strains A and B and their respective 
annotations. The MS Excel file forms an easy, quick reference framework for further studies 
(Figure 2.2, page 23).  
Curation of Alignments for Genes under Positive Selection 
        Putative orthologue identification is traditionally done using amino acid sequences as the 
amino acid alphabet contains more characters then the nucleotide alphabet and the latter is 
degenerate 101,102. However, use of translated amino acid sequences for identification of putative 
orthologous genes, especially from closely related bacterial species, can introduce artefacts 
caused by sequencing errors resulting in a shift of the translational reading frame (frameshift 
errors), leading to false positives. Hence, a curation step of aligned orthologous sequences is 
required. Some groups generate orthologous nucleotide alignments together with amino acid 
alignments and screen for possible errors before running the sequences through a pipeline 
approach, others make no mention of any curation steps 15,18. In this particular instance, all 
orthologous gene pairs identified as being under positive selection were checked using BLASTN 
nucleotide sequence alignments. The reasoning behind curating alignments after running the 
sequences through the pipeline is that one is only interested in how many gene alignments 
produce false positives, not how many putative orthologous gene pairs between the bacterial 
genomes have frameshift errors. Thus, one only examines the smaller sample space of genes 
identified as being under positive selection that is a subset of all orthologous gene pairs to gauge 
whether they are false positives caused by artefactual data. ClustalW alignments are not suitable 
for quality control checking of frameshifts or sequencing errors at the nucleotide level because it 
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is a global alignment programme that attempts to align the whole length of two orthologous 
sequences against each other, inevitably introducing gaps 105. BLAST being a local alignment 
programme will only align regions between genes that have a maximal score 99. Insertions or 
deletions within a gene in respect to its orthologous counterpart produces gaps which are 
multiples of 3 nucleotides as opposed to gaps of 1, 2, 4 and 5 nucleotides that result in a shift of 
the translational reading frame 18. A combination of BLASTN nucleotide alignments and 
ClustalW amino acid alignments can be used to determine whether gaps of 1, 2, 4, and 5 
nucleotides causes a shift in the translational reading frame within an amino acid alignment.   
        The following protocol involving manual curation was devised to examine orthologous 
BLASTN nucleotide alignments cross-referenced against their counterpart ClustalW amino acid 
alignments of all genes found to be under positive selection, and flag any potential false 
positives for exclusion from subsequent analyses: 
1) Extract all Fasta nucleotide coding sequences for genes under positive selection from 
bacterial strain A. 
2) Split the extracted nucleotide sequences from bacterial strain A into individual files. 
3) Create a BLAST database of bacterial strain B’s genome. 
4) BLASTN the extracted nucleotide sequences for strain A against strain B. 
5) Obtain the RBH for each nucleotide sequence of strain A against strain B. 
6) Check each of strain A’s nucleotide alignments against strain B’s genome for presence of 
gaps within the alignment. 
7) Count the number of gaps present in the nucleotide alignment, determine if the gaps are 
consecutive and note the results in an MS Excel workbook. 
8) Check the ClustalW amino acid alignments of the corresponding nucleotide alignments to 
determine if the gaps are consistent with differences in protein / gene lengths. 
9) Check the ClustalW amino acid alignments to determine the if corresponding position of the 
gap in the nucleotide alignment causes a change in reading frame by producing different 
amino acids at that nucleotide gap position within the amino acid alignment. 
10) Exclude all genes found to be under positive selection for which a frameshift can be detected 
for H. pylori, N. meningitidis and V. cholerae. 
        Manual examination of aligned nucleotide sequences cross-referenced against their amino 
acid alignments takes about 5 days each for H. pylori and N. meningitidis and approximately 1 
and half days for V. cholerae. The procedure can be automated by parsing the BLASTN results 
for the number of gaps contained in the alignment, however in this case manual curation of the 
alignments was preferred 18.  
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Virulence Gene Data Mining 
        The Microbial Virulence Database (MVirDB) and Virulence Factor Database (VFDB) 
containing virulence genes identified from database and literature sources were mined for H. 
pylori, N. meningitidis and V. cholerae known virulence genes 19,107. MVirDB contains data 
from eight different publicly available databases as off November 2006 which are summarised 
below in Table 2.2 107. 
Data Base Description 
Tox-Prot Subset of SwissProt database housing known protein toxins 
SCORPION Database of scorpion toxins 
PRINTS Database of virulence gene motifs 
VFDB Database of virulence genes compiled via literature mining 
TVFac Toxin and virulence factor database 
Islander Genomic islands database 
ARGO Database of antibiotic resistance genes 
VIDA Database of animal virus open reading frames 
 Table 2.2: Databases and a brief description of each database used by MVirDB to populate its 
“data warehouse” of known virulence genes.  
 
        MVirDB is not a curated resource at the sequence level as sequence entries obtained from 
the eight different databases (Table 2.2) are not merged resulting in a lot of sequence 
redundancy. MVirDB has multiple nucleotide and amino acid sequences of the same genes 
containing different accessions inherited from their parent databases and numerous motifs 
present within their virulence gene datasets. To deal with the high level of redundancy and 
numerous accessioning formats contained within MVirDB and obtain lists of unambiguous, 
unique virulence genes for H. pylori, N. meningitidis and V. cholerae, reciprocal BLASTs of 
bacterial genome genes against MVirDB organism specific datasets were conducted.  
        VFDB is highly curated of redundant entries and employs the same universal accession 
system adopted for use in this study 19. VFDB datasets of known virulence genes identified by 
literature mining for H. pylori, N. meningitidis and V. cholerae were downloaded and converted 
to text files. The text files were parsed by means of a PERL script using bacterial gene accession 
IDs for H. pylori, N. meningitidis and V. cholerae.  
        Virulence gene lists for H. pylori, N. meningitidis and V. cholerae obtained from MVirDB 
and VFDB were consolidated and duplicate entries between both databases were removed to 
provide a single, combined list of unique, unambiguous virulence gene accessions for each of 
the three bacterial organisms. 
 
 
 
 
 28 
Bacterial Gene Lists 
        There are three types of gene lists used for subsequent analyses which are constantly 
referred to within this study; 
1) Orthologous gene pairs found to be under positive selection (genes under positive 
selection) 
2) Known virulence genes obtained from data mining of MVirDB and VFDB (database 
identified virulence genes) 
3) All the protein coding genes within a bacterial genome (background / genomic gene list). 
        Each gene list type comprises of the original, unique bacterial gene accessions submitted by 
their respective sequencing groups. Great care was taken to ensure bacterial genes run through 
the positive selection detection pipeline maintained their unique bacterial gene accessions 
submitted by the sequencing groups for unambiguous gene identification. Maintaining the 
original bacterial gene accessions facilitates data-mining due to the universal usage of these 
accessions by mostly all databases and enables accession parsing to obtain representative gene 
counts of the different gene lists for use in ensuing statistical analyses.   
Bacterial Gene Features  
        Gene lengths and %GC content were obtained for genes under positive selection, database 
identified virulence genes and genomic genes to determine if differences between distributions 
in %GC content and gene length exist. The three different types of bacterial gene accession lists 
were used as input into the pickseq.pl∗ PERL programme to extract the relevant nucleotide 
sequences for each gene list type for H. pylori, N. meningitidis and V. cholerae. 
        The length of genes and %GC content of the nucleotide sequences extracted for bacterial 
genes under positive selection, database identified virulence genes and genomic genes belonging 
to H. pylori, N. meningitidis and V. cholerae were obtained using EMBOSS’s InfoSeq utility 98. 
InfoSeq was run on each of the three nucleotide sequence files for each bacterial organism 
resulting in a list of accessions with gene lengths and %GC content. The different gene list types 
were imported as text files into the R statistical environment where plots of the distributions of 
gene lengths and %GC content were created and statistical testing of the distributions between 
the different gene list types were performed 108. In the case of the genomic gene lists, tRNA and 
rRNA features of gene length and %GC content were excluded so as not to bias the background 
distribution towards shorter gene lengths and varying %GC content.  
                                                
∗
 http://dendrome.ucdavis.edu/resources/scripts/ 
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Gene Ontology Annotation of Bacterial Gene Lists 
        Functional annotation using Gene Ontology (GO) for genes under positive selection and 
database identified virulence genes were performed using the Database of Annotation, 
Visualisation and Integrated Discovery (DAVID, Version 6) 109-111. DAVID is an integrative 
resource that provides amongst other annotations, GO mappings for genes belonging to different 
eukaryotic and prokaryotic organisms 111. DAVID also executes a statistical enrichment analysis 
of GO terms mapped to an uploaded gene list with respect to the background distributions of GO 
terms mapped to the whole genome for the organism under study 111. The goal was to determine 
what functional gene classes and biological processes are over-represented in the positively 
selected and database identified virulence gene lists with respect to their genomic GO 
distributions. GO annotations consist of three categories; biological process, cellular component 
and molecular function, each comprising of a five-tiered hierarchy with broad biological terms 
placed on top of the hierarchy and more specific biological terms placed at the bottom of the 
hierarchy 109-111.  
        Genes under positive selection and database identified virulence gene lists for H. pylori, N. 
meningitidis and V. cholerae were uploaded to DAVID’s gene list manager to obtain 
functionally enriched GO terms with respect to each bacterial organism. To maintain 
consistency across all comparisons, gene list annotation and functional enrichment of GO terms 
for all gene lists was conducted at the 4th level of the GO hierarchy with an EASE score of 0.5 
using DAVID 109-111. The 4th level of the GO hierarchy was chosen for all gene list GO 
annotation and functional enrichment analyses after evaluation of GO annotations at all five 
different levels in an effort to maximise gene list coverage and obtain GO terms that are not too 
broad in their description as to be uninformative 109-111. Four types of GO term functional 
enrichment comparisons were conducted: 
 
1) Functional enrichment of GO terms for genes under positive selection with respect to the 
micro-organism’s genomic GO distribution. 
2) Functional enrichment of GO terms for database identified genes with respect to the 
micro-organism’s genomic GO distribution. 
3) Functional enrichment of GO terms for genes under positive selection with respect to 
database identified virulence genes for each micro-organism. 
4) Manual comparison of GO terms between database identified virulence genes and genes 
under positive selection as DAVID does not allow cross-species GO term comparisons. 
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Clusters of Orthologous Proteins Functional Annotation 
        Clusters of orthologous proteins (COGs) was devised to facilitate rapid annotation and 
characterisation of newly sequenced genomes using functional annotations transferred by 
orthology of genes 102,112. COGs comprises of twenty-five alphabetical codes, each one 
describing a particular high-level biological process 102,112. COG annotations for the genome, 
genes under positive selection and database identified virulence genes for H. pylori, N. 
meningitidis and V. cholerae were obtained from their respective annotation files from NCBI’s 
ftp repository. The rationale was to determine if there are any biological processes common 
between genes under positive selection and database identified virulence genes and if these 
biological processes differ significantly from the genomic distribution of COG biological 
processes.  
        COG annotations for genes under positive selection, database identified virulence genes 
and genomic genes were parsed from their respective bacterial annotation files using a PERL 
script (COG_parser.pl-Appendix A3A) based on accession matching and sorted according to 
their alphabetical codes. Counts of genes for each gene list type belonging to each alphabetical 
COG category were obtained within MS Excel for further statistical analysis.  
Sub-Cellular Localisation Determination 
        Sub-cellular localization of protein products for genes under positive selection, database 
identified virulence genes and genomic genes were obtained from the cPSORTb database 
(version 2.0) 113-116. The cPSORTb database contains predictions for sub-cellular locations of 
protein products computed by six independent bioinformatics modules, each analysing a specific 
biological feature of an amino acid sequence for various signatures 113-116. Each analytical 
module produces a score for a protein belonging to a certain sub-cellular site which is 
incorporated into a Bayesian probabilistic framework to produce a final score as to the 
likelihood that a protein localises to a particular sub-cellular site 113-116. The aggregate scoring 
scheme ranges from 1 to 10 with a score of 7.5 indicative of very good evidence for the 
predicted sub-cellular localization site 113-116. Depending on the type of bacterial gram stain, 
there are between five to six sub-cellular localization categories 113-116. Sub-cellular localisation 
categories for gram negative bacteria like H. pylori, N. meningitidis and V. cholerae are 
Cytoplasmic, Cytoplasmic Membrane, Periplasmic, Outer Membrane, Extra Cellular and 
Unknown 113-116.  
        The cPSORTdb was accessed via the select organism page and display options set to 
contain bacterial gene accessions, predicted sub-cellular localization and the PSORT sub-
cellular localization score fields for genomic genes belonging to H. pylori, N. meningitidis and 
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V. cholerae. A tab-delimited file of the following results was downloaded and a PERL parser 
was written (PSORT_parser.pl-Appendix A3B) which parses gene list accessions against gene 
accessions contained within the downloaded PSORT files of the respective bacterial organisms. 
The results are files containing PSORT scores and sub-cellular localizations for genes under 
positive selection and database identified virulence genes, both being a subset of the original 
genome wide PSORT annotation file. UNIX “grep” commands were used to obtain counts for 
genes belonging to each of the PSORT predicted sub-cellular categories for each gene list type 
for use in statistical analyses.   
Bacterial Metabolic Pathways 
        H. pylori, N. meningitidis and V. cholerae accessions for genes under positive selection and 
database identified virulence genes were used to mine organism specific BioCyc databases (H. 
pylori and V. cholerae Database Version 13.5, N. meningitidis Database Version 13.1) 117,118. 
The BioCyc database version for N. meningitidis differs from H. pylori and V. cholerae as the 
former is classified a Tier 3 database that has not undergone any form of curation while the latter 
two are Tier 2 databases whose contents have undergone some curation 117,118. The Pathway 
Tools Omics browser was used to upload gene lists accessions and tabular results of BioCyc 
metabolic pathways for H. pylori, N. meningitidis and V. cholerae gene lists were obtained by 
selecting a pathway interaction threshold of 1 to provide as broad a coverage of gene lists as 
possible 117-119. All metabolic pathways for H. pylori, N. meningitidis and V. cholerae gene lists 
in tabular format were downloaded and individual pathways of interest for each bacterial 
organism were further investigated by following BioCyc’s hyperlinks to pathway information 
pages 117-119.  
        Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways for H. pylori, N. 
meningitidis and V. cholerae genes under positive selection and database identified virulence 
genes were obtained by uploading respective gene list accessions to DAVID’s gene list manager 
and selecting KEGG pathway annotations 111,120,121. DAVID was chosen for KEGG pathway 
annotation of bacterial gene lists due to its ability to provide pathway annotations for whole gene 
lists, statistical calculation of gene enrichment for a KEGG pathway and the option of using a 
foreground gene list to query a another gene list set as the background to obtain shared KEGG 
pathways between gene lists types. Parameters selected for individual gene list KEGG 
annotations were a pathway threshold of 1 and an EASE score of 0.5 to maintain consistency 
when comparing results across bacterial species. When using genes under positive selection as a 
foreground list and database identified virulence genes as a background gene list to determine 
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KEGG pathways shared by both gene list types, an EASE score of 1 was selected to increase 
KEGG pathway annotation coverage by DAVID. 
Statistical Analyses and Graphics 
        All statistical analyses and summaries of datasets was conducted using the R statistical 
package (version 2.8.0) 108. As most of the datasets involve gene counts and are therefore 
categorical (nominal / ordinal) data, non-parametric Chi-Square tests with Yate’s continuity 
correction was mainly used for statistical testing 122.  
        Two types of Chi-Square tests were conducted, a one-way classification Chi-Square test to 
determine if any functional annotation categories have a statistically significant association at 
the P = 0.05 mark for either genes under positive selection or database identified virulence genes 
(Appendix A4) 122. The second type of Chi-Square test was a two-way classification to 
determine if genes under positive selection and database identified virulence genes have a 
statistically significant association at the P = 0.05 level for a particular functional annotation 
category (Appendix A4) 122. R functions were written to conduct both types of Chi-Square tests 
and where gene counts for a particular category were below 5, a Fisher’s Exact test was used 
(Appendix A4) 122. In the case of comparing gene lengths and %GC content distributions, non-
parametric Kolmogorov-Smirnov tests were conducted within R.  
        All results from statistical testing were corrected for multiple hypothesis testing using the 
Holm’s method as implemented within R 108,122. Statistical enrichment analysis of GO terms and 
KEGG pathways for gene lists was done by DAVID which uses a Fisher’s Exact test and utilises 
a variety of methods like Bonferroni to correct for multiple hypothesis testing 111. 
        Graphs and images were plotted using R’s graphical capabilities and the Lattice Package in 
R 108,123. Bacterial chromosomal wheels were constructed using the Microbial Genome Viewer 
online application 124. Cellular overviews of metabolic pathways for H. pylori, N. meningitidis 
and V. cholerae gene lists were generated using the Pathway Tools and Omics platform which is 
part of the BioCyc collection of tools 117,119. KEGG pathway maps containing genes from 
bacterial gene lists were obtained from DAVID 111,125. 
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Chapter 3 : Characterisation of Positive Selection and 
Bacterial Virulence Genes  
Introduction 
        The following chapter provides results and discussions for a variety of analyses conducted 
to obtain gene counts for orthologous gene pairs, genes under positive selection and database 
identified virulence genes for H. pylori, N. meningitidis and V. cholerae. The number of 
orthologous gene pairs indentified for H. pylori, N. meningitidis and V. cholerae are examined in 
relation to gene content of the different bacterial species. Counts of genes under positive 
selection after manual curation of orthologous sequence alignments, as well as an appraisal of 
how robust the results for genes under positive selection are by continuing to reject the null 
hypothesis at differing P value thresholds is explored. A review of published literature was 
undertaken to determine what factors may contribute towards nucleotide diversity within H. 
pylori, N. meningitidis and V. cholerae in order to understand differences in gene numbers 
observed to be under positive selection within each of the bacterial species. Recombination and 
its potential effects upon the results of a positive selection assay in general and with regards to 
the positive selection results obtained in this study is discussed. 
        Details of virulence gene data mining and gene counts obtained from each virulence 
database together with results of statistical tests to evaluate if database identified virulence genes 
are enriched for genes under positive selection is presented. The possibility of a database bias 
caused by differing numbers of virulence gene records contained within each virulence database 
and the effect it may have upon the statistical results when testing for an association between 
databases identified virulence genes and genes under positive selection is investigated.  
        Physical properties of genes under positive selection and database identified virulence 
genes were inspected to establish whether these gene lists follow similar distributions with 
respect to each other and the genome. The physical properties H. pylori, N. meningitidis and V. 
cholerae gene lists appraised are gene lengths and %GC content. Differences in distributions of 
physical properties for each gene list type were tested for within each individual bacterial 
organism and cross species comparisons of their distribution characteristics were conducted.   
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Identification of Bacterial Orthologous Genes 
        Putative orthologous genes between H. pylori (strains 26695 and J99), N. meningitidis 
(strains Z2491 and MC58) and V. cholerae (strains N16961 and O395) were identified by the 
reciprocal best hit (RBH) BLASTP method 101,102,126. If the top BLASTP hit of a gene in genome 
A is the top BLASTP hit in genome B and vice versa, putative orthology between gene pairs 
was inferred 101,126,127. The RBH BLASTP method enables one to one orthology between gene 
sets from bacterial strains to be established as opposed to one to many homologous relationships 
that arise by conducting a one way BLASTP search 101,126,128. Counts of putative orthologues 
identified by the RBH BLASTP are summarized below in Table 3.1. 
Bacterial 
Species Bacterial Strain 
No of Genes in 
Genome 
No of Putative 
Orthologues 
26695 1630 
H. pylori 
J99 1535 
1382 
MC58 2225 
N. meningitidis 
Z2491 2208 
1707 
N16961 4008 
V. cholerae 
O395 3998 
3431 
Table 3.1 : Number of genes annotated within each bacterial genome and the number of putative 
orthologues identified by RBH BLASTP searches.  
 
        The number of orthologous gene pairs identified mirrors the bacterial gene content of the 
bacterial organisms (Table 3.1). For instance, the difference between orthologous gene counts 
for H. pylori and V. cholerae is 2,049 genes, similar to the difference of 2,378 genes between H. 
pylori 26695 and V. cholerae N16961 (Table 3.1). Similarly, N. meningitidis and V. cholerae 
orthologous gene counts differ by 1,724 genes, comparable to the gene content difference of 
1,783 genes between N. meningitidis MC58 and V. cholerae N16961 (Table 3.1). Differences in 
gene content between the three bacterial species (Table 3.1) may possibly reflect the various 
lifestyles adopted by those bacterial species. Host dependent, obligate pathogens such as H. 
pylori are known to have smaller gene contents compared to free living, environmental bacterial 
organisms, like V. cholerae 13,38,39. 
        Intra-species differences in gene content may arise from gene duplications, expansions, 
decay or inactivation as well as an element of error introduced by gene finding algorithms and 
the constant refinement of genome annotations for each of the bacterial strains 36,129,130. 
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Orthologous Bacterial Genes subject to Positive Selection 
        In-frame, codon aligned orthologous gene pairs for H. pylori, N. meningitidis and V. 
cholerae were assayed for positive selection using CODEML from the PAML package 58,106. 
CODEML utilises a rigorous statistical framework derived from Maximum Likelihood theory 
and codon based models of evolution 58,66. Maximum Likelihood methods simultaneously 
calculate likelihoods for the occurrence of neutral evolution and positive selection based on 
explicit codon substitution models that are parameterised from the underlying, input sequence 
data 58,61,65,66. Codon based models of evolution whose parameters are derived from the 
underlying data have increased power for detecting positive selection as the dN / dS ratio is not 
calculated as an average over the length of a sequence alignment 58,61,63. Greater power by 
Maximum Likelihood methods is achieved by enabling ω (ratio of dN/dS) to vary amongst sites 
(codons) as opposed to the entire length of a sequence alignment 58,61,65,106. The null hypothesis, 
(M1a) fixes ω to 1 while the positive selection model, (M2a) estimates ω as a free parameter 
from the underlying data 58,61,65,106. Results from the two models, (M1a and M2a), are subjected 
to a likelihood ratio test (LRT) and compared to a Chi-Square distribution, enabling either 
rejection the positive selection hypothesis in favour of the null hypothesis of no selection or vice 
versa 58,61,65,106. Maximum Likelihood methods have been meticulously tested using simulated 
and real data and found to be consistent in their output, leading to their widespread use in many 
positive selection analyses 15,18,131,132. However, like most computational methods, results of 
positive selection assays are only as good as the quality of the aligned input sequences. 
        Orthologous gene pair alignments initially found to be under positive selection for H. 
pylori, N. meningitidis and V. cholerae were manually curated to ensure the fidelity of the 
positively selected gene datasets by removal of false positives which may introduce an element 
of error upon further analyses. Manual curation of orthologous alignments was conducted by 
examining nucleotide alignments for gaps of 1, 2, 4 and 5 basepairs (bp) 18. The position of the 
gaps was recorded and cross checked against their counter-part amino acid alignments to 
determine if a shift in reading frame has occurred from the start of a gap 18. An example of an 
orthologous gene pair found to be under positive selection due to a gap in the nucleotide 
alignment resulting in a frameshift translation of the amino acid sequence is presented overleaf 
in Figures 3.1 and 3.2.  
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Figure 3.1 : A single gap in the BLASTN nucleotide alignment of H. pylori J99 jhp0189 against 
the genome of H. pylori 26695. A 1 bp gap at nucleotide position 237 was recorded and cross 
checked with its counterpart amino acid alignment (Figure 3.2). 
Figure 3.2 : Examination of the counterpart ClustalW amino acid alignment within BioEdit 
indicates a change of amino acid consensus alignment at position 79 corresponding to a shift of 
the translational reading frame from nucleotide position 237 (237/3 = 79th amino acid).  
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The number of orthologous gene pairs found to be under positive selection before and after 
manual curation are summarised below in Table 3.2. A full list of orthologous genes pairs found 
to be under positive selection after manual curation for H. pylori, N. meningitidis and V. 
cholerae with their annotations obtained from their submitted GenBank annotation files can be 
found in Appendix B1. 
No of Orthologous gene pairs under 
Positive Selection Bacterial 
Species Bacterial Strain 
No of Putative 
Orthologues Before Manual 
Curation 
After Manual 
Curation 
26695 
H. pylori 
J99 
1382 311 230 
MC58 
N. meningitidis 
Z2491 
1707 259 218 
N16961 
V. cholerae 
O395 
3431 79 23 
Table 3.2 : Orthologous gene pair numbers found to be under positive selection following a 
LRT test using a Chi-Square critical value of P = 0.05 before and after manual curation of 
alignment datasets for H. pylori, N. meningitidis and V. cholerae.  
 
        A characteristic reduction in gene numbers is observed from the number of orthologous 
gene pairs identified, to the number of genes under positive selection after manual curation 
(Table 3.2).  The manual curation approach employed is an in silico method and as such, is 
conservative. Changes in reading frames caused by single base pair insertions or deletions 
within a gene in respect to its orthologous counterpart may be a bona fide biological events that 
has occurred within the lineage of one of the bacterial strains. The only way to be absolutely 
certain that single base pair insertions or deletions are artefactual or bona fide biological 
occurrences is to re-sequence the genetic loci in question (Figures 3.1 and 3.2, page 36) 82,129.  
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Robustness of Positive Selection Results  
        LRT scores of genes under positive selection after manual curation (Table 3.2, page 37) 
were parsed under increasingly stringent P values to determine how many positively selected 
genes continue to reject the null hypothesis of no selection. The number of orthologous gene 
pairs found to be under selection at varying P-values is presented below in Figure 3.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 : Gene counts of orthologous alignments found to reject the null hypothesis of no 
selection under increasingly stringent P-values for H. pylori, N. meningitidis and V. cholerae. 
 
        The number of orthologous gene pairs which continue to reject the null hypothesis of no 
selection decreases with increasingly stringent P-value thresholds (Figure 3.3). The ability of an 
orthologous gene pair to reject the null hypothesis of no selection at increasingly stringent P 
values is not a reflection of the strength of selective pressure occurring on that particular gene. 
Instead, orthologous gene pairs found to be under positive selection at increasingly stringent P 
values are indicative of how closely differences between an orthologous gene sequence pair 
follows a particular model distribution, thereby making the alternative hypothesis harder to 
reject. As the accepted standard for reporting statistical significance in biomedical literature is 
placed at the P = 0.05 level, orthologous gene pairs that equal to or surpass the P = 0.05 
threshold after manual curation were retained for subsequent analysis 122,133.  
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Differences in Positive Selection Gene Numbers between Bacterial 
Species 
        The number of genes under positive selection appears to follow an inverse trend in 
comparison to gene content and number of orthologues identified within H. pylori, N. 
meningitidis and V. cholerae (Table 3.2, page 37). H. pylori has the least number of genes and 
orthologues identified, yet has more genes under positive selection in comparison to N. 
meningitidis and V. cholerae (Table 3.2 page 37). If all forces driving genome diversification for 
H. pylori, N. meningitidis and V. cholerae were equal, one would expect the number of genes 
under positive selection to increase with gene content and genome size, as observed with the 
number of orthologous gene pairs identified (Table 3.1, page 34).  
        The proportionally large number of genes under positive selection suggests high levels of 
nucleotide diversity between H. pylori and N. meningitidis strains, in comparison to V. cholerae 
strains (Table 3.2, page 37). To determine why an inverse relationship between genome size and 
genes under positive selection is observed for H. pylori, N. meningitidis and V. cholerae, factors 
contributing to nucleotide diversity within the bacterial species are examined in detail.  
H. pylori Nucleotide Diversity 
 
        The high level of nucleotide diversity observed between the two H. pylori strains is 
attributable to a high mutation rate and frequent recombination 134-141. H. pylori is described as a 
panmictic species, whose frequency of recombination events exceeds those of other bacterial 
species such N. meningitidis or E. coli 136,140,142. High allelic diversity generated by 
recombination events in H. pylori suggests colonization of a host occurs by mixed populations 
of H. pylori strains 78,137,139,140. Paradoxically, clonal lineages of H. pylori exhibiting little 
variation in genome diversity have been observed over durations as great as nine years within 
individuals 78,139,143,144. Clonal population structures of H. pylori are also observed in different 
ethnic groups partitioned geographically, as well as within related family units 145,146. These 
observations imply that although recombination events are frequent in H. pylori, they operate 
over extended evolutionary timescales and require an initial infection by a mixed population of 
H. pylori strains 137,139,146.  
        Although recombination is a major driver of genome diversity in H. pylori, it does not 
adequately explain the large proportion of genes under positive selection within H. pylori for a 
number of reasons. Firstly, recombination between H. pylori strains would require a multiple 
strains of H. pylori to be present 78,136,137,139,140,146. H. pylori 26695 and H. pylori J99 were 
isolated from different patients at different geographical regions with little information to 
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suggest a mixed or single strain H. pylori infection, and therefore any possible contact or 
recombination occurring between H. pylori 26695 and J99 strains within those two patients 14,77. 
Secondly, analysis of core genes show H. pylori 26695 and J99 can be partitioned into separate 
geographical population groups, the former strain placed in an hpEurope group (common to 
Europe) and the latter strain into an hpAfrica1 group (common to Africa) 75,84. Thirdly, chronic 
H. pylori infections resolve to form a single, stable clonal population over time after an initial 
mixed strain infection 137,139,143,146. Fourthly, H. pylori strain 26695 and J99 would have been 
clonal in nature as they were repeatedly sub-cultured before being sequenced 14,77.         
        The frequency of mutations undergone in H. pylori is much greater in comparison to other 
bacterial species such as E. coli 78,135,136,141. The high mutational rate observed within H. pylori 
is attributed to an absence of defined homologues for well characterised DNA repair pathways 
such as base excision repair (BER) or the mismatch repair (MMR) systems 78,141. Higher 
mutational rates within H. pylori compared to certain E. coli mutator strains has led to growing 
speculation H. pylori implements de novo mutational tactics as an adaptable response to 
changing environments 53,78,135,141. Though the majority of mutations that occur in H. pylori are 
synonymous substitutions, H. pylori does have a higher rate of divergence at non-synonymous 
sites when compared to other bacterial species like E. coli 14,83,140,141. Another contributing factor 
towards the large nucleotide diversity observed within H. pylori is a lack of any known genetic 
bottlenecks as there is no known, naturally occurring reservoir for H. pylori 39,78,139,141,147,148. The 
vertical mode of H. pylori transmission would produce a reduced effective population size 
whose fitness is not governed by their ability to scavenge nutrients within a free-living 
environment, therefore decreasing the intensity and efficacy of purifying selection to expunge 
mutations 39,78,139,141,147,149. Hence, H. pylori’s vertical mode of transmission from family 
members to offspring may result in a possible absence of purifying selection 139,145,146.  
        Interestingly, variability between H. pylori strains that colonize different compartments of 
the stomach has been observed 14,77,134,139,146,147.  As H. pylori J99 and 26695 were isolated from 
different patients displaying different pathologies, it is conceivable the two H. pylori strains 
under study have undergone adaptations to facilitate colonization of their respective gastric 
niches 14,77,134,139,146,147. The high adaptability and plasticity of H. pylori’s genome, coupled with 
its sometimes clonal population structure as indicated by chronic infections in differing gastric 
compartments indicates the proportionally large number of genes under positive selection 
between H. pylori 26695 and J99 is to be expected.  
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N. meningitidis Nucleotide Diversity 
 
        Similar to H. pylori, N. meningitidis genome fluidity is generated by a mixture of 
recombination and mutation which needs to be counter-balanced by genome stabilizing 
mechanisms, to ensure survival and prevent de-speciation 96,150-153. N. meningitidis posses DNA 
repair pathways, although the complexity and efficacy of these DNA repair pathways are much 
reduced in comparison to E. coli with genes like mutS and mutL undergoing repeated mutational 
and recombinational deterioration 96,151,153.  
        Neisserial species are characterised as naturally competent throughout their life-cycle with 
homologous recombination occurring by exogenous DNA recognition of a ten basepair DNA 
uptake sequence (DUS, (5’-GCCGTCTGAA-3’)), transportation / uptake of the exogenous 
DNA via the type IV pilus apparatus and RecA mediated recombination 96,154-156. While intra-
species recombination is frequent, transformation studies show gene flow between neisserial and 
non-genus related bacterial species is rare, with so far a single recorded event 87,96,153,157,158. 
Recombination is usually regarded as a source for generating genetic diversity, a less well 
reported aspect is recombination’s homogenizing effect on microbial populations like N. 
meningitidis 96,153,159. Neisserial DUSs are concentrated in loci responsible for DNA fidelity such 
mis-match repair genes, leading to a growing hypothesis that recombination events within N. 
meningitidis are mainly involved with genome repair and stability through their homogenizing 
effect 96,153,154,160. Promotion of genome stability by DUSs opposed to genome diversification 
caused by their recombinational effect, has recently been verified with lower densities of DUSs 
found within regions of N. meningitidis’s dispensable genome opposed to its core genome, thus 
preserving genome homogeneity 160.  
        Although N. meningitidis is a naturally competent bacterium with high rates of 
recombination, most disease causing strains termed as “hyper-invasive” are clonal as determined 
by multi-locus sequence typing (MLST) 96,150-153. Many of these hyper-invasive meningococcal 
strains are robust over time and geographical ranges with their clonal structure intact, indicating 
they are immune to diversification caused by recombination 90,96,153,161. Reduced efficacy of 
DNA fidelity maintaining pathways within neisserial species may provide a mechanism whereby 
numerous, genotypic variants are produced, with the most successful variants resulting in host 
colonization 90,96,153,161. Consistent with this hypothesis are the small regulatory networks found 
in N. meningitidis suggesting that meningococcal adaptation is punctuated by mutational and not 
regulated responses96,153.  
        In addition to an elevated global mutational rate, mutational hotspots within N. 
meningitidis’ genome that drive variability exist 90,96,97,153. Localised hypermutational rates are 
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caused by short repeat sequences such as micro-satellites which are prevalent within the N. 
meningitidis genome, resulting in a phenomenon known as phase variation 90,96,97,153. Phase 
variation is an altered state of gene expression at the transcriptional and / or translational level 
causing either “on” or “off” gene expression and is caused by tandem repeat sequence expansion 
/ contraction within a gene’s promoter region or coding sequence 90,96,153. The expansion / 
contraction of repeat sequences within N. meningitidis is largely caused by slipped strand 
mispairing, which on the synthesis DNA strand results in expansions while deletions occur by 
mispairing on the DNA template strand during DNA replication and repair of these repeat 
sequences 90,96,153. Hypermutable loci which result in phase variation modulate expression of 
outer membrane proteins, adhesions and pilli and are dubbed as “contingency loci” 96,153,162. An 
advantage of these hypermutable loci is the creation of numerous, phenotypic variants allowing 
for selection of advantageous phenotypes in varying environments and enhanced transmissibility 
as many hyper-invasive meningococcal strains have elevated rates of phase variation 90,96,153,161.  
V. cholerae Nucleotide Diversity 
 
        Vibrio choleare strains O395 and N16961 are closely related and belong to the same O1 
serogroup, the former strain is categorized as a classical biotype, while the latter strain is 
classified as an El Tor biotype 91,93,94,163. Both the N16961 and O395 V. cholerae genomes 
display remarkable conservation in terms of gene content differing by approximately 1% 
(between 36 and 77 genes), although this number is likely to be higher due to the asymmetric 
usage of N16961 micro-arrays 17,163. In terms of genome stability, from 126 bacterial genomes 
surveyed, V. cholerae ranks 26th where as N. meningitidis ranks 121st (H. pylori not included in 
the study), indicating V. cholerae gene content and order is highly conserved 164. DNA repair, 
replication and fidelity mechanisms within V. cholerae are intact with well defined homologues 
present which may contribute to a low level of nucleotide diversity 28.  
        The small number of genes found to be under positive selection within V. cholerae is 
consistent with comparative nucleotide sequence analysis of the mdh housekeeping gene locus 
within 23 strains belonging to the O1 serotype, including N16961 and O395, whereby only nine 
polymorphic sites were identified, eight being synonymous substitutions 93. A comparative 
genomics study of V. cholerae N16961 and O395 also supports the low level of nucleotide 
diversity observed by identifying a total of 45 polymorphic sites between the lineages leading to 
N16961 and O395, and a further 519 occurring along the branches leading to V. cholerae O395 
and N16961 91. Both sets of authors suggest sequence conservation amongst sites between O1 V. 
cholerae biotypes implies a recent evolutionary divergence for N16961 and O395 strains, with 
Feng et al dating the time of divergence between these two biotypes at approximately 1880 91,93.    
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        As both V. cholerae N16961 and O395 strains occupy similar environmental niches and 
geographical locations, the recent time of divergence would suggest insufficient time and 
separation between the two strains has not occurred for an accumulation of adaptive mutations to 
be fixed. Additionally, the episodic waves of cholera pandemics suggest that in between such 
pandemics, V. cholerae residing within its natural aquatic reservoir would be subject to strong 
purifying selection in order to expunge any mutations arising during the founder flush period 93. 
Hence, the recent time of divergence, intact DNA repair and replication mechanisms and strong 
purifying selection within their aquatic environments may all contribute to the small number of 
genes observed to be under positive selection between V. cholerae N16961 and O395. 
Recombination and Positive Selection 
        In terms of phylogenetic studies and assaying for positive selection, recombination between 
organisms may produce erroneous results due to the assumption of vertical transmission of 
genetic material being violated 103,131,165. When assaying for positive selection using gene pairs, 
the effect of recombination is less severe in producing false positives compared to using 
multiple sequences from more then two bacterial strains♦. Within a multiple sequence 
alignment, both phylogenetic tree topology and branch lengths are assumed to be constant along 
the length of the alignment during positive selection analyses 103,131,165. In the presence of 
recombination, both phylogenetic tree topology and branch lengths will differ amongst sites in 
the multiple sequence alignment, thereby providing erroneous results due to different sites 
having different phylogenetic histories 103,131,165.  
        In contrast, pairwise sequence comparisons consist of a single branched phylogenetic tree 
whose topology and branch length remains constant along the sequence alignment and therefore 
is unaffected by recombination events. A disadvantage of using pairwise sequence comparisons 
though is reduced power for detection of positive selection as more sequences from more 
bacterial strains provide more data increasing the power to detect positive selection 58,60,66. 
Efforts were made to conduct a recombination assay for the three bacterial organisms under 
study, but all recombination software require at minimum four to five aligned sequences in order 
to test for recombination breakpoints 103,165. At the time this study was conducted, there were 
only two bacterial strains whose genomes had been sequenced for each of the species and placed 
in the public domain. The pipeline approach utilized in this study can easily be scaled to 
incorporate those new genomes with the addition of a recombinational assay.  
 
                                                
♦
 Personal Communication; Dr. Cathal Seoighe 
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Bacterial Virulence Genes and Positive Selection 
        Bacterial virulence genes for H. pylori, N. meningitidis and V. cholerae were mined from 
the Virulence Factor Database and Microbial Virulence Database (VFDB and MVirDB 
respectively) 19,107. MVirDB and VFDB aim to provide compilations of known bacterial 
virulence genes collated from numerous scattered literature and database sources 19,107. Data 
obtained from MVirDB was curated for sequence redundancy to obtain a list of unambiguous, 
unique virulence genes for H. pylori, N. meningitidis and V. cholerae. VFDB differs from 
MVirDB in that it is highly curated, thereby providing non-redundant lists of virulence genes 
and their accessions 19,107. Lists of virulence genes obtained from MVirDB and VFDB were 
merged and duplicate entries between the two virulence gene lists were removed to prevent 
double counting during statistical and functional analyses. The result is a single list of known 
virulence genes for each of the bacterial organisms under study (Appendix B2). The number of 
unique and common genes obtained from MVirDB and VFDB is presented below in Table 3.3. 
 
Bacterial 
Organism H. pylori N. meningitidis V. cholerae 
Virulence 
Database MVirDB VFDB MVirDB VFDB MVirDB VFDB 
No of Virulence 
Genes 138 87 37 65 33 165 
No of Virulence 
Genes in Common 72 34 29 
No of Database 
Unique Virulence 
Genes 
66 15 3 31 4 136 
No  of Unique 
Virulence Genes 
in Merged Gene 
List 
153 68 169 
Table 3.3: Gene counts of database identified virulence genes after curation for redundancy 
from MVirDB and VFDB. Gene counts include the total number of virulence genes found in 
each database, number of virulence genes common to and unique to each database as well as the 
number of merged, unique virulence genes.  
 
        The number of virulence gene records within MVirDB and VFDB for H. pylori, N. 
meningitidis and V. cholerae differ, VFDB contains more unique virulence genes for V. cholerae 
and N. meningitidis while MVirDB has more unique virulence genes for H. pylori compared to 
VFDB (Table 3.3). Differences in database records between VFDB and MVirDB may occur due 
to differing definitions of the term “virulence factor” and data acquisition methods used to 
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construct both the databases 19,71,107. MVirDB uses a broad data mining strategy based on 
keyword searches of other databases, VFDB utilizes a focalized curation approach based on 
primary literature and categorization of identified virulence genes into classes 19,107. In terms of 
database bias, MVirDB contain more unique virulence genes for H. pylori while VFDB has 
more unique records for N. meningitidis and V. cholerae (Table 3.3, page 44). The intersections 
between positively selected genes and database identified virulence genes from VFDB and 
MVirDB for H. pylori, N. meningitidis and V. cholerae are presented as a series of Venn 
diagrams overleaf in Figure 3.4. 
        To determine if there is a statistically significant enrichment of virulence genes undergoing 
positive selection, one way classification Chi-Square tests were conducted and the results are 
presented below in Table 3.4, the full output of the Chi-Square tests are contained within 
Appendix B3.   
 
Bacterial Species 
No of Genes 
under Positive 
Selection 
No of 
Virulence 
Genes 
No of Virulence 
Genes under 
Positive 
Selection 
P - value 
H. pylori 230 153 22 0.9192 
N. meningitidis 218 68 14 0.005074 
V. cholerae 23 169 1 1 
Table 3.4 : Results of Chi-Square tests conducted to determine if there is a statistically 
significant intersection between database identified virulence genes and genes undergoing 
positive selection within H. pylori, N. meningitidis and V. cholerae.  
 
        For H. pylori and V. cholerae there is no statistically significant enrichment of known 
virulence genes undergoing positive selection at the P = 0.05 mark (Table 3.4). N. meningitidis 
does have a statistically significant association between known virulence genes and genes 
undergoing positive selection at the P = 0.05 threshold (Table 3.4). Genes under positive 
selection, database identified virulence genes and virulence genes under positive selection for H. 
pylori, N. meningitidis and V cholerae have been mapped to the genomes of their respective 
bacterial species and are presented as chromosomal wheels in Figures 3.5, 3.6 and 3.7 on pages 
47, 48 and 49 respectively. 
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Figure 3.4 : Gene counts for the intersections between positively selected genes and unique 
virulence genes mined from MVirDB and VFDB for : A. H. pylori ; B. N. meningitidis ; C. V. 
cholerae.   
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    Key  
                                  Genes under Positive Selection 
                                  Database identified Virulence Genes 
                                  Virulence genes under Positive Selection 
                                  H. pylori 26695 genes on the plus strand 
                                  H. pylori 26695 genes on the minus strand 
                                  % GC content 
 
Figure 3.5 : Chromosomal wheel of H. pylori 26695 genome displaying the location of genes 
under positive selection between H. pylori 26695 and J99, database identified virulence genes, 
virulence genes under positive selection above genes contained on the plus and minus strand and 
their %GC content. 
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Figure 3.6 : Chromosomal wheel depicting the location of genes found to be under positive 
selection between N. meningitidis Z2491 and MC58, database identified virulence genes, 
virulence genes under positive selection, genes on the plus and minus strand as well as %GC 
content for N. meningitidis Z2491’s genome. 
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                                       V. cholerae N16961 genes on the plus strand 
                                       V. cholerae N16961 genes on the minus strand 
                                       % GC content 
 
Figure 3.7 : Chromosomal wheels of V. cholerae N16961 chromosome I and chromosome II 
depicting the genomic location of genes found to be under positive selection between V. 
cholerae N16961 and O395, database identified virulence genes, virulence genes under positive 
selection, genes on the plus and minus strand as well as %GC content.                                                                               
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N16961 
Chromosome  
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Influence of Databases on Virulence Genes Under Positive Selection 
        Both MvirDB and VFDB contain gene records of different virulence genes for H. pylori, N. 
meningitidis and V. cholerae (Table 3.3, page 44; Figure 3.4 page 46). To investigate if the 
differing virulence gene numbers mined from MVirDB and VFDB may possibly skew the P-
values when testing for an enrichment of virulence genes undergoing positive selection (Table 
3.4, page 45), the number of virulence genes identified from each database and the overlap 
between genes under positive selection was tested individually. Results of one-way 
classification Chi-Square tests to determine if virulence gene records within either MVirDB or 
VFDB individually may have a statistically significant intersection with genes under positive 
selection within H. pylori, N. meningitidis and V. cholerae are presented below in Table 3.5. 
Bacterial Organism  
H. pylori N. meningitidis V. cholerae 
No of Genes under 
Positive Selection 
230 218 23 
Virulence Gene 
Database MVirDB VFDB MVirDB VFDB MVirDB VFDB 
No of Virulence 
Genes 
138 87 37 68 33 165 
No of Virulence 
Genes under 
Positive Selection 
19 13 12 14 1 1 
P - value 0.7685 0.8858 0.0001258 0.005074 0.4735 0.6367 
 Table 3.5 : One-way classification Chi-Square tests were conducted to determine if either 
MVirDB or VFDB identified virulence genes are statistically enriched for genes undergoing 
positive selection. Full output of the Chi-Square test results are contained in Appendix B3. 
 
        For H. pylori and V. cholerae, neither VFDB nor MVirDB database identified virulence 
genes are statistically enriched for genes undergoing positive selection at the P = 0.05 threshold 
(Table 3.5). There is no database bias in terms of a skewed P value for H. pylori and V. cholerae 
with regards to the number of virulence gene records present within MVirDB or VFDB and their 
association with genes under positive selection as their P values are similar (Table 3.5). The P 
value for the one-way classification Chi-Square test for genes under positive selection and 
virulence genes for N. meningitidis is much smaller for MVirDB compared to VFDB (Table 
3.5). It is possible the larger identified virulence gene dataset from VFDB could result in a 
slightly higher overall P value when testing for a significant overlap between VFDB and 
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MVirDB virulence genes and genes undergoing positive selection within N. meningitidis (Table 
3.4 page 45). The skewing of the P value caused by VFDB is supported by the overall P value 
for the intersection between the merged virulence gene list and genes under positive selection 
within N. meningitidis (P = 0.005074; Table 3.4 page 45) being the same as the P value obtained 
when testing between VFDB and genes under positive selection in N. meningitidis (P = 
0.005074; Table 3.5, page 50 ), compared to the P value obtained when testing between 
MVirDB and N. meningitidis genes under positive selection (P = 0.0001258; Table 3.5, page 
50). 
Positive Selection and Virulence Gene Features 
        Apart from N. meningitidis, database identified virulence genes for H. pylori and V. 
cholerae do not display a statistically significant enrichment for genes under positive selection. 
As there is no significant association between genes under positive selection and database 
identified virulence genes, are there other features that these gene sets may or may not share? To 
investigate any commonalities or differences between genes under positive selection and 
database identified virulence genes, traits such as gene lengths and Guanine-Cytosine percentage 
content (%GC content) of the two gene type subsets were examined in detail, and compared to 
the overall genome gene length and %GC content distributions.   
        Gene lengths in basepairs and %GC content of genes under positive selection, database 
identified virulence genes and all genes contained within the genome (excluding tRNAs and 
rRNAs) for H. pylori, N. meningitidis and V. cholerae were obtained using EMBOSS’s InfoSeq 
utility 98. An example of an outputted EMBOSS InfoSeq file is presented below in Figure 3.8. 
 
Name Accession Type Length %GC 
HP0022 - N 1566 39.97 
HP0033 - N 2226 39.44 
HP0037 - N 1056 38.16 
HP0038 - N 738 39.97 
HP0048 - N 2310 41.77 
HP0052 - N 993 34.74 
HP0056 - N 3558 40.84 
HP0060 - N 2442 39.03 
HP0062 - N 261 39.46 
HP0063 - N 1491 38.83 
HP0065 - N 354 35.59 
HP0066 - N 2496 40.06 
HP0069 - N 765 40.92 
 
Figure 3.8: Example of an output list from EMBOSS’s InfoSeq utility containing bacterial gene 
features for genes under positive selection in H. pylori 26695. The name column contains 
bacterial gene accessions used through out this study. The type field indicates sequence type 
(nucleotide in this instance), the length field is the gene length in basepairs and the %GC column 
the %GC content calculated over the length of a gene. 
 
 
 
 
 52 
        The workflow used to obtain gene lengths and %GC content for all gene list types for H. 
pylori, N. meningitidis and V. cholerae is presented below in Figure 3.9. 
 
                        Bacterial Gene Features Analyses Workflow 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 : Workflow schema employed in order to obtain the gene lengths of nucleotide 
sequences and %GC content for each of the genes under positive selection, database identified 
virulence genes and  genomic genes for H. pylori, N. meningitidis and V. cholerae to statistically 
test the distributions of genes belonging to each of the three gene list types with respect to each 
other. 
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Comparisons of Gene Length Distributions 
        Distributions of the three gene list types (genes under positive selection, database identified 
virulence genes and genomic genes) for H. pylori, N. meningitidis and V. cholerae are presented 
as series of histograms below and overleaf in Figures 3.10, 3.11 and 3.12. Descriptive statistics 
of gene length datasets for genes under positive selection, database identified virulence genes 
and genome genes belonging to H. pylori, N. meningitidis and V. cholerae are presented in 
Appendix B4, Table B4A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 : Histograms providing distributions, mean and median of gene lengths obtained for 
all genes in the genome (Yellow), genes under positive selection (Green) and database identified 
virulence genes (Red) for H. pylori.  
Mean = 958.8 bp 
Median = 807 bp 
Mean = 1289 bp 
Median = 1113 bp 
Mean = 1190 bp 
Median = 942 bp 
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Figure 3.11 : Distributions, mean and median gene lengths for N. meningitidis genes in the 
genome (Yellow), genes under positive selection (Green) and database identified virulence 
genes (Red).  
Mean = 1280 bp 
Median = 1026 bp 
Mean = 1281 bp 
Median = 1038 bp 
Mean = 857.8 bp 
Median = 717 bp 
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Figure 3.12 : Histograms providing the distribution, mean and median gene lengths for all genes 
present V. cholerae chromosome I and II (Yellow), genes under positive selection (Green) and 
database identified virulence genes (Red). 
Mean = 1230 bp 
Median = 957 bp 
Mean = 1871 bp 
Median = 1230 bp 
Mean = 922 bp 
Median = 783 bp 
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        The distributions of gene lengths between genomic genes, genes under positive selection 
and database identified virulence genes for H. pylori, N. meningitidis and V. cholerae does not 
follow a normal distribution (Figures 3.10, 3.11, and 3.12; pages 53, 54, and 55 respectively). To 
test if the distributions of gene lengths significantly differ between genes under positive 
selection, database identified virulence genes and genomic genes, non-parametric Kolmogorov-
Smirnov tests were conducted and P-values were adjusted using the Holm’s method to correct 
for multiple hypotheses testing as implemented within R 108.  
Bacterial Organism Gene Lists Tested P – Value Adjusted P – Value 
Positive Selection 
vs 
Virulence Genes 
0.01218 0.02436 
Positive Selection 
vs 
Genomic Genes 
1.395e – 07 4.170e – 07 H. pylori 
Virulence Genes 
vs 
Genomic Genes 
0.02079 0.02436 
Positive Selection 
vs 
Virulence Genes 
0.5515 0.5515 
Positive Selection 
vs 
Genomic Genes 
7.664e – 11 2.2992e – 10 N. meningitidis 
Virulence Genes 
vs 
Genomic Genes 
4.386e – 05 8.772e – 05 
Positive Selection 
vs 
Virulence Genes 
0.04792 0.04792 
Positive Selection 
vs 
Genomic Genes 
0.0005018 0.0010036 V. cholerae 
Virulence Genes 
vs 
Genomic Genes 
0.0001114 0.0003342 
Table 3.6 : Distributions of gene lengths between genes under positive selection, database 
identified virulence genes and genomic genes for H. pylori, N. meningitidis and V. cholerae 
were tested against each other using a Kolmogorov-Smirnov test with P values being adjusted 
for multiple hypotheses testing using the Holm’s method.   
 
        Gene lengths of H. pylori genes under positive selection, database identified virulence 
genes and genomic genes follow different, statistically significant distributions at the P = 0.05 
interval (Table 3.6). Genes under positive selection within H. pylori have a distribution skewed 
towards longer genes compared to database identified virulence genes and genomic genes 
 
 
 
 
 57 
(Figure 3.10, page 53). On average, H. pylori genes under positive selection are 99bp and 
~330bp longer then database identified virulence genes and genomic genes respectively (Figure 
3.10, page 53). Database identified H. pylori virulence genes are also biased towards a longer 
gene length distribution compared to genomic genes (adjusted P = 0.02436, Table 3.6, page 56) 
and on average, are ~ 231bp longer in length (Figure 3.10, page 53). Genes under positive 
selection and database identified virulence gene length distributions differ significantly enough 
from genomic genes for them to be distinguished as two separate subsets within the H. pylori 
genome (adjusted P = 0.02436 , adjusted P = 4.170e – 7, Table 3.6, page 56).   
        Gene length distributions of genes under positive selection and database identified 
virulence genes for N. meningitidis do not differ statistically at the P = 0.05 mark (adjusted P = 
0.5515). Mean gene lengths for N. meningitidis genes under positive selection and database 
identified virulence genes are quite similar at 1,280bp (Figure 3.11, page 54). Both genes under 
positive selection and database identified virulence genes for N. meningitidis are biased towards 
a longer gene length distribution, compared to the genomic mean of 858bp (Figure 3.11, page 54 
and Table 3.6, page 56). Hence, N. meningitidis database identified virulence genes and genes 
under positive selection are on average, longer then the normal gene length distribution within 
the genome (adjusted P = 8.772e – 05 and P = 2.2992e – 10 respectively, Table 3.6, page 56) 
and share similar gene length distributions. As there is a statistically significant enrichment of 
virulence genes undergoing positive selection in N. meningitidis (Table 3.5, page 50), one would 
expect similar gene length distributions between the two gene lists.  
        V. cholerae differences in gene length distributions are similar to those observed in H. 
pylori with genes under positive selection being on average, longer then database identified 
virulence genes and genomic genes (Figure 3.12, page 55). V. cholerae gene length distribution 
between genes under positive selection and database virulence genes differs statistically at the P 
= 0.05 value (adjusted P = 0.04792, Table 3.6, page 56). Gene length differences between genes 
under positive selection and database identified virulence genes are smaller, compared to 
differences in gene lengths by both sets of gene list types to genomic genes (adjusted P = 
0.0010036 and P = 0.0003342, respectively, Table 3.6, page 56). 
        A similarity shared by H. pylori, N. meningitidis and V. cholerae is that on average, genes 
under positive selection are longer then database identified genes which in turn, are longer then 
mean genomic gene lengths (Figures 3.10, 3.11 and 3.12, pages 53, 54 and 55). A possible 
reason for why genes under positive selection may be biased towards longer gene lengths is a 
longer sequence will contain a larger number of codons within the alignment, thereby providing 
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more data making the null hypothesis of no selection easier to reject by CODEML♣. The 
observation that longer sequences are more likely to reject the null hypothesis of no selection is 
validated by examining the mean lengths of genes undergoing positive selection with an LRT 
score significant at the P = 0.001 level, and comparing them with the mean gene lengths of all 
genes undergoing positive selection with an LRT score significant at P = 0.05 mark (Figure 3.3, 
page 38). For H. pylori, the mean length of the 83 genes whose LRT score is significant at the P 
= 0.001 level (Figure 3.3, page 38) is 1,605bp compared 1,289bp for all 230 genes whose LRT 
score is significant at the P = 0.05 level (Figure 3.3, page 38, Figure 3.10 page 53). Similarly, for 
N. meningitidis and V. cholerae the mean lengths of the 92 and 6 genes equal to or surpassing 
the significance test at P = 0.001 are 1,511bp and 2,558bp respectively, compared to 1,281bp 
and 1,871bp for all genes making the P = 0.05 threshold (Figure 3.3, page 38, Figure 3.11, page 
54 and Figure 3.12, page 55).  
        The fact that CODEML is more likely to reject the null hypothesis of no selection for genes 
whose lengths are greater then the genomic mean could be an artefact of longer genes containing 
more codons thereby increasing the probability of non-synonymous substitutions occurring, 
rather then a selective bias by CODEML for genes of a certain length. The reason that 
CODEML is not selectively biased towards identifying genes of a certain length to be under 
positive selection is supported by examining the longest genes within H. pylori, N. meningitidis 
and V. cholerae genomes which are HP0289 (8,682bp), NMA0688 (6,048bp) and VC1451 
(13,677bp) respectively which were found not to be under positive selection by CODEML. In 
comparison, the maximum gene lengths of genes under positive selection within H. pylori, N. 
meningitidis and V. cholerae are HP0887 (3,873bp), NMA0905 (5,322bp) and VCA0849 
(9,792bp) respectively. 
        The finding that virulence genes on average tend to be longer then the genomic gene mean 
for H. pylori, N. meningitidis and V. cholerae is surprising (Figures 3.10, 3.11 and 3.12, pages 
53, 54 and 55). There does not appear to be any literature which would suggest a priori that 
genes involved in virulence processes should be on average, longer then the genomic gene 
length average. 
 
 
 
 
 
                                                
♣
  Personal Communication with Dr. Cathal Seoighe  
 
 
 
 
 59 
Comparisons of %GC Content Distributions 
        The %GC content for the three gene list types (genes under positive selection, database 
identified virulence genes and genomic genes) were obtained in a similar fashion to the gene 
lengths using EMBOSS’s InfoSeq utility for H. pylori, N. meningitidis and V. cholerae (Figure 
3.9, page 52) 98. Distributions of %GC for the three gene list types for each bacterial organism 
under study were visualized as a series of histograms presented in Figures 3.13, 3.14 and 3.15 
(below and pages 60, 61). Descriptive statistics of the %GC datasets for H. pylori, N. 
meningitidis and V. cholerae are presented in Table B4B, Appendix B4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13 : Distribution of %GC content for all genes within H. pylori’s genome (Yellow), 
genes under positive selection (Green), database identified virulence genes (Red) as well as the 
mean and median for each gene list type. 
Mean = 39.78 % 
Median = 39.97 % 
Mean = 39.29 % 
Median = 39.48 % 
Mean = 39.11 % 
Median = 39.44 % 
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Figure 3.14 : N. meningitidis %GC content for all the genomic genes (Yellow), genes under 
positive selection (Green) and database identified virulence genes (Red) as well as the mean and 
median %GC content for each gene list type. 
Mean = 50.07 % 
Median = 51.74 % 
Mean = 54.95 % 
Median = 55.6 % 
Mean = 51.65 % 
Median = 53.4 % 
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Figure 3.15 : Histograms showing %GC distributions, mean and medians for V. cholerae 
genomic genes (Yellow), genes under positive selection (Green) and database identified 
virulence genes (Red).  
Mean = 47.04 % 
Median = 48.8 % 
Mean = 47 % 
Median = 47.9 % 
Mean = 48.97 % 
Median = 49.6 % 
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        Distributions of %GC content for genes under positive selection and database identified 
virulence genes were tested against each other and against the genomic distribution to determine 
if there are any differences between the three gene list types for H. pylori, N. meningitidis and V. 
cholerae using Kolmorogov – Smirnov tests and Holm’s correction for multiple testing, the 
results are presented below in Table 3.7. 
Bacterial Organism Gene Lists Tested P – Value Adjusted P – Value 
Positive Selection 
vs 
Virulence Genes 
0.02705 0.08115 
Positive Selection 
vs 
Genomic Genes 
0.2814 0.28140 H. pylori 
Virulence Genes 
vs 
Genomic Genes 
0.08131 0.16262 
Positive Selection 
vs 
Virulence Genes 
8.634e – 12 2.5902e – 11 
Positive Selection 
vs 
Genomic Genes 
3.398e – 10 6.796e – 10 N. meningitidis 
Virulence Genes 
vs 
Genomic Genes 
0.0001082 0.0001082 
Positive Selection 
vs 
Virulence Genes 
0.1096 0.1096 
Positive Selection 
vs 
Genomic Genes 
0.004702 0.014106 V. cholerae 
Virulence Genes 
vs 
Genomic Genes 
0.04080 0.0612 
Table 3.7 : Results of Kolmorogov – Smirnov tests conducted to determine if the %GC content 
distributions for genes under positive selection, database identified virulence genes and genomic 
genes statistically differ from each other with P values corrected for multiple hypotheses testing 
using Holm’s method. 
 
        No statistically significant differences in %GC distributions could be found between H. 
pylori genes under positive selection, database identified virulence genes and genomic genes at 
the P = 0.05 value (Table 3.7). The mean %GC value for H. pylori genomic genes, genes under 
positive selection and database identified virulence genes exhibits slight variations at the 39% 
interval, with virulence genes being slightly more %GC rich with a mean of 39.78% compared 
to the genomic mean of 39.11% (Figure 3.13, page 59). The similarity of mean %GC content of 
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database identified virulence genes compared to the genomic mean for H. pylori is surprising as 
one would expect the Cag pathogenicity island (Cag PAI) contained within the virulence gene 
dataset to skew the %GC content away from the genomic mean. The mean %GC content of 
genes present within the Cag PAI (HP0520 – HP0548; excluding HP0533), was calculated to be 
35% which is significantly different from the genomic distribution mean of 39.11% (P = 2.047e-
07, Kolmogorov – Smirnov test). Hence, although there are differences between specific 
virulence gene subsets with regards to %GC distribution, these differences are smoothened out 
when the %GC content of the whole virulence dataset, as opposed to subsets, are compared to 
the %GC content of genomic genes and genes under positive selection in H. pylori.  
        For N. meningitidis, all three types of gene lists have statistically significant differences in 
their %GC content distributions (Table 3.7, page 62). Genes under positive selection are skewed 
towards a more %GC rich content compared to genomic genes (adjusted P = 6.796e-10) and 
database identified virulence genes (adjusted P = 2.5902e-11; Table 3.7, page 62, Figure 3.14, 
page 60). Database identified virulence genes for N. meningitidis are skewed towards a smaller 
mean %GC content compared to the mean genomic distribution (Figure 3.14, page 60). 
Compared to genes under positive selection, the %GC content distribution of database identified 
virulence genes is closer to the genomic %GC content distribution as seen by the larger P-values 
(adjusted P = 0.0001082 compared to adjusted P = 2.5902e-11, Table 3.7, page 62). The 
closeness of N. meningitidis %GC content distribution of database identified virulence genes 
towards genomic genes and not genes under positive selection is unexpected. N. meningitidis 
database identified virulence genes are enriched for genes under positive selection and thus, a 
similar %GC content distribution would be expected, as in the case of gene lengths (Table 3.6, 
page 56). However, more database identified virulence genes for N. meningitidis below the 50% 
GC content interval can be seen compared to genes under positive selection (Figure 3.14, page 
60). Hence, although database identified virulence genes are enriched for genes undergoing 
positive selection, the two gene list types can be differentiated based upon their %GC content 
distributions (Table 3.7, page 62, Figure 3.14, page 60). N. meningitidis database identified 
virulence genes can also be differentiated from genomic genes by having a statistically 
significant %GC content distribution that is less then the genome, while genes under positive 
selection can be differentiated from the genome by having higher %GC contents (Table 3.7, 
page 62, Figure 3.14, page 60).  
        Compared to genomic genes, genes under positive selection within V. cholerae have a 
different statistically significant %GC distribution (adjusted P = 0.014106, Table 3.7, page 62) 
and are on average, more GC rich (Figure 3.15, page 61). Genes under positive selection and 
database identified virulence genes for V. cholerae do not have a statistically significantly 
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different %GC distribution (adjusted P = 0.1096, Table 3.7, page 62). Genomic genes and 
database identified virulence genes also do not have a statistically significantly different %GC 
distribution at the P = 0.05 threshold (adjusted P = 0.0612, Table 3.7, page 62).  
        N. meningitidis and V. cholerae genes under positive selection tend to have a slightly 
higher mean %GC content compared to database identified virulence genes and the genome as a 
whole (Figures 3.14 and 3.15, pages 60 and 61). H. pylori database identified virulence genes 
have a higher mean %GC content as compared to genomic genes (Figure 3.13, page 59) while N. 
meningitidis and V. cholerae database identified virulence genes have lower %GC means 
compared to genomic genes with the differences in %GC content being more pronounced within 
N. meningitidis (Figures 3.14 and 3.15, pages 60 and 61).   
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Chapter 4 : Functional Annotation 
Introduction 
        Genes under positive selection and database identified virulence genes for H. pylori, N. 
meningitidis and V. cholerae have so far been examined based on gene counts and physical 
properties, such as gene lengths and %GC content. Within this chapter, biological properties of 
genes under positive selection and database identified virulence genes for H. pylori, N. 
meningitidis and V. cholerae are investigated to elucidate the biological properties of each gene 
list type. Different functional annotation systems were employed to scrutinize genes under 
positive selection to establish what biological processes are under positive selection and to what 
extent do any functional similarities or differences exist across the three bacterial species. 
Additionally, functional characterization of database identified virulence genes was undertaken 
to determine whether virulence processes for an obligatory pathogen, commensal / opportunistic 
pathogen and free living facultative pathogen (H. pylori, N. meningitidis and V. cholerae 
respectively) have any similarities. 
        Functional annotation of gene lists occurs at a 1 – dimensional level and routine genome 
sequencing has propelled the proliferation of annotation systems, controlled vocabularies and 
tools that seek to provide meaningful, biological contextualization of sequence based 
information 36. Different systems of functional classification either use a controlled vocabulary 
of terms (ontologies), for which putative function is assigned to a gene sequence based on 
homology or where possible, experimental evidence. Other systems utilize algorithmic 
prediction methods based upon sequence features to classify gene sequences into biologically 
relevant categories. Regardless of the approach used, the coverage and depth of biological 
annotations for an organism present within that functional classification system will have a 
direct impact upon functional analyses of experimentally generated gene lists.  
        Functional annotation of genes under positive selection and database identified virulence 
genes was conducted using controlled vocabularies from Gene Ontology (GO) and Clusters of 
Orthologous Groups of proteins (COGs) to determine if there are any enriched biological 
processes under positive selection and to characterize database identified virulence gene 
processes 102,110,112. Sub-cellular localization predictions of protein products for genes under 
positive selection and database identified virulence genes for H. pylori, N. meningitidis and V. 
cholerae was investigated 113-115.   
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        Gene Ontology (GO) Functional Annotation of Bacterial  Gene 
Lists 
        A major aim of the collaborative GO effort is to describe the purpose of a gene and its 
products within an organism through the use of a universal, unambiguous organized vocabulary 
of biological terms 110. GO annotations comprise of three descriptive facets; biological process, 
molecular function and cellular component to describe the biological role a gene’s product 
contributes to, the biochemical reaction a gene may be involved in and the position within a cell 
where gene’s product is active 110. Each of the three GO descriptive facets encompass a five-
tiered hierarchy which have broad biological terms placed on top of the hierarchy and more 
specific biological terms placed at the bottom of the hierarchy 109-111.  
The biological community has widely adopted GO annotations with over 2,940 publication 
citations♣ and has given rise to numerous bioinformatics tools that seek to annotate and find GO 
term associations amongst gene lists generated from high throughput experiments♠. A popular 
tool providing GO annotations coupled with statistical interpretation of GO term significance for 
a gene list of interest is the Database of Annotation, Visualization and Integrated Discovery 
(DAVID) 111,166. DAVID aims to expedite the biological discovery process from 
experimentation by providing a centralized, integrated resource of numerous annotation types 
for characterizing a gene list of interest’s biological associations and to date, has been used in 
over 1,000 publications 111,166.  
        Lists of genes under positive selection for H. pylori, N. meningitidis and V. cholerae were 
uploaded to DAVID’s web – interface and an enrichment of GO terms were assayed for using 
genome wide GO annotations of the respective bacterial species as background lists. Identified 
GO annotations for genes under positive selection were compared across the three bacterial 
species to determine what biological processes are undergoing positive selection and if those 
processes are similar or discrete. Similarly, database identified virulence genes were also 
uploaded to DAVID’s web – interface and an over representation of GO terms relative to the 
bacterial organism’s genome was obtained. GO annotations of database identified virulence gene 
lists were obtained to determine if the three bacterial species use similar or differing biological 
processes in their pathogenesis. Finally, comparisons of GO annotations of genes under positive 
selection and database identified virulence genes lists was conducted manually and through the 
use of DAVID’s gene list manager to ascertain whether any commonalities between biological 
processes under positive selection and bacterial virulence exist.  
                                                
♣
 http://www.geneontology.org/cgi-bin/biblio.cgi - As of November 2009 
♠
 http://www.geneontology.org/GO.tools.shtml#out_house  
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GO Processes under Positive Selection 
        Bacterial gene list annotation using GO terms was done at the 4th level of the GO hierarchy 
with an EASE score of 0.5 within DAVID for all bacterial gene lists so as to maintain 
consistency when comparing GO terms across all three bacterial species. After evaluation of all 
GO terms at the five different levels of the GO hierarchy, selection of GO annotation terms at 
the 4th level of the GO hierarchy was settled upon in an attempt to maximize gene list coverage 
and at the same time, obtain GO terms that are not too diffuse in their definitions. DAVID 
utilizes a Fisher’s exact test when assaying for GO category functional enrichment and makes 
corrections for multiple hypothesis testing using a number of methods, thereby providing a good 
statistical metric that can be compared across bacterial systems 111,166. Coverage of the number 
of genes mapped to GO terms for the uploaded lists of genes under positive selection are 
summarized below, in Table 4.1. 
 
Bacterial Organism N
o
 of Genes under 
Positive Selection 
No of Genes under 
Positive Selection 
with GO Terms 
Mapped 
Percentage (%) of 
Gene List GO 
Term Coverage 
H. pylori 230 97 42% 
N. meningitidis 218 64 29% 
V. cholerae 23 7 30% 
Table 4.1 : Coverage of gene lists for genes under positive selection that could be mapped to 
GO terms using the DAVID system in numbers and percentage.  
 
        GO term annotation coverage of H. pylori genes under positive selection is higher 
compared to coverage of GO term annotations for genes under positive selection within the N. 
meningitidis and V. cholerae bacterial systems (Table 4.1). In terms of functional enrichment of 
GO categories for genes under positive selection, no statistically significant enrichment for a 
particular GO category could be found at the P = 0.05 mark after correcting for multiple 
hypothesis testing.  
        The GO terms for genes under positive selection within H. pylori, N. meningitidis and V. 
cholerae and the number of genes mapped to each GO term is presented overleaf, in Figure 4.1. 
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GO Annotations of Genes under Positive Selection
Number of Genes
G
O
 
Te
rm
GO:0000160~two-component signal transduction system (phosphorelay)GO:0000270~peptidoglycan metabolic process
GO:0000287~magnesium ion binding
GO:0000902~cell morphogenesis
GO:0003755~peptidyl-prolyl cis-trans isomerase activity
GO:0004003~ATP-dependent DNA helicase activity
GO:0004091~carboxylesterase activity
GO:0004518~nuclease activity
GO:0004783~sulfite reductase (NADPH) activityGO:0006281~DNA repair
GO:0006400~tRNA modification
GO:0006412~translation
GO:0006520~amino acid metabolic process
GO:0006886~intracellular protein transport
GO:0006935~chemotaxis
GO:0008320~protein transmembrane transporter activity
GO:0009072~aromatic amino acid family metabolic process
GO:0009110~vitamin biosynthetic process
GO:0009165~nucleotide biosynthetic process
GO:0009309~amine biosynthetic process
GO:0009310~amine catabolic process
GO:0009380~excinuclease repair complex
GO:0009432~SOS response
GO:0009982~pseudouridine synthase activity
GO:0015031~protein transport
GO:0015144~carbohydrate transmembrane transporter activity
GO:0015399~primary active transmembrane transporter activity
GO:0015450~P-P-bond-hydrolysis-driven protein transmembrane transporter activity
GO:0016021~integral to membrane
GO:0016053~organic acid biosynthetic processGO:0016070~RNA metabolic process
GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor
GO:0016668~oxidoreductase activity, acting on sulfur group of donors, NAD or NADP as acceptor
GO:0016747~transferase activity, transferring groups other than amino-acyl groups
GO:0016758~transferase activity, transferring hexosyl groups
GO:0016780~phosphotransferase activity, for other substituted phosphate groups
GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
GO:0016836~hydro-lyase activity
GO:0016876~ligase activity, forming aminoacyl-tRNA and related compounds
GO:0016884~carbon-nitrogen ligase activity, with glutamine as amido-N-donor
GO:0019001~guanyl nucleotide binding
GO:0019438~aromatic compound biosynthetic process
GO:0019752~carboxylic acid metabolic process
GO:0019867~outer membrane
GO:0022603~regulation of anatomical structure morphogenesis
GO:0022604~regulation of cell morphogenesis
GO:0022884~macromolecule transmembrane transporter activity
GO:0030313~cell envelope
GO:0030554~adenyl nucleotide binding
GO:0031224~intrinsic to membrane
GO:0031668~cellular response to extracellular stimulusGO:0032555~purine ribonucleotide binding
GO:0032989~cellular structure morphogenesis
GO:0042254~ribosome biogenesis and assembly
GO:0042330~taxis
GO:0042435~indole derivative biosynthetic process
GO:0043285~biopolymer catabolic process
GO:0044255~cellular lipid metabolic process
GO:0044267~cellular protein metabolic process
GO:0044270~nitrogen compound catabolic process
GO:0044271~nitrogen compound biosynthetic process
GO:0044272~sulfur compound biosynthetic process
GO:0044425~membrane part
GO:0044462~external encapsulating structure part
GO:0045184~establishment of protein localization
GO:0046493~lipid A metabolic process
GO:0046907~intracellular transport
GO:0046914~transition metal ion binding
GO:0051188~cofactor biosynthetic process
GO:0051649~establishment of cellular localization
10 20 30 40 50 60
H.pylori N.meningitidis V.cholerae
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 : Level four GO annotations that map to genes under positive selection within H 
pylori, N meningitidis and V cholerae using the DAVID system.
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        Nine common GO terms are shared between H. pylori and N. meningitidis genes under 
positive selection with purine ribonucleotide binding (GO:0032555), adenyl nucleotide binding 
(GO:0030554) and cellular metabolic process (GO:0044267) sharing the most genes between 
the two organisms (Figure 4.1, page 68). H. pylori and N. meningitidis share other DNA and 
RNA metabolism GO categories such as guanyl nucleotide binding (GO:0019001) and RNA 
metabolic processes (GO:0016070) that are under positive selection within the two bacterial 
systems (Figure 4.1, page 68). A second class of common biological processes under positive 
selection within H. pylori and N. meningitidis involves formation of biosynthetic compounds 
such as amino acids (GO:0006520), nitrogenous (GO:0044271) and aromatic bio-molecules 
(GO:0019438). The large number of genes involved with DNA metabolism that are under 
positive selection within H. pylori and N. meningitidis may possibly reflect the active 
maintenance of DNA uptake and incorporation apparatuses. Most pathogenic bacteria operate 
within a framework that favours gene loss, yet numerous pathogenic bacteria tend to actively 
maintain systems for exogenous DNA uptake which are energy intensive 5,38,69,84. Both H. pylori 
and N. meningitidis have high rates of recombination and are naturally competent species, with 
N. meningitidis requiring DNA uptake to maintain its genomic integrity 78,153. An interesting 
extension to this hypothesis is selection for DNA metabolism and continual recombination 
between strains may enhance the survival of a species and increase its virulence potential by 
producing new phenotypes with novel antigens to counter adaptive immune responses, as is the 
case with hyper-invasive N. meningitidis strains 69,78,90,153. For H. pylori, DNA metabolism terms 
such as adenyl nucleotide binding (GO:0030554) may reflect a selective pressure on its growth 
rate as defined media culture studies reveal a reduction in the growth rate of H. pylori by as 
much as 50% in low concentration adenine and purine media 167,168. 
        Shared GO terms for H. pylori and V. cholerae genes under positive selection mainly relate 
to genes which are intrinsic (GO:0031224) and integral for cell membrane structure 
(GO:0016021) (Figure 4.1, page 68). N. meningitidis does have some genes under positive 
selection which are part of the cell envelope (GO:0030313), though these GO terms do not 
overlap with membrane associated GO terms for H. pylori and V. cholerae (Figure 4.1, page 68). 
A common GO term under positive selection across all three bacterial species is carboxylic acid 
metabolic processes (GO:0019752) which involves pathways and chemical reactions utilizing 
carboxylic acids, mainly pertaining to the energy producing glycolysis pathway that operates 
under anaerobic conditions 169. 
        Unique GO terms for H. pylori genes under positive selection involve protein 
transmembrane transport (GO:0008320), intracellular protein transport (GO:0006886), 
chemotaxis (GO:0006935), cell morphogenesis (GO:0000902) and establishment of cellular 
 
 
 
 
 70 
localization (GO:0051649), amongst others (Figure 4.1, page 68). N. meningitidis unique GO 
terms for genes under positive selection involve processes such as DNA repair like the SOS 
response (GO:0009432) and excinuclease repair complex (GO:0009380), translation 
(GO:0006412) and the outer membrane (GO:00019867) (Figure 4.1, page 68). Overall, V. 
cholerae genes under positive selection share more GO terms with H. pylori genes under 
positive selection as compared to N. meningitidis (Figure 4.1, page 68).  
GO Processes of Bacterial Virulence Genes  
        Enterez Gene IDs of database identified virulence gene lists for H. pylori, N. meningitidis 
and V. cholerae were uploaded to the DAVID system and the 4th level of the GO hierarchy was 
chosen for annotation. The number of database identified virulence genes and their coverage by 
GO annotation terms is presented below in Table 4.2. 
Bacterial Organism 
No of Database 
Identified 
Virulence Genes 
No of Virulence 
Genes with GO 
Terms Mapped 
Percentage (%) of 
Gene List GO 
Term Coverage 
H. pylori 153 90 59% 
N. meningitidis 68 24 35% 
V. cholerae 168 98 58% 
Table 4.2 : The number of database identified virulence genes with 4th level GO terms and the 
percentage of gene list coverage.  
 
        In all instances, database identified virulence genes have a higher percentage of genes with 
GO terms mapped to them compared to genes under positive selection (Table 4.2, Table 4.1, 
page 67). Higher coverage of database identified virulence genes with 4th level GO annotations 
may represent a bias in terms of these gene sets being intensively studied. The majority of 
database identified virulence genes are mined from the literature and hence, have been well 
characterised. GO annotation curators also use published literature where possible to assign GO 
terms to genes thereby resulting in a higher coverage of GO annotations for database identified 
virulence genes. GO terms for database identified virulence genes for H. pylori, N. meningitidis 
and V. cholerae are presented overleaf, in Figure 4.2.  
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GO Annotations of Database Identified Virulence Genes
Number of Genes
G
O
 
Te
rm
GO:0000160~two-component signal transduction system (phosphorelay)GO:0000902~cell morphogenesis
GO:0001539~ciliary or flagellar motility
GO:0004091~carboxylesterase activity
GO:0004601~peroxidase activity
GO:0004888~transmembrane receptor activity
GO:0005509~calcium ion binding
GO:0005976~polysaccharide metabolic process
GO:0006461~protein complex assembly
GO:0006811~ion transport
GO:0006812~cation transport
GO:0006818~hydrogen transport
GO:0006873~cellular ion homeostasis
GO:0006886~intracellular protein transport
GO:0006935~chemotaxis
GO:0008320~protein transmembrane transporter activity
GO:0008610~lipid biosynthetic process
GO:0008643~carbohydrate transport
GO:0008653~lipopolysaccharide metabolic process
GO:0009101~glycoprotein biosynthetic process
GO:0009103~lipopolysaccharide biosynthetic process
GO:0009237~siderophore metabolic process
GO:0009238~enterobactin metabolic process
GO:0009288~flagellin-based flagellum
GO:0009306~protein secretion
GO:0009405~pathogenesis
GO:0015031~protein transport
GO:0015075~ion transmembrane transporter activity
GO:0015144~carbohydrate transmembrane transporter activity
GO:0015291~secondary active transmembrane transporter activity
GO:0015399~primary active transmembrane transporter activity
GO:0015450~P-P-bond-hydrolysis-driven protein transmembrane transporter activity
GO:0015628~protein secretion by the type II secretion system
GO:0015774~polysaccharide transport
GO:0015992~proton transport
GO:0016021~integral to membrane
GO:0016051~carbohydrate biosynthetic process
GO:0016758~transferase activity, transferring hexosyl groups
GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidesGO:0016812~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides
GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances
GO:0018958~phenol metabolic process
GO:0019627~urea metabolic process
GO:0019725~cellular homeostasis
GO:0019861~flagellum
GO:0019867~outer membrane
GO:0022884~macromolecule transmembrane transporter activity
GO:0030554~adenyl nucleotide binding
GO:0031224~intrinsic to membrane
GO:0032555~purine ribonucleotide binding
GO:0032940~secretion by cell
GO:0032989~cellular structure morphogenesis
GO:0032990~cell part morphogenesis
GO:0042330~taxis
GO:0043284~biopolymer biosynthetic process
GO:0044255~cellular lipid metabolic process
GO:0044262~cellular carbohydrate metabolic process
GO:0044264~cellular polysaccharide metabolic process
GO:0044425~membrane part
GO:0044460~flagellum part
GO:0044461~flagellin-based flagellum part
GO:0044463~cell projection partGO:0045184~establishment of protein localization
GO:0046907~intracellular transport
GO:0046914~transition metal ion binding
GO:0051649~establishment of cellular localization
GO:0065003~macromolecular complex assembly
20 40 60
H.pylori N.meningitidis V.cholerae
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 : GO terms at the 4th level of the GO hierarchy that map to database identified 
virulence genes within H pylori, N meningitidis and V cholerae using the DAVID system.
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        Database identified virulence genes show greater congruence between the bacterial species 
with eight common GO terms shared by all three bacterial species (Figure 4.2, page 71), 
compared to a single GO term mapped to all three bacterial species for genes under positive 
selection (Figure 4.1, page 68). A number of GO terms for database identified virulence genes 
were found to statistically significantly enriched at the P = 0.05 level, even after stringent 
Bonferroni corrections for multiple hypothesis testing, as implemented by DAVID. Enriched 
GO terms found to statistically significant for H. pylori, N. meningitidis and V. cholerae together 
with their Bonferroni adjusted P-values are presented below, in Table 4.3. 
Bacterial Species and Adjusted P – value GO ID ~ Term 
H. pylori N. meningitidis V. cholerae 
GO:0006935~chemotaxis 0.002287881 NIL 0.039493473 
GO:0044463~cell projection part 9.13e - 05 NIL 1.35e - 10 
GO:0045184~establishment of protein 
localization 1.27e - 05 NIL 8.94e - 11 
GO:0051649~establishment of cellular 
localization 0.043026936 NIL 7.30e - 13 
GO:0019861~flagellum 9.50e - 17 NIL 9.70e - 35 
GO:0001539~ciliary or flagellar motility 1.01e - 15 NIL 1.16e - 18 
GO:0009288~flagellin-based flagellum 7.21e - 08 NIL 1.63e - 19 
GO:0044461~flagellin-based flagellum 
part 9.13e - 05 NIL 1.35e - 10 
GO:0015031~protein transport 0.023301077 NIL NIL 
GO:0015144~carbohydratetransmembrane 
transporter activity NIL 0.038649114 NIL 
GO:0000902~cell morphogenesis NIL NIL 6.29e - 06 
GO:0032989~cellular structure 
morphogenesis NIL NIL 6.29e - 06 
GO:0032990~cell part morphogenesis NIL NIL 9.22e - 11 
GO:0032940~secretion by cell NIL NIL 1.96e - 12 
GO:0009306~protein secretion NIL NIL 7.83e - 12 
GO:0015628~protein secretion by the type 
II secretion system NIL NIL 2.67e - 07 
Table 4.3 : Enriched GO Terms for database identified virulence genes for H. pylori, N. 
meningitidis and V. cholerae at the P = 0.05 level and their Bonferroni adjusted P values. 
  
        H. pylori and V. cholerae database identified virulence gene lists share more GO terms that 
are statistically enriched at the P = 0.05 level, then either organism shares with N. meningitidis 
(Table 4.3). Majority of the GO terms for database identified virulence genes shared by H. pylori 
and V. cholerae involve the flagellum (GO:0019725), chemotaxis (GO:0006935) and motility 
(GO:0001539) (Figure 4.2, page 71, Table 4.3). Common GO terms for database identified 
virulence genes shared by all three bacterial species are transport of molecules (GO:0006812, 
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GO:0015301), protein secretion (GO:0009306) and outer membrane proteins (GO:0019867) 
(Figure 4.2, page 71). Unique GO terms for N. meningitidis database identified virulence genes 
include lipid and carbohydrate metabolism (GO:0044255, GO:0044262) and genes intrinsic to 
the cell membrane (GO:0031224) (Figure 4.2, page 71). Unique GO terms for database 
identified virulence genes for H. pylori and V. cholerae mainly pertain to metabolism and 
transporter activity (Figure 4.2, page 71).  
        Genes under positive selection for H. pylori, N. meningitidis and V. cholerae have 70 GO 
terms which could be assigned (Figure 4.1, page 68). Database identified virulence genes for H. 
pylori, N. meningitidis and V. cholerae have a total of 68 GO terms which could be assigned 
(Figure 4.2, page 71). The intersection between the 70 GO terms for genes under positive 
selection (Figure 4.1, page 68) and the 68 GO terms for database identified virulence genes 
(Figure 4.2, page 71) is 27 (~39% of 68 and 70 GO terms), based on manual cross-checking of 
GO terms. Manual cross-checking of GO terms for genes under positive selection and database 
identified virulence genes reveal that some GO terms under positive selection within one 
bacterial organism, are the same as GO terms for database identified virulence genes within 
another organism. For example, the GO terms purine ribonucleotide binding (GO:0032555) and 
adenyl nucleotide binding (GO:0030554) are represented in genes under positive selection for H. 
pylori and N. meningitidis (Figure 4.1, page 68), the same GO terms are also present within 
database identified virulence genes for V. cholerae (Figure 4.2, page 71). Other GO terms for 
genes under positive selection within H. pylori include protein transmembrane transporter 
activity (GO:0008320) which is present on the list of V. cholerae database identified virulence 
genes (Figures 4.1, 4.2, pages 68, 71). Hence, it is possible that not all virulence processes have 
been characterized uniformly across all three bacterial species as a substantial overlap exists 
between genes under positive selection in one bacterial species that have the same GO terms as 
database identified virulence genes for another bacterial species. Alternatively, virulence 
processes for a certain bacterial species like V. cholerae are unique to that bacterial species and 
are not considered to be virulence processes within another bacterial species like H. pylori, 
thereby identifying species unique modes of pathogenicity.  
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Common GO Processes between Genes under Positive Selection and 
Database Identified Virulence Genes 
        To determine what GO terms are represented between genes under positive selection and 
database identified virulence genes, Entrez Gene IDs of database identified virulence genes for 
H. pylori, N. meningitidis and V. cholerae were combined into a single file and uploaded to 
DAVID’s web-interface as a background gene list. Similarly, a combined file of Entrez Gene 
IDs for genes under positive selection within H. pylori, N. meningitidis and V. cholerae was 
uploaded to DAVID’s list manager as the foreground list. The foreground list (H. pylori, N. 
meningitidis and V. cholerae genes under positive selection) was compared to the background 
list (H. pylori, N. meningitidis and V. cholerae database identified virulence genes) to establish 
what GO terms are shared between the two gene list types. This form of gene list type 
comparison differs from the manual cross-checking of GO terms obtained for genes under 
positive selection and database identified virulence genes by use of a specific gene list type as 
the background instead of the bacterial species’ genome. Results of the comparison for genes 
under positive selection and database identified virulence genes lists are presented overleaf, in 
Figure 4.3. 
        No statistically significant enrichment of GO terms at the P = 0.05 level could be found 
when comparing genes under positive selection and database identified virulence gene lists for 
H. pylori, N. meningitidis and V. cholerae. However, there is a high overlap between GO Terms 
for the two types of gene lists. The number of common GO terms between the gene lists under 
positive selection and database identified virulence genes, as determined by DAVID, is 22 
(Figure 4.3, page 75). Of those 22 common GO terms (Figure 4.3, page 75), 15 are the same as 
the 27 Go terms obtained by manual cross-checking of GO terms from Figure 4.1 (page 68) and 
Figure 4.2 (page 71) while 7 and 12 GO terms are unique to each type of comparison. Hence, of 
the 27 common GO terms obtained by manual cross-checking of GO terms, a further 7 shared 
GO terms can be determined between genes under positive selection and database identified 
virulence genes.   
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Common GO Terms between Database Identified Virulence Genes and 
 Genes Under Positive Selection
Number of Genes
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GO:0001539~ciliary or flagellar motility
GO:0006811~ion transport
GO:0006886~intracellular protein transport
GO:0006935~chemotaxis
GO:0015031~protein transport
GO:0015144~carbohydrate transmembrane transporter activity
GO:0015267~channel activity
GO:0015399~primary active transmembrane transporter activity
GO:0016021~integral to membrane
GO:0016758~transferase activity, transferring hexosyl groups
GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides
GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances
GO:0019861~flagellum
GO:0019867~outer membrane
GO:0031224~intrinsic to membrane
GO:0032555~purine ribonucleotide binding
GO:0032940~secretion by cell
GO:0042330~taxis
GO:0044267~cellular protein metabolic process
GO:0044425~membrane part
GO:0045184~establishment of protein localization
GO:0051649~establishment of cellular localization
2 4 6 8
H.pylori
N.meningitidis
V.cholerae
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 : GO terms that were found to be common between database identified virulence 
genes (background gene list) and genes under positive selection within H. pylori, N. meningitidis 
and V. cholerae (foreground gene list) using the DAVID system.  
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        Differences in the number of GO terms obtained by manual cross-checking of GO terms 
across bacterial species and gene list comparisons performed using DAVID’s list manager are 
mainly due to two factors. Firstly, the background gene lists differ, in the case of manual cross-
checking of GO terms, the respective bacterial organism’s genome was used as the background 
gene list, thereby providing more GO terms mapped to the bacterial organism’s genome. In the 
instance of gene list comparisons done within DAVID, only the GO terms mapped to a bacterial 
organism’s gene list are used, providing a much smaller subset of mapped GO terms. Secondly, 
manual cross-checking of GO term annotations is comparative in nature resulting in a transfer of 
annotations from a gene list type of one bacterial organism, to another gene list type of another 
bacterial organism 1,3,4,7. 
        The number of genes identified belonging to a specific GO term such as purine 
ribonucleotide binding (GO:0032555) also differ between Figures 4.3 (page 75), 4.1 (page 68) 
and 4.2 (page 71). When assaying for common GO terms between all genes under positive 
selection (foreground gene list) and all database identified virulence genes (background gene 
list), the combined gene lists submitted to DAVID are automatically partitioned into species 
specific gene lists, and used for GO term analysis that is species defined. Thus, similar GO terms 
for one gene list type can not obtained for another gene list belonging to a different bacterial 
species within the DAVID system, resulting in absence of GO terms for V. cholerae in Figure 
4.3 (page 75), although GO annotations clearly exist (Figures 4.1, 4.2, pages 68 and 71).  
        Although there are no functionally enriched GO terms between genes under positive 
selection and database identified virulence genes for H. pylori, N. meningitidis and V. cholerae, 
the two gene list types share a total of 34 GO terms based on comparative and direct gene list 
characterisation. Hence, genes under positive selection and database identified virulence genes 
for H. pylori, N. meningitidis and V. cholerae do share a number of common biological 
processes based on GO annotations. In terms of genes under positive selection, H. pylori has 
more shared GO terms with N. meningitidis which is not surprising given the low number of 
genes under positive selection within V. cholerae. However, database identified virulence genes 
for H. pylori have more shared and statistically enriched GO terms in common with V. cholerae 
then either organism has compared to N. meningitidis, possibly due to H. pylori and V. cholerae 
adopting similar lifestyles in that they are enteric pathogens while N. meningitidis is not 14,28,85.  
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Clusters of Orthologous Proteins (COGs) Functional Annotation         
        Clusters of Orthologous Proteins (COGs) is an annotation strategy based on phylogeny and 
evolutionary orthology comprising of twenty-five alphabetical codes describing high level 
biological processes within a sequenced genome 102,112. COGs was devised to characterize newly 
sequenced genomes, mostly prokaryotic, by identification of evolutionary orthologous gene sets 
between genomes representative of key phylogenetic lineages 102,112. Genes from sequenced 
bacterial organisms are used to conduct reciprocal BLASTs to delineate orthologous 
relationships from paralogous ones 102,112. Identified orthologous genes are functionally grouped 
into COG alphabetical categories based upon transfer of functional information available from 
well characterized genes 102,112. COGs’ stringent identification of orthologues provides 
phylogenetically and taxonomically well defined gene sets for use in annotating newly 
sequenced prokaryotic genomes and studying functional processes specific or common to 
different taxonomic lineages 15,102,112.  
        COG annotations differ from GO annotations in that not all genes within a given genome 
will be annotated as only orthologous gene sets from distinct phylogenetic lineages are classified 
by COGs whereas GO seeks to annotate all gene products within a given genome 102,109,110,112. 
COGs also uses evolutionary orthology based on phylogeny for annotation purposes in contrast 
to functional homology and literature based methods GO annotation pipelines use 102,109,110,112. 
However, GO has a significant element of ongoing human curation of annotated gene products 
while COGs is mostly automated in its annotation strategy 102,109,110,112. GO was initially 
designed for annotation of eukaryotic genomes while COGs initial focus was prokaryotic 
genome annotation, although that is changing 112,170.  
        COG annotations for all genes in the genome, genes under positive selection and database 
identified virulence genes for H. pylori, N. meningitidis and V. cholerae were obtained from 
their respective GenBank submitted genome annotation files. Statistical testing was conducted to 
determine if any alphabetical COG categories display a significant association for genes under 
positive selection and database identified virulence genes belonging to H. pylori, N. meningitidis 
and V. cholerae. Statistical testing was also performed to determine whether any alphabetical 
COG categories share an abundance of database identified virulence genes which are under 
positive selection for H. pylori, N. meningitidis and V. cholerae. 
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COG Functional Annotation of Bacterial Gene Lists 
        COG identifiers for genome genes, genes under positive selection and database identified 
virulence genes were parsed from their respective genome annotation files and sorted according 
to their alphabetical COG category codes. The total number of COG annotations for each 
microbial genome, genes under positive selection and database identified virulence genes placed 
in a COG category and the percentage coverage of each gene list type for H. pylori, N. 
meningitidis and V. cholerae are summarized below in Table 4.4. 
Bacterial Organism 
No of Genes in 
Genome placed in a 
COG Category 
(%) 
No of Genes under 
Positive Selection 
placed in a COG 
Category (%) 
No of Database 
Identified Virulence 
Genes placed in a 
COG Category (%) 
H. pylori 
978 
(62 % of 1,576 genes) 
178 
(77 % of 230 genes) 
118 
(77 % of 153 genes) 
N. meningitidis 
1356 
(66 % of 2,065 genes) 
199 
(91 % of 218 genes) 
47 
(69 % of 68 genes) 
V. cholerae 
2507 
(65 % of 3,835 genes) 
18 
(78 % of 23 genes) 
142 
(85 % of 168 genes) 
Table 4.4 : Number of genes for each gene list type which could be placed in a COG 
alphabetical functional category and percentage coverage of each gene list type for H. pylori, N. 
meningitidis and V. cholerae. 
 
        COG annotation coverage for genes under positive selection and database identified 
virulence genes for H. pylori, N. meningitidis and V. cholerae (Table 4.4) is greater compared to 
GO annotation coverage of the same gene lists (Table 4.1, page 67, Table 4.2, page 70). GO 
annotation coverage does not surpass 50% of genes under positive selection (Table 4.1, page 67) 
while COG annotation coverage for the same gene lists is greater then 75% (Table 4.4). 
Similarly, higher coverage of database identified virulence genes for H. pylori, N. meningitidis 
and V. cholerae is achieved by COGs compared to GO annotations (Table 4.4, Table 4.2, page 
70). Apart from V. cholerae, COG annotation coverage for genes under positive selection is 
equal to or greater then COG annotation coverage for database identified virulence genes (Table 
4.4). Counts of genome genes, genes under positive selection and database identified virulence 
genes for H. pylori, N. meningitidis and V. cholerae belonging to each COG functional category 
are presented overleaf in Figure 4.4. 
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Gene Counts of each Gene List Type for COG Categories
Number of Genes
CO
G
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[Z] Cytoskeleton
[W] Extracellular structures
[V] Defense mechanisms
[U] Intracellular trafficking and secretion
[T] Signal transduction mechanisms
[S] Function unknown
[R] General function prediction only
[Q] Secondary metabolites biosynthesis, transport and catabolism
[P] Inorganic ion transport and metabolism
[O] Posttranslational modification, protein turnover, chaperones
[N] Cell motility
[M] Cell wall/membrane biogenesis
[L] Replication, recombination and repair
[K] Transcription
[J] Translation
[I] Lipid transport and metabolism
[H] Coenzyme transport and metabolism
[G] Carbohydrate transport and metabolism
[F] Nucleotide transport and metabolism
[E] Amino acid transport and metabolism
[D] Cell cycle control, mitosis and meiosis
[C] Energy production and conversion
[B] Chromatin structure and dynamics
[A] RNA processing and modification
0 100 200 300
Genome Count
0 5 10 15 20 25
Positive Selection Genes
0 20 40 60
Virulence Genes
H pylori N meningitidis V cholerae
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 : Gene counts of genome genes, genes under positive selection and database 
identified virulence genes for H. pylori, N. meningitidis and V. cholerae belonging to each 
alphabetical COG category. 
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        Similar to GO annotations, genes under positive selection for H. pylori, N. meningitidis and 
V. cholerae are less well annotated compared to database identified virulence genes, although 
the percentage coverage of the two gene list types by COG annotations are similar (Table 4.4, 
page 78). The mean percentage coverage of genes under positive selection for H. pylori, N. 
meningitidis and V. cholerae by COG annotations is 82% (Table 4.4, page 78). The mean 
percentage coverage of database identified virulence genes for H. pylori, N. meningitidis and V. 
cholerae by COG annotations is 77% (Table 4.4, page 78). If uninformative COG categories 
such as [R] general function prediction and [S] Function unknown are excluded (Figure 4.4, 
page 79), mean percentage COG annotation coverage for H. pylori, N. meningitidis and V. 
cholerae genes under positive selection drops to 64%. Similar calculations of mean percentage 
coverage by COG annotations for H. pylori, N. meningitidis and V. cholerae database identified 
virulence genes will result in 71% being annotated by COG categories other then [R] general 
function prediction and [S] Function unknown (Figure 4.4, page 79). Mean percentage coverage 
by COG annotations for genes under positive selection for H. pylori, N. meningitidis and V. 
cholerae (64%) is almost double compared to GO annotations of the same gene lists which is 
34% (Table 4.1, page 67). The higher coverage of gene lists by COG annotations in comparison 
to GO annotations is due to COGs being established longer then the GO system and COGs’ 
initial focus on prokaryotic genome annotation 102,109,110,112.      
        From the genome gene list, V. cholerae have the largest count for almost all of the COG 
alphabetical categories followed by N. meningitidis and H. pylori, possibly reflecting the order 
of gene content between the three bacterial organisms (Figure 4.4, page 79). V. cholerae has the 
smallest count of genes under positive selection belonging to each COG alphabetical category 
due to the small proportion of genes under positive selection compared to N. meningitidis and H. 
pylori (Figure 4.4, page 79). One way-classification Chi-Square tests with Holm’s correction for 
multiple testing to determine if any COG alphabetical categories (Figure 4.4, page 79) have a 
statistically significant abundance of genes under positive selection for H. pylori, N. meningitidis 
and V. cholerae show no statistically significant abundance for any COG alphabetical category 
at the P = 0.05 level (Appendix C1). N. meningitidis genes under positive selection have the 
highest count for COG categories; [F] Nucleotide transport and metabolism, [H] Co-enzyme 
transport and metabolism, [J] Translation, [M] Cell wall/membrane biogenesis and [U] 
Intracellular trafficking and secretion compared to H. pylori and V. cholerae (Figure 4.4, page 
79). The above mentioned COG categories for N. meningitidis genes under positive selection 
roughly mirror the GO terms found to be specific to N. meningitidis genes under positive 
selection (Figure 4.1, page 68). Analogous to GO specific terms for H. pylori genes under 
positive selection (Figure 4.1, page 68), COG categories [E] Amino acid transport and 
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metabolism, [G] Carbohydrate transport and metabolism, [I] Lipid transport and metabolism as 
well as [T] Signal transduction mechanisms have the highest counts of H. pylori genes under 
positive selection (Figure 4.4, page 79). 
        Database identified virulence genes show a statistically significant association for a number 
of alphabetical COG categories at the P = 0.05 level, after correction for multiple hypothesis 
testing. Alphabetical COG categories statistically enriched for H. pylori, N. meningitidis and V. 
cholerae database identified virulence genes are presented below in Table 4.5 and in Appendix 
C1. 
COG Category H. pylori N. meningitidis V. cholerae 
[E] Amino acid transport and metabolism NIL NIL 0.003138 
[J] Translation 0.03517 NIL NIL 
[K] Transcription NIL NIL 0.029953 
[L] Replication, recombination and repair 0.03517 NIL NIL 
[M] Cell wall/membrane biogenesis NIL 4.3056e – 15 NIL 
[N] Cell motility 2.86e – 15 1.76e – 15 3.08e – 15 
[P] Inorganic ion transport and metabolism 5.5748e – 4 NIL NIL 
[U] Intracellular trafficking and secretion 2.86e – 15 1.76e – 15 3.08e – 15 
Table 4.5 : P values for Chi-Square tests conducted to determine which alphabetical COG 
categories have a statistical enrichment of database identified virulence genes for H. pylori, N. 
meningitidis and V. cholerae. The P values presented have been adjusted for multiple hypotheses 
testing using Holm’s correction method. 
 
        COG categories enriched for database identified virulence genes common to all three 
bacterial species are [N] Cell motility and [U] Intracellular trafficking and secretion (Table 4.5), 
V. cholerae has the highest gene count for both the above mentioned COG categories followed 
by H. pylori and N. meningitidis respectively (Figure 4.4, page 79). Cell motility is generally 
considered to be a virulence factor in aiding movement towards hospitable environmental niches 
for colonization and procurement of nutrients 6,11,12,72. The main form of contact and interaction 
a bacterial cell has with its environment is through the uptake of nutrients crossing through the 
cell membrane and secretion of waste products and colonisation enhancing factors such as toxins 
into its surroundings 6,11,12,72. Species specific COG categories statistically enriched for N. 
meningitidis database identified virulence genes are [M] Cell wall/membrane biogenesis (Table 
4.5). For H. pylori database identified virulence genes, COG categories [J] Translation, [L] 
Replication, recombination and repair and [P] Inorganic ion transport and metabolism are unique 
to this micro-organism and are statistically significantly enriched (Table 4.5). Species specific 
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COG categories statistically enriched for V. cholerae database identified virulence genes are [E] 
Amino acid transport and metabolism and [K] Transcription (Table 4.5, page 81). 
        Two way classification Chi-Square tests to determine whether any alphabetical COG 
categories have a statistically significant association between genes under positive selection and 
database identified virulence genes identify two COG categories for N. meningitidis at the P = 
0.05 level (Appendix C1). The two COG categories enriched for N. meningitidis genes under 
positive selection and database identified virulence genes are [M] Cell wall/membrane 
biogenesis (adjusted P = 0.007115) and [N] Cell motility (adjusted P = 0.007115). H. pylori 
genes under positive selection and database identified virulence genes shows some statistically 
significant association for alphabetical COG categories [N] Cell motility and [J] Translation at 
the P = 0.05 mark, although this statistically significant association does not hold after 
correcting for multiple hypotheses testing (Appendix C1). For V. cholerae, the only gene pair 
that is under positive selection and is a database identified virulence gene (VC0837: 
VC0395_A0362; Figure 3.4, page 46) does not belong to any COG category.  
        Similar to GO annotations, no statistically significant functional grouping for genes under 
positive selection in H. pylori, N. meningitidis and V. cholerae could be found using COG 
alphabetical categories, even though the gene list coverage is almost double that of GO 
annotations. Common and species unique COG alphabetical categories are found to be enriched 
for database identified virulence genes indicating some commonalities as well as differences 
between characterised virulence processes for H. pylori, N. meningitidis and V. cholerae exist 
(Table 4.5, page 81).   
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Subcellular Localization of Bacterial Proteins  
        Bacterial contact, colonization and infection of a host requires interactions between a 
bacterial cell and a host which may occur through use of surface exposed proteins such as 
adhesins, as in the case of N. meningitidis, secretion of bio-molecules like cholera toxin or 
urease from V. cholerae and H. pylori respectively, transport of survival factors or movement to 
hospitable environmental niches through chemotaxis and flagellum motility 6,11,70,71,74,81. These 
pathogen-host interactions are mediated by proteins and factors that have well defined sub-
cellular localisation sites. Elucidation of subcellular sites for an active gene product 
compliments functional annotation of bacterial gene lists as both the location and function of an 
active gene product are intertwined, evolutionary conserved attributes 113,115,171. Knowledge of 
subcellular sites for an active gene product provides insights as to what evolutionary pressures 
may operate on a particular gene, e.g. surface exposed proteins are known to be under 
diversifying selection to avoid recognition by the immune system 6,55,162. 
        GO and COG functional annotation of genes under positive selection and database 
identified virulence genes for H. pylori, N. meningitidis and V. cholerae indicate a number of 
genes involved in transport, metabolism, secretion, cell membrane structure and motility 
amongst others (Figures 4.1, 4.2, 4.3 and 4.4, pages 68, 71, 75 and 79 respectively). GO and 
COGs are inherently biologically process driven functional annotation systems providing little 
information as to the precise subcellular site proteins of genes under positive selection and 
database identified virulence genes operate within a cell 102,109,110,112. 
        Subcellular localization prediction of proteins is amenable to bioinformatic analysis as cues 
governing the subcellular compartments where a protein is active are usually embedded within 
the synthesized protein 113,115,172. Possible encoded signals within a synthesized protein include 
distinctive amino acid profiles, alpha-helical secondary structures integral to cytoplasmic 
membrane proteins, beta-barrel secondary structures for gram negative bacterial cells that extend 
across the outer membrane, or N-terminal hydrophobic signal peptides which chauffer the export 
of a protein from the cytoplasm 115. Numerous bioinformatics systems predicting protein 
subcellular localization have been developed by different groups concentrating on various 
organisms and proteins using an assortment of approaches ranging from Hidden Markov Models 
to support vector machine learning methods 113-115. A popular bioinformatics system developed 
for sub-cellular localization prediction within bacterial organisms is PSORTb which relies on 
multiple sequence features as classifiers and is based upon the PSORT I method, originally 
implemented by Nakai and Kanehisa 113-115,172.  
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PSORTb Subcellular Localization Prediction of Bacterial Proteins  
        PSORTb (version 2) uses six independent bioinformatics software modules for subcellular 
localization prediction and integrates scores from these six modules using a Bayesian network 
statistical approach to generate a final subcellular site prediction for a given protein 114-116. 
PSORTb uses SCL-BLAST for homology based prediction, an outer membrane motif 
identification module, Hidden Markov Model for Topology prediction (HMMTOP) for 
transmembrane helix prediction and a signal peptide identification module also based on a 
Hidden Markov Model 113-116. A motif and a profile matching module both trained on PROSITE 
data are also used, the latter differing from the former by inclusion of a position specific 
weighted matrix 113-116. PSORTb version 2 differs from version 1.1 by implementation of a 
support vector machine learning algorithm which uses recurring sub sequences within a protein 
to delineate between pre-defined subcellular localization sites, resulting in increased precision 
(specificity) and bacterial proteome coverage 113-115. Each module outputs a probability value 
that is normalised by a factor 10 multiplication, and passed onto a Bayesian network to generate 
a final prediction score for a particular subcellular site 113-115.  The Bayesian network appraises 
score distributions for each subcellular site and predicts a site depending on the score 
distributions’ biasness for a particular site 113-115. The scoring scheme for PSORTb ranges from 0 
to 10, scores greater then a recommended threshold of 7.5 are used to generate the final 
subcellular localization prediction site with a high precision (96%) 114,115. 
        The subcellular localization prediction sites defined by PSORT for gram negative bacteria 
like H. pylori, N. meningitidis and V. cholerae are Cytoplasmic, Cytoplasmic Membrane, 
Periplasmic, Outer Membrane, Extra Cellular and Unknown. Cytoplasmic Membrane is the 
region between the cytoplasm and the inner cell wall and is usually associated with the 
movement of vesicles for the export of cell products to the external environment (exocytosis) or 
intake of products from the external environment into the bacterial cell (endocytosis). The 
Periplasmic interval (interval between the Cytoplasmic membrane and Outer Membrane for 
gram negative bacteria) is of great interest as proteins within this region form components of 
Type II and III secretion systems and two-component sensors e.g. histadine-kinase sensors 
which facilitate interaction and movement of bio-molecules between internal and external 
environments of a bacterial cell. Outer Membrane proteins are located on the outer bacterial cell 
membrane like adhesins while Extra Cellular proteins are secreted by the bacterial cell into the 
environment e.g. siderophores. A protein may have multiple localization sites within a bacterial 
cell, an equal distribution of scores for a number subcellular localization sites or not reach the 
7.5 confidence score threshold, in such instances they are classified as Unknown 113-116. 
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PSORTb Subcellular Localization Prediction of Bacterial Gene Lists 
        Subcellular localization predictions of database identified virulence genes, genes under 
positive selection and all genes within the genome for H. pylori, N. meningitidis and V. cholerae 
were obtained from cPSORTdb (version 2) 114,116. Bacterial gene products that did not make the 
recommended PSORTb threshold score of greater then 7.5 were excluded from subsequent 
analysis. In all instances, bacterial proteins with a final score below the 7.5 threshold were 
classified by PSORTb as Unknown. In terms of coverage, PSORTb will place every protein for 
a gram negative bacterial proteome into one of six subcellular localization categories and if the 
category Unknown is included, gene list coverage would reach 100%. However, as the category 
Unknown is uninformative and all genes not making the 7.5 cut-off for a subcellular localization 
site fall into this category, gene counts for Unknown were excluded from calculating percentage 
coverage of gene lists and statistical analysis. Gene list coverage by PSORTb for database 
identified virulence genes, genes under positive selection and all genomic genes for H. pylori, N. 
meningitidis and V. cholerae are presented below in Table 4.6. 
Bacterial Organism 
No of Genome Genes 
belonging to a 
PSORTb subcellular 
localization site 
(%) 
No of Genes under 
Positive Selection 
belonging to a 
PSORTb 
subcellular 
localization site 
(%) 
No of Database 
Identified Virulence 
Genes belonging to 
a PSORTb 
subcellular 
localization site 
(%) 
H. pylori 
861 
(55 % of 1,576 genes) 
151 
(66 % of 230 genes) 
94 
(61 % of 153 genes) 
N. meningitidis 
1103 
(53 % of 2,065 genes) 
131 
(60 % of 218 genes) 
33 
(49 % of 68 genes) 
V. cholerae 
2162 
(56 % of 3,835 genes) 
14 
(61 % of 23 genes) 
95 
(57 % of 168 genes) 
Table 4.6 : Number of genes for H. pylori, N. meningitidis and V. cholerae genome, database 
identified virulence genes and genes under positive selection that pass the recommended 7.5 
PSORTb score threshold belonging to a subcellular localization site other then Unknown and 
percentage coverage of those gene list types. 
 
        Percentage coverage of genes under positive selection by PSORTb is higher then 
percentage coverage of database identified virulence genes in all instances (Table 4.6). The 
number of H. pylori, N. meningitidis and V. cholerae genes belonging to each PSORTb 
subcellular localization site for all gene list types is presented overleaf in Figure 4.5. 
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Number of Genes Predicted for a PSORT Subcellular Localization Site
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Figure 4.5 : Gene counts for genome genes, genes under positive selection and database 
identified virulence genes for H. pylori, N. meningitidis and V. cholerae belonging to a specific 
PSORTb subcellular localization site. 
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        The majority of genomic genes localize within the Cytoplasmic and the Cytoplasmic 
Membrane regions for H. pylori, N. meningitidis and V. cholerae (Figure 4.5, page 86). H. pylori 
has a larger proportion of genomic genes present on the Outer Membrane compared to N. 
meningitidis and V. cholerae, V. cholerae has more Extra Cellular proteins then either H. pylori 
or N. meningitidis (Figure 4.5, page 86). The preponderance of genes under positive selection 
for H. pylori, N. meningitidis and V. cholerae localize to the Cytoplasmic and Cytoplasmic 
Membrane locations (Figure 4.5, page 86). Compared to N. meningitidis and V. cholerae, H. 
pylori has more genes under positive selection localized to the Outer Membrane and only V. 
cholerae does not have any genes under positive selection predicted to localize within the 
Periplasmic interval (Figure 4.5, page 86). One-way classification Chi-Square tests reveal a 
statistically significant association for the PSORTb Outer Membrane subcellular localization site 
for H. pylori (Adjusted P = 0.00768) and N. meningitidis (Adjusted P = 0.04582) genes under 
positive selection. The full results of the Chi-Square tests conducted are available in Table C2A, 
Appendix C2. 
        A large proportion of database identified virulence genes for V. cholerae are predicted to be 
Extra Cellular and Periplasmic in comparison to H. pylori and N. meningitidis (Figure 4.5, page 
86). Both H. pylori and N. meningitidis have more database identified virulence genes associated 
with the Outer Membrane compared to V. cholerae (Figure 4.5, page 86). A number of PSORTb 
subcellular localization sites that are statistically enriched for database identified virulence genes 
together with their adjusted P values for H. pylori, N. meningitidis and V. cholerae are presented 
below in Table 4.7. 
Bacterial Organism and Adjusted P Values PSORTb Subcellular 
Localization Site H. pylori N. meningitidis V. cholerae 
Cytoplasmic 0.000428 0.000145 2.571e – 05 
Cytoplasmic Membrane 1 1 1 
Periplasmic 1 1 1 
Outer Membrane 8.99e – 07 3.285e – 09 5.695e – 07 
Extra Cellular 0.0178 0.3438 2.6784e – 06 
Table 4.7 : P values of Chi-Square tests with Holm’s correction for multiple hypothesis testing 
for database identified virulence genes association with specific subcellular localization sites for 
H. pylori, N. meningitidis and V. cholerae. Full results of statistical testing for all PSORTb 
categories for database identified virulence genes for H. pylori, N. meningitidis and V. cholerae 
is contained in Table C2B, Appendix C2.  
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        Database identified virulence gene products show a statistically significant association at 
the P = 0.05 level for subcellular localization sites Cytoplasmic and Outer Membrane (Table 4.7, 
page 87). Across all three bacterial species, database identified virulence gene products have the 
strongest association, based on P values, for being located on the Outer Membrane (Table 4.7, 
page 87) compared to all other PSORTb subcellular localization sites. Gene products for 
database identified virulence genes do not have a statistical association at the P = 0.05 level for 
being localized at the Cytoplasmic membrane or Periplasmic interval across all three bacterial 
species (Table 4.7, page 87).  
        Two-way classification Chi-Square tests to determine if there is an association between 
database identified virulence genes that are under positive selection for a PSORTb site indicate 
that no particular PSORTb subcellular localization site has a statistically significant association 
at the P = 0.05 level (Table C2C, Appendix C2, page 87). Hence, although gene products for 
genes under positive selection and database identified virulence genes show a statistical 
enrichment at the P = 0.05 level for localization to the Outer Membrane when tested 
individually, the overlap between the two gene lists does not appear to be statistically 
significant. The absence of strong statistical association between database identified virulence 
genes and genes under positive selection may indicate that not all Outer Membrane genes for H. 
pylori or N. meningitidis are virulence genes, under which a large proportion of genes under 
positive selection belong to. Alternatively, the absence of strong statistical association between 
Outer Membrane genes undergoing positive selection and database identified virulence genes 
may reflect an incomplete virulence gene characterization repertoire for the three bacterial 
species as functional gene annotation is an ongoing process 6,82,129.  
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Chapter 5 : Metabolic Pathways 
Introduction 
        Biological cells are complex systems whose phenotypic behaviour is governed by 
expression of its constituent genotype. As in all complex systems, components of the system (in 
this instance genes and their products) do not function in isolation. Instead, genes and their 
products function in an organised, concerted manner creating biological networks of various 
complexities based upon interconnectivity 173-176. Biological networks form a natural extension 
for leveraging high throughput genomics data to decipher the organisation and information flow 
within complex, biological systems 36,173-179. Biological networks can be defined at a variety of 
levels ranging from physical gene clustering in a genome, gene expression networks, signalling 
networks, transcriptional regulatory networks, neurological networks, biochemical metabolic 
networks and protein-protein interaction maps 36,173-178. Each type of biological network differs 
in the experimental datasets used to establish the network, the topologies and interconnectivity 
of the resulting networks and the species used to derive the network 36,173-178. A common goal of 
most biological network studies is the contextualisation of biological information within a 
systematic framework allowing the grouping and characterisation of similar, interacting 
components under pre-specified biological conditions to provide an integrative view of how a 
complex biological system functions 36,173-179.          
        Network modelling of biological systems demonstrate they share similarities with other 
types of networks from non-biological complex systems in that they are non-random and are 
scale-free 36,173-179. Networks are modelled using graph theory within which members of the 
network are termed as “nodes” and links between nodes are termed as “edges” 36,173-179. Edges 
between nodes in a network may be directed whereby there is a unidirectional process flow from 
one node to another or they may be undirected whereby a bi-directional process flow between 
nodes occurs 36,173-179. Random network models assume the number of edges a node has to other 
nodes within the network follows a Poisson distribution with most nodes having a similar 
number of edges to the average number of edges for all nodes within the network 173-175,177. 
Empirical studies of networks in complex systems show these networks do not follow a Poisson 
distribution but instead are scale free whereby the distribution of edges for a given node can be 
described with a power law and in contrast to random network models, are non-uniform 36,173-179. 
Scale free networks are characterised by having a few central nodes known as hubs that connect 
to numerous other nodes within the network and unlike random network models based on a 
Poisson distribution, a single node and the number of edges it contains can not be used to typify 
other nodes within the network 36,173-179. 
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        Using protein-protein interaction data, Fraser et al showed interacting proteins within 
eukaryotic organisms co-evolve and genes involved in the same pathways have similar rates of 
evolution 173,180. If interacting genes have similar rates of evolution, can genes under positive 
selection for H. pylori, N. meningitidis and V. cholerae be segregated into similar metabolic 
pathways? In addition, do database identified virulence genes also function as modules within 
any metabolic pathways and do these pathways overlap with genes under positive selection for 
H. pylori, N. meningitidis and V. cholerae?  
Metabolic Pathways and Databases 
        Analyses of metabolic networks which places metabolites as nodes and edges as reactions 
catalysed by enzymes have established they are scale free networks 173,175,177-179. The majority of 
metabolic substrates are engaged in a few biochemical reactions while the minority form hubs 
connected to numerous biochemical reactions 173,175,177-179. Within metabolic networks, there are 
modules or pathways of interacting nodes which are coupled together to accomplish specific 
biochemical reactions 173,175,177-179. Edges between nodes in metabolic networks and pathways 
are generally directed as the end product of one metabolic reaction forms the substrate for 
another 173,175,177-179. Construction of metabolic pathways and networks is based upon four levels 
of varying detail 36,178,179. Within the first level of detail, the metabolic pathway, gene products 
involved within the pathway, metabolites, substrates and the type of reaction catalysed are 
defined 36,178,179. The second level of detail defines the charged chemical formulae of metabolites 
catalysed by enzymatic reactions within the pathway 36,178,179. Balancing of charges within the 
chemical equation formulae of enzymatic reactions provides the exact molecular proportions of 
metabolites that flow through the metabolic pathway providing the third level of detail while the 
fourth level of detail is represented by the directionality of substrate flow through the metabolic 
pathway 36,178,179.  
        Two popular, well documented pathway databases which provide collections of metabolic 
pathways are the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the BioCyc 
collection of individual organism specific databases 36,117,118,120,125,181. BioCyc and KEGG aim to 
connect genomic information with molecular interaction and functional information of gene 
products within the context of biological pathways 117,118,120,125,181. Both KEGG and BioCyc have 
genome sequence information and gene product annotations linked to substrate specificity, 
metabolite formulae, stoichiometry, enzymatic pathway directionality as well as incorporate 
literature and experimental evidence for curation of their metabolic pathways 36,117,118,120,125,181. 
Methods used to construct the KEGG and BioCyc databases differ although both initially begin 
with well defined maps of central metabolism common to all organisms 36,117,118,120,125,181.  
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        KEGG contains manually constructed maps of metabolic networks upon which enzymatic 
gene products with known functions are overlaid to form a reference map 120,121,125. Homology 
searches of reference map genes are conducted to identify orthologous genes from other 
organisms which are assigned their relevant Enzyme Commission (EC) numbers 120,121,125. The 
EC numbers are matched to EC numbers in the reference maps and used to computationally 
generate metabolic pathway maps that are organism specific 120,121,125. BioCyc is a collection of 
databases each housing individual organism specific metabolic pathways and a heavily curated 
reference database of metabolic pathways that is organism independent (MetaCyc) 117,118. 
Organism genome information for all databases in BioCyc is obtained from publically available 
sources and metabolic pathway information is incorporated through the use of the PathoLogic 
programme 117,118,182. The PathoLogic programme identifies enzymes and their EC numbers 
from the genome under annotation, determines their corresponding EC counterparts from the 
reference database of metabolic pathways (MetaCyc) and assigns appropriate pathway 
information to that genome 117,118,182. In the current state, the organism specific pathway 
database created is termed as “Tier 3” whose information is solely based on metabolic pathways 
obtained from MetaCyc and have not undergone any review 117,118. Tier 1 databases within the 
BioCyc collection, like MetaCyc and EcoCyc, have undergone years of manual curation and are 
constantly being updated to add experimentally determined pathways 117,118. Tier 2 databases are 
similar to Tier 3 databases in that they are computationally generated, but differ by having some 
level of manual curation to establish the fidelity of the pathway predictions contained within 
them 117,118.  
        Metabolic pathways of genes under positive selection and database identified virulence 
genes for H. pylori, N. meningitidis and V. cholerae were investigated using KEGG and 
BioCyc’s organism specific databases and web-based Pathway Tools 117,118,120,125,182. BioCyc 
databases for H. pylori (strain 26695) and V. cholerae (strain N16961) are classified as Tier 2 
databases while N. meningitidis (strains Z2491 and MC58) are categorised as Tier 3 databases•. 
Metabolic pathway annotations from KEGG for genes under positive selection and database 
identified virulence genes were obtained using DAVID. DAVID’s gene list manager enables one 
to interrogate KEGG pathway annotations to obtain pathways that are common between genes 
under positive selection and database identified virulence genes.  
 
 
 
                                                
•
 http://biocyc.org/biocyc-pgdb-list.shtml 
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H. pylori  BioCyc Metabolic Pathways 
        H. pylori accessions for genes under positive selection and database identified virulence 
genes were used to query BioCyc’s (Version 13.5) H. pylori (strain 26695) database for 
metabolic pathway annotations selecting a threshold of 1 for individual metabolic pathways. In 
terms of coverage, 54 (23% of 230) H. pylori genes under positive selection and 22 (14% of 
153) H. pylori database identified virulence genes can be placed in a metabolic pathway by 
BioCyc. BioCyc coverage of H. pylori gene lists may not be an accurate measure of annotation 
depth as not all genes within the H. pylori genome are involved in metabolic pathways e.g. 
adhesins or flagellum. However, there are “pathway holes” in some metabolic pathways for 
which the corresponding genes remain to be elucidated, it is feasible that some genes on the 
gene lists will be assigned to these pathway holes once experimental evidence for their function 
becomes available 183,184. Metabolic pathways obtained from BioCyc for H. pylori genes under 
positive selection and database identified virulence genes are presented overleaf in Table 5.1. 
        The 54 H. pylori genes under positive selection belong to thirty-nine different metabolic 
pathways, the 22 H. pylori database identified virulence genes map to fifteen different metabolic 
pathways within BioCyc (Table 5.1, page 93). The combined number of metabolic pathways 
represented by H. pylori genes under positive selection and database identified virulence genes 
is fifty-four. Of these fifty-four metabolic pathways, six are shared between genes under positive 
selection and database identified virulence genes (Table 5.1, page 93). As there are 22 genes in 
common between H. pylori positive selection and database identified virulence gene lists (Figure 
3.4, page 46), some overlap in metabolic pathways between the two gene lists is not unexpected. 
Of the 22 H. pylori database identified genes under positive selection, 4 genes map to four 
different BioCyc metabolic pathways; Arginine Degradation VI (Arginase 2 pathway), Arginine 
Degradation VII, Enterobacterial Common Antigen Biosynthesis and Urea Degradation II 
(Table 5.1, page 93). A further two BioCyc metabolic pathways for H. pylori genes under 
positive selection and database identified virulence genes that is not based on the overlap of the 
two gene lists are Colanic Acid Building Blocks Biosynthesis and GDP-Mannose Metabolism 
(Table 5.1, page 93). 
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Row 
NO 
BioCyc Metabolic Pathways of H. 
pylori Genes under Positive 
Selection 
BioCyc Metabolic Pathways 
of H. pylori Database 
Identified Virulence Genes 
BioCyc Metabolic Pathways 
Common to H. pylori Genes 
under Positive Selection and 
Database Identified 
Virulence Genes 
1 Arginine Degradation VI (Arginase 2 pathway) 
Arginine Degradation VI 
(Arginase 2 pathway) 
Arginine Degradation VI 
(Arginase 2 pathway) 
2 Arginine Degradation VII Arginine Degradation VII Arginine Degradation VII 
3 Colanic Acid Building Blocks Biosynthesis 
Colanic Acid Building Blocks 
Biosynthesis 
Colanic Acid Building Blocks 
Biosynthesis 
4 Enterobacterial Common Antigen Biosynthesis 
Enterobacterial Common 
Antigen Biosynthesis 
Enterobacterial Common 
Antigen Biosynthesis 
5 GDP-Mannose Metabolism GDP-Mannose Metabolism GDP-Mannose Metabolism 
6 Urea Degradation II Urea Degradation II Urea Degradation II 
7 Cardiolipin Biosynthesis I Glutamate Biosynthesis II 
8 CDP Diacylglycerol Biosynthesis II Glutamate Biosynthesis III 
9 Chorismate Biosynthesis Glutamate Degradation I 
10 Fatty Acid Biosynthesis Initiation II Glutamine Biosynthesis I 
11 Fatty Acid Biosynthesis Initiation III Glutamine Biosynthesis II 
12 Fatty Acid Elongation (saturated) Lipid-A-precursor Biosynthesis 
13 Fatty Fcid ß Oxidation I Proline Biosynthesis II 
14 FormylTHF Biosynthesis I Thioredoxin Pathway 
15 Gluconeogenesis   UDP Glucose Conversion 
16 Glyceraldehyde 3-Phosphate Degradation 
17 Glycolysis I 
18 Glycolysis IV (plant cytosol) 
19 Homoserine Biosynthesis 
20 Lysine Biosynthesis I 
21 NAD Biosynthesis I (from Aspartate) 
22 Peptidoglycan Biosynthesis I 
23 Proline Degradation II 
24 Purine nucleotides de novo Biosynthesis I 
25 Quinate Degradation 
26 Respiration (anaerobic) 
27 Salvage Pathways of Purine and Pyrimidine nucleotides 
28 Serine Biosynthesis 
29 Superpathway of Fatty acid Biosynthesis Initiation (E. coli) 
30 TCA Cycle Variation II 
31 Tetrahydrofolate Biosynthesis I 
32 Tetrapyrrole Biosynthesis I 
33 tRNA Charging Pathway 
34 Tryptophan Biosynthesis 
35 UDP-N-acetyl-D-glucosamine Biosynthesis I 
36 Thiamine Biosynthesis 
 
 
Table 5.1 : BioCyc metabolic pathways determined for H. pylori genes under positive selection, 
database identified virulence genes and metabolic pathways common to both gene lists. 
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A cellular overview of H. pylori’s BioCyc metabolic pathways for genes under positive 
selection, database identified virulence genes and metabolic pathways shared between the two 
gene list types is presented overleaf in Figure 5.1. The Urea Degradation II pathway containing 
database identified virulence genes under positive selection (Figure 5.1, Box 1, page 95) is 
catalysed by the enzyme urease within H. pylori and is vital for the organism’s survival and 
colonisation within the acidic gastric environment and maintenance of pH homeostasis within 
the bacterial cell 76,81,185,186. H. pylori produces ammonia by the urea degradation pathway to 
buffer the pH of its micro-environment within the stomach and urease enzyme synthesis within 
H. pylori is prolific contributing to approximately 10% of the total protein content 76,81,185-187.  
        Arginine Degradation VI and VII (Figure 5.1, Boxes 2 and 3 respectively, page 95) 
pathways are variant pathways of the arginine degradation super pathway producing different 
end product metabolites. Arginine degradation pathways are used by bacteria which have limited 
sources of free nitrogen, L-arginine is hydrolysed by the enzyme arginase (HP1399 - rocF) to 
create urea and L-ornithine 117,118. H. pylori has altered its physiology to exploit amino acids like 
arginine as a carbon source instead of carbohydrates due to the unavailability of free nitrogen 
and the constant pressure on the bacterium to raise the pH of its micro-environment within its 
gastric niche 176. Two of four Arginine Degradation VII pathway genes within H. pylori are 
under positive selection, the first gene in the Arginine Degradation VII pathway is a database 
identified virulence gene under positive selection (Figure 5.1, Box 3, page 95).  
        Enterobacterial Common Antigen (ECA) (Figure 5.1, Box 4, page 95) is an outer 
membrane glycolipid found in enterobacterial members from the proteobacterial lineage 188-190. 
Deficiencies in the ECA pathway are known to reduce motility within H. pylori, E. coli and 
Serratia marcescens, motility is an essential factor for H. pylori chemo-taxis and colonisation of 
the gastric niche 76,188-190.   
        The GDP-Mannose metabolic pathway (Figure 5.1, Box 5, page 95) is a common pathway 
present in eukaryotic and prokaryotic organisms 191. GDP-α-D-mannose is converted to GDP-L-
fucose which is a component of the lipopolysaccharide (LPS) O-antigen of H. pylori 191,192. 
Fucosylation of LPS O-chains is important in mediating bacterial cell adhesion to host cells and 
enables Lewis antigen mimicry which is directly linked to gastritis 193-195.  
        Colanic acid or M antigen (Figure 5.1, Box 6, page 95) is an exopolysaccharide which also 
contains GDP-L-fucose and is common to enterobacterial species 196-198. Within E. coli, colonic 
acid synthesis has no known role in bacterial virulence but is postulated to prevent desiccation 
and enable survival of the bacterium when not host-associated 196-198. Within H pylori, genes 
under positive selection and database identified virulence genes are part of the colanic acid 
biosynthesis pathway (Figure 5.1, Box 6, page 95). 
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Figure 5.1 : BioCyc metabolic pathways for H. pylori genes under positive selection (yellow lines), database identified virulence genes (blue lines) and 
pathways common to both gene lists (red lines). Six common metabolic pathways between H. pylori genes under positive selection and database identified 
virulence genes are highlighted in numbered boxes; 1 – Urea Degradation II, 2 and 3 – Arginine Degradation VI and VII respectively, 4 – Enterobacterial 
Common Antigen Biosynthesis, 5 – GDP-Mannonse Metabolism, 6 – Colanic Acid Building Blocks Biosynthesis (Table 5.1, page 93)
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        KEGG Pathways of H. pylori Genes 
        KEGG pathways for H. pylori genes under positive selection and database identified 
virulence genes were obtained using DAVID 111,121,125. DAVID was chosen for KEGG pathway 
determination for reasons including ease of acquiring KEGG pathway annotations for complete 
gene lists and statistical enrichment analyses for genes belonging to a KEGG pathway. 
Additionally, DAVID provides shared KEGG pathways between gene lists by using a specific 
gene list as a foreground and another as a background gene list. H. pylori accessions for genes 
under positive selection and database identified virulence genes were uploaded to DAVID’s 
gene list manager and an EASE score of 0.5 was selected to maximise gene list coverage and 
maintain consistency across comparisons.  
        From 230 H. pylori genes identified as being under positive selection, 19% (44 of 230 
genes) could be placed into fifteen different KEGG pathways. None of the KEGG pathways 
show a statistical enrichment for genes under positive selection at the P = 0.05 level after 
correction for multiple hypotheses testing. The fifteen KEGG pathways H. pylori genes under 
positive selection are mapped to is presented below in Table 5.2.  
KEGG Pathway Reference KEGG Pathway Description 
hpy00330 Arginine and proline metabolism 
hpy00300 Lysine biosynthesis 
hpy00970 Aminoacyl-tRNA biosynthesis 
hpy00550 Peptidoglycan biosynthesis 
hpy05120 Epithelial cell signaling in Helicobacter pylori infection 
hpy00790 Folate biosynthesis 
hpy00450 Selenoamino acid metabolism 
hpy00770 Pantothenate and CoA biosynthesis 
hpy03060 Protein export 
hpy00061 Fatty acid biosynthesis 
hpy03030 DNA polymerase 
hpy00400 Phenylalanine, tyrosine and tryptophan biosynthesis 
hpy02030 Bacterial chemotaxis – General 
hpy02010 ABC transporters – General 
hpy02020 Two-component system – General 
Table 5.2 : Description of KEGG pathways and pathway identifiers mapped to H. pylori genes 
under positive selection obtained via DAVID.  
 
 
 
 
 
 97 
        KEGG pathway descriptions and maps are more general and have less detail compared to 
BioCyc’s metabolic pathways which are discrete and have well defined organism specific 
metabolic pathways 118 
        Of 153 H. pylori database identified virulence genes, 54% (83 of 153 genes) could be 
placed into thirteen different KEGG pathways. Of these thirteen KEGG pathways, five show a 
statistical enrichment for database identified virulence genes at the P = 0.05 interval after 
stringent Bonferroni corrections for multiple hypothesis testing. The fourteen KEGG pathways 
for H. pylori database identified virulence genes and P values obtained from DAVID are 
summarised below in Table 5.3. 
KEGG Pathway 
Reference 
KEGG Pathway Description Adjusted P 
Value 
hpy05120 Epithelial cell signalling in Helicobacter pylori infection 6.59e-30 
hpy02040 Flagellar assembly 1.15e-27 
hpy03080 Type IV secretion system 8.81e-10 
hpy03070 Type III secretion system 1.28e-06 
hpy02030 Bacterial chemotaxis – General 2.53e-05 
hpy02020 Two-component system – General 0.0918 
hpy00220 Urea cycle and metabolism of amino groups 0.987 
hpy00643 Styrene degradation 1 
hpy00632 Benzoate degradation via CoA ligation 1 
hpy00791 Atrazine degradation 1 
hpy00460 Cyanoamino acid metabolism 1 
hpy00051 Fructose and mannose metabolism 1 
hpy00360 Phenylalanine metabolism 1 
 Table 5.3 : KEGG pathway identifiers and descriptions for H. pylori database identified 
virulence genes. Bonferroni adjusted P values show statistical enrichment of H. pylori database 
identified virulence genes for five out of thirteen KEGG pathways at the P = 0.05 level.  
 
        Epithelial cell signalling during H. pylori infection, flagellar assembly, chemotaxis and 
secretion systems (type III and IV) are KEGG pathways statistically enriched for H. pylori 
database identified virulence genes at the P = 0.05 level (Table 5.3). Examination of the five 
KEGG pathway maps enriched for H. pylori database identified virulence genes to determine 
where those genes are located reveal in some cases, they constitute all genes present within that 
specific KEGG pathway map. H. pylori database identified virulence genes and their locations 
on KEGG pathway maps for Epithelial cell signalling in H. pylori infection and Flagellar 
assembly are presented in Figures 5.2 and 5.3 overleaf. 
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Figure 5.2 : KEGG pathway map (hpy05120) for Epithelial cell signalling in H. pylori 
infection, all genes in green boxes except ATPeV and PrtC are H. pylori database identified 
virulence genes that are part of this KEGG pathway map. The KEGG pathway depicts the 
insertion of the vacuolating cytotoxin (VacA) into the plasma membrane of an epithelial cell and 
translocation of CagA into the epithelial cell by the Cag type IV secretion system.  
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Figure 5.3 : KEGG pathway map for Flagellar assembly (hpy02040) in H. pylori. All genes in 
green boxes are database identified virulence genes for H. pylori that can be placed onto this 
KEGG pathway map. The pathway depicts components of gene products used to construct the 
flagellum within H. pylori. The flagellum within H. pylori is essential for motility of the 
organism and enables movement to high pH gradients within the stomach. 
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       H. pylori genes under positive selection were set as the foreground list and database 
identified virulence genes as the background gene list in DAVID to ascertain if the two gene 
lists have any shared KEGG pathways. An EASE score of 1 was selected as no KEGG pathways 
between the two gene list types were found to be statistically significant at an EASE threshold of 
0.5, and to provide as many shared KEGG pathways as possible. Five KEGG pathways are 
shared by H. pylori genes under positive selection and database identified virulence genes; 
Protein export (hpy03060), Bacterial chemotaxis (hpy02030-general pathway), Two-component 
system (hpy02020-general pathway), Type IV secretion system (hpy03080) and Epithelial cell 
signaling in H. pylori infection (hpy05120). The VacA, BabA and CagA genes are shared by H. 
pylori database identified virulence genes and genes under positive selection for the Epithelial 
cell signaling in H. pylori infection KEGG pathway (hpy05120), (Figure 5.2, page 98). The 
general bacterial chemotaxis KEGG pathway (hpy02030), presented below in Figure 5.4, has 
three H. pylori database identified virulence genes under positive selection; MCP, CheA and 
CheV. 
 
   
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 : The general bacterial chemotaxis KEGG pathway map (hpy02030) for which H. 
pylori genes under positive selection and database identified virulence can be placed (MCP, 
CheA and CheV). The CheA histadine kinase is autophosphorylated providing the substrate for 
the CheY response regulator which modulates the flagellum motor (Figure 5.3, page 99), 
resulting in bacterial motility. 
 
        Although no statistical enrichment of KEGG pathways for H. pylori genes under positive 
selection and database identified virulence genes could be found, these two gene lists have 
common elements that function in two characterised pathways that are involved in H. pylori 
virulence processes of epithelial cell signalling and chemotaxis / motility.  
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N. meningitidis BioCyc Metabolic Pathways  
        N. meningitidis BioCyc databases are classified as Tier 3 as their contents have not been 
reviewed or manually curated like Tier 2 H. pylori and V. cholerae BioCyc databases 117,118. 
BioCyc’s N. meningitidis database (strain Z2491, Version 13.1) was queried using N. 
meningitidis accessions for genes under positive selection and database identified virulence 
genes with a metabolic pathway threshold of 1. Of the 218 N. meningitidis genes under positive 
selection, 34% (75 of 218 genes) belong to sixty-four BioCyc metabolic pathways which are 
summarised below in Table 5.4.  
BioCyc Metabolic Pathways of N. meningitidis 
Genes under Positive Selection (Part 1) 
BioCyc Metabolic Pathways of N. meningitidis Genes 
under Positive Selection (Part 2) 
5-aminoimidazole ribonucleotide biosynthesis I heme biosynthesis from uroporphyrinogen II 
acrylonitrile degradation homolactic fermentation 
aerobic respiration -- electron donor II lipid-A-precursor biosynthesis 
arginine biosynthesis I lysine biosynthesis I 
arginine biosynthesis II (acetyl cycle) methylerythritol phosphate pathway 
arginine degradation I (arginase pathway) methylglyoxal degradation I 
asparagine degradation I mixed acid fermentation 
autoinducer AI-2 biosynthesis NAD biosynthesis I (from aspartate) 
biotin biosynthesis I NAD salvage pathway I 
biotin-carboxyl carrier protein NADH to cytochrome bd oxidase electron transfer 
CDP-diacylglycerol biosynthesis I NADH to cytochrome bo oxidase electron transfer 
CDP-diacylglycerol biosynthesis II ornithine biosynthesis 
CDP-diacylglycerol biosynthesis III peptidoglycan biosynthesis I 
chorismate biosynthesis I peptidoglycan biosynthesis III 
citrulline degradation ppGpp biosynthesis 
CMP-KDO biosynthesis I proline degradation I 
colanic acid building blocks biosynthesis respiration (anaerobic) 
fatty acid activation S-adenosyl-L-methionine cycle I (prokaryotic) 
fatty acid ß-oxidation I serine biosynthesis 
flavin biosynthesis I (bacteria) siroheme biosynthesis 
folate transformations sulfate reduction I (assimilatory) 
formaldehyde oxidation I TCA cycle variation I 
formylTHF biosynthesis I TCA cycle variation II 
formylTHF biosynthesis II TCA cycle variation IV 
GDP-mannose biosynthesis I tetrahydrofolate biosynthesis 
GDP-mannose biosynthesis II thiamin biosynthesis I 
gluconeogenesis I threonine biosynthesis from homoserine 
glutathione biosynthesis tRNA charging pathway 
glycine betaine degradation tryptophan biosynthesis 
glycine biosynthesis I ubiquinone-8 biosynthesis (prokaryotic) 
glycolysis I  uridine-5'-phosphate biosynthesis 
glycolysis III (Thermotoga) UDP-galactose biosynthesis (salvage pathway from galactose using UDP-glucose) 
Table 5.4 : Sixty-four BioCyc metabolic pathways that 75 N. meningitidis genes under positive 
selection are mapped to. The above table is divided into two columns (Part 1 and Part 2) 
providing thirty-two BioCyc metabolic pathways descriptions each. 
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        N. meningitidis BioCyc coverage of genes under positive selection (34% of 218 genes) is 
greater then BioCyc’s coverage of H. pylori genes under positive selection (23% of 230 genes). 
N. meningitidis genes under positive selection map to twenty-eight more BioCyc metabolic 
pathways compared to H. pylori genes under positive selection (Table 5.4, page 101, Table 5.1, 
page 93). N. meningitidis and H. pylori BioCyc databases have 155 and 143 BioCyc metabolic 
pathways respectively. Hence, the greater number of metabolic pathways for N. meningitidis 
genes under positive selection compared to H. pylori is not necessarily a reflection of N. 
meningitidis having more metabolic pathways then H. pylori. Instead, increased BioCyc 
coverage of N. meningitidis genes under positive selection compared to BioCyc’s H. pylori 
coverage might be due to a higher false positive rate 118,182. The PathoLogic prediction scoring 
scheme is deliberately designed to be as expansive as possible by favouring recall (sensitivity) 
over precision (specificity), resulting in potential false positive pathway predictions 118,182. 
Creators of BioCyc reason the provision of an expansive overview of metabolic pathway 
predictions for the user to scrutinise and investigate further is better then the total omission of 
ambiguous metabolic pathways 118,182. Also, the H. pylori BioCyc database is a Tier 2 database 
which has been manually reviewed and curated compared to N. meningitidis’ Tier 3 database 
status. Tier 3 databases have neither been reviewed nor curated and are therefore likely to 
contain a higher number of metabolic pathway predictions compared to Tier 2 databases 118,182.  
        Of the 68 N. meningitidis database identified virulence genes, 13% (9 of 68 genes) map to 
three BioCyc metabolic pathways. Even though database identified virulence gene list coverage 
by BioCyc for N. meningitidis (13% of 68 genes) is similar to that of H. pylori (14% of 153 
genes), N. meningitidis database identified virulence genes belong to twelve less BioCyc 
metabolic pathways compared to H. pylori. Lipid A-core biosynthesis, CMP-N-
acetylneuraminate biosynthesis II (bacteria) and enterobacterial common antigen biosynthesis 
are the three BioCyc metabolic pathways N. meningitidis database indentified virulence genes 
belong to and are mutually exclusive from the sixty-four metabolic pathways identified for N. 
meningitidis genes under positive selection (Table 5.4, page 101). Absence of shared metabolic 
pathways between N. meningitidis genes under positive selection and database identified 
virulence genes is surprising given the statistically significant intersection between both gene list 
types. It is possible common elements between the two N. meningitidis gene list types are 
involved in processes other then metabolic interactions e.g. transport, adhesion, cell membrane 
integrity. A cellular overview of metabolic pathways which N. meningitidis genes under positive 
selection and database identified virulence genes can be mapped to is presented overleaf in 
Figure 5.5. 
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Figure 5.5 : Cellular overview of N. meningitidis’ BioCyc metabolic pathways for genes under positive selection (yellow lines), database identified 
virulence genes (blue lines) and genes common to both gene lists (red lines). Numbered boxes are 1: Capsule polysaccharide import / export membrane 
proteins, 2: IgA1 / Fibrin peptide, 3: Siroheme Biosynthesis, 4: Proline degradation I, 5: lipid A-core biosynthesis, 6: CMP-N-acetylneuraminate 
biosynthesis II (bacteria) and 7: Enterobacterial Common Antigen Biosynthesis.
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        The observation N. meningitidis genes under positive selection and database identified 
virulence genes do not share any metabolic pathways because genes common to both gene lists 
are involved in processes other then metabolism is confirmed by N. meningitidis’ cellular 
overview map (Figure 5.5, page 103). Four N. meningitidis database identified virulence genes 
under positive selection are capsular polysaccharide transporters (Box 1, Figure 5.5, page 103) 
and a fifth gene is an IgA1 protease (Box 2, Figure 5.5, page 103).    
        The capsular polysaccharide transporters (Box1 – red lines, Figure 5.5, page 103) are part 
of the ctr capsular polysaccharide transport operon in N. meningitidis. Capsular polysaccharides, 
mainly composed of sialic acid polymers, are virulence factors linked to invasive N. meningitidis 
meningococcal disease and confer resistance to the bacterium against host bactericidal 
antibodies and innate immune responses like phagocytosis 199-201. The ctr operon encodes for 
four proteins; ctrB, ctrD, ctrC and ctrA (Box 1 - red lines from left to right, Figure 5.5, page 
103) which function as an ABC transporter exporting synthesised capsular polysaccharides from 
the bacterial cell 199-201. Interestingly, other genes close to the ctr transport cluster are also ABC 
transporters which have yet to be characterised and similar to the ctr genes, are under positive 
selection although they are not deemed as virulence genes by any of the virulence databases 
(Box1 – yellow lines, Figure 5.5, page 103).  
        The IgA1 protease (Box 2, Figure 5.5, page 103) cleaves peptide bonds within the human 
IgA hinge region, is an N. meningitidis database identified virulence gene undergoing positive 
selection 202-204. Human IgA is predominantly found in the upper respiratory tract and mucosal 
surfaces where it limits bacterial infection by adhering to the bacterial cell’s exterior causing 
agglutination and preventing epithelial cell receptor-adhesin mediated synergy 202-204. IgA1 
protease is an important virulence factor as non-pathogenic neisserial species do not posses the 
enzyme and invasive N. meningitidis strains have higher levels of IgA1 protease expression 
compared to commensal N. meningitidis strains 204. Within the BioCyc metabolic map (Box 2, 
Figure 5.5, page 103), IgA1 is predicted to cleave fibrin into soluble products like plasmin 
recruited from the bacterium’s host 205,206.    
        N. meningitidis genes under positive selection form discrete metabolic pathway modules 
whereby other genes within the same pathway are also under positive selection (Figure 5.5, page 
103). Two highlighted metabolic pathways within which all genes are under positive selection in 
N. meningitidis are siroheme biosynthesis and proline degradation I (Figure 5.5, page 103, 
Boxes 3 and 4 respectively).     
        Siroheme, synthesised by the siroheme pathway (Box 3, Figure 5.5, page 103), is a 
prosthetic heme like group of the bacterial and yeast enzyme sulphite reductase which catalyses 
the reduction of sulphite to sulphide, sulphide is used as a substrate for synthesis of sulphur 
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containing amino acids like cysteine 207-209. Microarray gene expression characterisation of N. 
meningitidis upon contact with epithelial cells in vitrio show genes involved in amino acid 
synthesis like siroheme synthase and sulphate uptake genes are up-regulated, leading the authors 
to conclude sulphur metabolism and acquisition have an important role in N. meningitidis 
adhesion 210. In addition to sulphite reduction, an intermediate compound of the siroeheme 
biosynthesis pathway known as sirohydrochlorin, a metal free precursor of siroheme, is used for 
vitamin B12 synthesis 207-209. 
        The proline degradation I pathway (Box 4, Figure 5.5, page 103) is conserved amongst 
many bacterial species with the PutA enzyme catabolising L-proline to L-glutamate, L-
glutamate is used as an energy and carbon source or a source of nitrogen for growth in bacterial 
species like E. coli 211,212. Within E. coli, the PutA enzyme is found to have a variety of roles 
depending on proline concentrations; during proline availability PutA functions as an inner 
cytoplasmic membrane linked enzyme catabolising proline to glutamate, during proline deficient 
conditions PutA functions as a DNA binding transcriptional repressor of genes involved in the 
proline pathway degradation after moving to the cytoplasm 211,212. For a fastidious micro-
organism like N. meningitidis that utilises limited carbon sources for growth, energy producing 
pathways like the proline degradation pathway are important because establishment of micro-
colonies in the respiratory tract mucosa by founder micro-organisms requires rapid growth and 
short generation times 97.  
        Of the three BioCyc metabolic pathways determined for N. meningitidis database identified 
virulence genes (Lipid A-core biosynthesis, CMP-N-acetylneuraminate biosynthesis II-bacteria 
and enterobacterial common antigen biosynthesis), the enterobacterial common antigen 
biosynthesis pathway (Box 7, Figure 5.5, page 103) is shared by H. pylori and N. meningitidis 
database identified virulence gene lists. The lipid A-core biosynthesis pathway (Figure 5.5, Box 
5, page 103) produces lipooligosaccharides (LOS) which are pro-inflammatory and abets in 
meningococcal adherence and invasion of host epithelial cells 213,214. The lipid A component of 
LOS acts as an hydrophobic anchor for LOS just below the outer membrane and directly induces 
inflammatory responses within the host 213,214.  
        The CMP-N-acetylneuraminate biosynthesis II (bacteria) pathway (Figure 5.5, Box 6, page 
103) produces sialic acid, which in mammals facilitates cell to cell adhesion and recognition 
while in bacterial species, like N. meningitidis, sialic acid enables bacteria to circumvent host 
immune responses 199-201,215,216. Sialic acid constitutes a major component of the N. meningitidis 
capsule and differences in sialic acid polymers are used for capsular serotyping, vaccine targets 
and epidemiological markers 199-201,215,216. The synthesised sialic acid polymers are exported to 
the bacterial cell surface by the ctr ABC transporters (Box 1, Figure 5.5, page 103) 199-201. 
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KEGG Pathways of N. meningitidis Genes. 
        KEGG pathway maps for N. meningitidis genes under positive selection and database 
identified virulence genes were mined from DAVID (Version 6) using a pathway threshold of 1 
and an EASE score of 0.5. KEGG pathway coverage of N. meningitidis genes under positive 
selection is 28% (62 genes of 218) which belong to nineteen different KEGG pathways. None of 
the nineteen KEGG pathways are statistically enriched for N. meningitidis genes under positive 
selection at the P = 0.05 interval after correction for multiple hypotheses testing. The nineteen 
KEGG pathways which N. meningitidis genes under positive selection belong to are summarised 
below in Table 5.5.   
KEGG Pathway Reference KEGG Pathway Description 
nma02010 ABC transporters – General  
nma00970 Aminoacyl tRNA biosynthesis 
nma00330 Arginine and proline metabolism 
nma00780 Biotin metabolism 
nma00460 Cyanoamino acid metabolism 
nma03030 DNA polymerase 
nma00251 Glutamate metabolism 
nma00260 Glycine, serine and threonine metabolism 
nma00630 Glyoxylate and dicarboxylate metabolism 
nma00540 Lipopolysaccharide biosynthesis 
nma00760 Nicotinate and nicotinamide metabolism 
nma00550 Peptidoglycan biosynthesis 
nma00400 Phenylalanine, tyrosine and tryptophan biosynthesis 
nma00860 Porphyrin and chlorophyll metabolism 
nma00230 Purine metabolism 
nma00240 Pyrimidine metabolism 
nma03090 Type II secretion system 
nma00220 Urea cycle and metabolism of amino groups 
nma00290 Valine, leucine and isoleucine biosynthesis 
Table 5.5 : Nineteen KEGG pathway map identifiers and descriptions N. meningitidis genes 
under positive selection belong to.   
 
        N. meningitidis and H. pylori genes under positive selection have six KEGG pathways in 
common from a total of thirty four; ABC transporters-General, aminoacyl tRNA 
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biosynthesis,arginine and proline metabolism, DNA polymerase, peptidoglycan biosynthesis and 
phenylalanine, tyrosine and tryptophan biosynthesis (Table 5.5, page 106, Table 5.2, page 96).  
        KEGG pathway coverage of N. meningitidis database identified virulence genes is 35% (24 
of 68 genes) that belong to four separate KEGG pathways which are summarised below in Table 
5.6. 
KEGG Pathway 
Reference KEGG Pathway Description 
Adjusted P 
Value 
nma03090 Type II secretion system 6.14e-19 
nma02010 ABC transporters – General 0.193231417 
nma01031 Glycan structures - biosynthesis 2 0.999998372 
nma00540 Lipopolysaccharide biosynthesis 1 
Table 5.6 : KEGG pathway identifiers, descriptions and Bonferroni adjusted P values for KEGG 
pathway enrichment of N. meningitidis database identified virulence genes.  
 
        Of the four KEGG pathways, only the Type II secretion system (nma03090) displays a 
statistical enrichment for N. meningitidis database identified virulence genes at the P = 0.05 
level (Table 5.6). N. meningitidis genes under positive selection and database identified 
virulence genes share three common KEGG pathways; Type II secretion system, ABC 
transporters-general and Lipopolysaccharide biosynthesis (Table 5.6 and Table 5.5, page 106). 
Comparison of KEGG pathway map descriptions show there are no common KEGG pathways 
between N. meningitidis and H. pylori database identified virulence genes (Table 5.6 and Table 
5.3 page 97).   
        The KEGG N. meningitidis Type II secretion system pathway map (nma03090) contains 
both genes under positive selection and database identified virulence genes and is presented 
overleaf in Figure 5.6. Type II secretion systems enable movement of proteins from the 
cytoplasm across the inner and outer membranes to the cell surface 217-219. Genes mapped within 
the N. meningitidis Type II secretion KEGG pathway are mainly involved with Type IV pilus 
assembly and secretion (Figure 5.6, page 108) and are evolutionary interrelated sharing many of 
the protein secretion components 217-219. Pili are ancillary filamentous glycosylated protein 
adhesins which mediate bacterial attachment to host cells and are associated with neisserial 
competence 220,221. The type IV pili of N. meningitidis comprises of repetitive PilE protein 
subunits capped with a potential adhesin (PilC) on the pili tip 220,221. Pili are synthesised within 
the cytoplasm and transported to the periplasm were they are folded and exported across the 
outer cell membrane by a multi-protein complex comprising of general secretion pathway 
proteins that form a structure termed the secreton (Figure 5.6, page 108) 217-219.   
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Figure 5.6 : KEGG Type II secretion and Type IV pilus N. meningitidis pathway map 
(nma03090). The pilA, pilV, pilW and pilE genes are under positive selection and the pilQ, pilB, 
pilC, pilA, pilD, pilF, pilP, pilQ, pilN, pilM, pilT, pilU, pilY1 and pilE are database identified 
virulence genes. The KEGG pathway map depicts conserved proteins used for the synthesis, 
assembly and export of the Type IV pilus across the bacterial periplasm to the bacterial cell 
surface.   
 
 
 
 
 109 
V. cholerae BioCyc Metabolic Pathways 
        The BioCyc V. cholerae Tier 2 database (strain N16961, Version 13.5) was mined for 
metabolic pathways containing genes under positive selection and database identified virulence 
genes using accessions for each gene list and a pathway threshold setting of 1. BioCyc coverage 
of the 23 V. cholerae genes under positive selection is 26% (6 of 23 genes). The 6 V. cholerae 
genes under positive selection map to seventeen BioCyc metabolic pathways presented below in 
Table 5.7. Four of the seventeen metabolic pathways determined within V. cholera are also 
represented by H. pylori and N. meningitidis genes under positive selection and are boldly 
italicised in Table 5.7 below.  
BioCyc Metabolic Pathways of V. cholerae Genes Under Positive Selection 
ectoine biosynthesis 
pyruvate fermentation to acetate II 
valine degradation I 
superpathway of KDO2-lipid A biosynthesis 
KDO2-lipid A biosynthesis I 
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass 
lactate oxidation 
valine degradation II 
acetyl-CoA biosynthesis (from pyruvate) 
proline biosynthesis I 
lysine biosynthesis VI 
citrate fermentation to diacetyl 
homoserine biosynthesis 
respiration (anaerobic) 
fatty acid β-oxidation I 
lysine biosynthesis I 
tRNA charging pathway 
Table 5.7 : Seventeen BioCyc metabolic pathways V. cholerae genes under positive selection 
belong to. Four metabolic pathways that contain genes under positive selection within V. 
cholerae, H.  pylori and N. meningitidis are marked in bold italic font.  
         
        Manual examination of the four BioCyc pathways containing genes under positive selection 
from all three bacterial species (Table 5.7) reveal different genes within different steps of the 
metabolic pathways are under positive selection as opposed to functional homologues.  
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        BioCyc coverage of V. cholerae database identified virulence genes is 6% (10 of 169 
genes) and is comparatively lower then H. pylori (22% of 153 genes) and N. meningitidis (13% 
of 68 genes) coverage of database identified virulence genes. Low coverage of V. cholerae 
database identified virulence genes may indicate they are not involved in any metabolic 
processes and therefore have not been mapped to BioCyc’s metabolic pathways or alternatively, 
the metabolic processes those virulence genes are involved in are yet to be elucidated. The 10 V. 
cholerae database identified virulence genes map to three BioCyc metabolic pathways; 2,3-
dihydroxybenzoate biosynthesis, enterobacterial common antigen biosynthesis and 1,4-
dihydroxy-2-naphthoate biosynthesis I. There are no shared BioCyc metabolic pathways 
between V. cholerae genes under positive selection and database identified virulence genes. The 
enterobacterial common antigen biosynthesis pathway is the only pathway common to database 
identified virulence genes across all three bacterial organisms and only within H. pylori, are 
genes belonging to this pathway under positive selection. A cellular overview of BioCyc 
metabolic pathways for V. cholerae genes under positive selection and database identified 
virulence genes is presented in Figure 5.7 overleaf. 
        Ectoine, produced from aspartate by the ectoine biosynthesis pathway (Box 1, Figure 5.7, 
page 111), is an osmoprotectant facilitating survival of halophilic bacteria like V. cholerae in 
conditions of variable salinity 222,223. V. cholerae constantly encounters fluctuations in salinity 
within it native environmental niche and during passage through the digestive tract, differences 
in osmolarity within the digestive tract are postulated to activate virulence mechanisms like 
production of cholera toxin 222,223. Salinity also plays an important role in V. cholerae’s survival, 
optimal growth by the bacteria is reached in conditions that have similar salinity levels as its 
estuarine habitat 222,223.  V. cholerae ectoine synthesis is upregulated during growth in highly 
saline conditions and deletion of genes encoding for ectoine synthesis is shown to impair V. 
cholerae’s growth in those conditions 222,223.     
        The anaerobic respiration pathway within V. cholerae (Box 2, Figure 5.7, page 111) is 
activated in response to low oxygen conditions such as those encountered by the bacterium in 
the intestine 224,225. Exposure to anaerobic conditions are known to trigger the expression of 
virulence genes for a number of enteric pathogens like Salmonella typhi 226,227. However, in V. 
cholerae growth under in vitro anaerobic conditions was found to repress expression of the 
cholera toxin although expression of the positive regulator of the cholera toxin genes, toxT, was 
found to increase 226. In vivo transcriptional profiling studies also support the upregulation of 
other V. cholerae virulence gene regulators like toxR, tcpP and tcpH 224,225. Hence, V. cholerae 
virulence gene regulation and expression under anaerobic growth conditions and their relation to 
pathogenesis has yet to be fully deciphered within V. cholerae 224,225.  
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Figure 5.7 : Cellular overview of V. cholerae metabolic pathways for genes under positive selection (yellow lines) and database identified virulence genes 
(blue lines). Metabolic pathways highlighted in numbered boxes are: Box 1 – Ectoine Biosynthesis, Box 2 – Anaerobic Respiration, Box 3 – Fatty acid β-
oxidation I, Box 4 – Lysine Biosynthesis I, 5 - 2,3-dihydroxybenzoate Biosynthesis and 6 - Enterobacterial Common Antigen Biosynthesis.
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        The fatty acid β-oxidation I metabolic pathway has genes under positive selection in all 
three bacterial organisms (Table 5.7, page 109). The fatty acid β-oxidation pathway (Box 3, 
Figure 5.7, page 111) is used by bacterial species to generate energy for growth and as a carbon 
source, two versions of this pathway exist that function either under aerobic or anaerobic 
conditions 228-230. Studies in E. coli indicate that enteric bacteria utilise the anaerobic fatty acid 
β-oxidation pathway as the only source of carbon for growth and respiration within the oxygen 
poor intestinal environment 228,230. Although most studies of the fatty acid β-oxidation pathway 
have been carried out within E. coli, it is possible the anaerobic version of this pathway applies 
to H. pylori and V. cholerae as both are enteric pathogens that encounter low oxygen 
concentrations in the human digestive system 228,230. The anaerobic version of the fatty acid β-
oxidation pathway may not apply to N. meningitidis as the bacterium is mainly aerobic and not 
starved of oxygen within the nasopharynx.   
        The lysine biosynthesis pathway I which has genes under positive selection in V. cholerae 
(Box 4, Figure 5.7, page 111), uses the diaminopimelate (DAP) pathway to anabolically convert 
aspartate to lysine, an essential amino acid for protein synthesis and has genes under positive 
selection in all three bacterial organisms (Table 5.7, page 109) 231-233. Both DAP and lysine form 
important components of the bacterial peptidoglycan cell wall and is essential for bacterial cell 
growth which is why the lysine biosynthesis pathway I is currently being investigated as an 
antibacterial drug target due the absence of this pathway in mammals as lysine is acquired 
through dietary intake 231-233.   
        Iron is an essential element required for V. cholerae growth, respiration, DNA metabolism, 
electron transport and a co-factor for enzymes 234-238. The bulk of iron contained within a 
mammalian host is firmly attached to proteins like haemoglobin, hence bacterial species like V. 
cholerae have evolved high affinity iron-sequestering molecules like siderophores that bind and 
transport extracellular iron into the bacterial cell 234-238. All genes contained within the 2,3-
dihydroxybenzoate biosynthesis pathway synthesising vibriobactin are database identified 
virulence genes (Box 5, Figure 5.7, page 111). The 2,3-dihydroxybenzoate biosynthesis pathway 
(Box 5, Figure 5.7, page 111) is part of the enterobactin biosynthesis super-pathway within 
BioCyc which synthesises the catecholate siderophore vibriobactin during iron deficient 
conditions 235,236. V. cholerae does not produce enterobactin, a structurally similar catecholate 
siderophore produced by E. coli, although the bacterium does have receptors to bind and use 
enterobactin synthesised by other bacteria 234,237,238. Vibriobactin comprises of three residues of 
2,3-dihydroxybenzoyl attached to polyamine backbone of norspermindine and is used to 
scavenge iron from the bacterial’s host and environment 237,238.  
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KEGG Pathways of V. cholerae Genes 
        V. cholerae accessions of genes under positive selection and database identified virulence 
genes were used to query DAVID for KEGG pathways using an EASE score of 0.5. Coverage of 
the 23 V. cholerae genes under positive selection for KEGG pathways within DAVID is 15% (3 
of 23 genes) which belong to two KEGG pathways; Butanoate metabolism (vch00650) and 
Valine, leucine and isoleucine biosynthesis (vch00290), none of which are statistically enriched 
for genes under positive selection at the P = 0.05 level. The valine, leucine and isoleucine 
biosynthesis KEGG pathway (vch00290) is the only pathway in common between V. cholerae 
and N. meningitidis genes under positive selection (Table 5.5, page 106), V. cholerae and H. 
pylori genes under positive selection do not have any shared KEGG pathways (Table 5.2, page 
96).  
        Of the 169 V. cholerae database identified virulence genes, 54% (92 of 169 genes) map to 
eleven KEGG pathways, presented below in Table 5.8.  
KEGG Pathway 
Reference KEGG Pathway Description 
Adjusted P 
Value 
vch02040 Flagellar assembly 5.90e-37 
vch03090 Type II secretion system 3.53e-10 
vch05114 Cholera - Life cycle 6.03e-10 
vch05111 Cholera – Colonization 1.19e-07 
vch03070 Type III secretion system 2.26e-06 
vch05110 Cholera – Infection 8.23e-04 
vch01053 Biosynthesis of siderophore group nonribosomal 
peptides 
0.009017124 
vch05113 Cholera – Environment 0.011914327 
vch02030 Bacterial chemotaxis – General 0.892170334 
vch02020 Two-component system - General 0.995410557 
vch05112 Cholera – Diarrhoea 1 
Table 5.8 : KEGG pathway identifiers and description for V. cholerae genes database identified 
virulence genes as well as Bonferroni corrected results for pathway enrichment analysis.  
 
        Eight of the eleven KEGG pathways mapped to V. cholerae database identified virulence 
genes show a statistical enrichment at the P = 0.05 interval after stringent Bonferroni corrections 
for multiple hypothesis testing (Table 5.8). Four of eleven KEGG pathways are common 
between V. cholerae and H. pylori; flagellar assembly, type III secretion system, bacterial 
chemotaxis and two-component system (Table 5.8 and Table 5.3, page 97).  V. cholerae and N. 
meningitidis database identified virulence genes have only one common KEGG pathway; type II 
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secretion system (Table 5.8 and Table 5.6, pages 113 and 107). The higher number of shared 
KEGG pathways between V. cholerae and H. pylori database identified virulence genes may 
indicate a gross similarity in their lifestyles as they are both enteric pathogens using similar 
strategies such as motility and chemo-taxis while N. meningitidis is not an enteric pathogen and 
utilises different strategies during colonisation like pili mediated adhesion. 
        Comparison of V. cholerae genes under positive selection and database identified virulence 
genes reveal there are no common KEGG pathways mapped to both gene list types.  Similar to 
H. pylori KEGG pathway maps, V. cholerae database identified virulence genes constitute all 
the genes mapped to some KEGG pathways. An example of two KEGG pathway maps 
comprising exclusively of V. cholerae database identified virulence genes are presented below 
and overleaf in Figures 5.8 and 5.9 respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 : KEGG pathway map for V. cholerae Flagellar assembly (vch02040). Genes in 
green boxes encode protein products used in the assembly of the V. cholerae flagellum that is 
exported to the bacterial outer membrane using a Type III secretion system. Similar to H. pylori 
(Figure 5.3, page 99), all genes contained within this KEGG pathway map highlighted in green 
boxes are database identified virulence genes. 
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Figure 5.9 : KEGG pathway map for Biosynthesis of siderophore group nonribosomal peptides 
(vch01053) depicting the synthesis of the V. cholerae vibriobactin siderophore, all genes and 
enzymes highlighted in green boxes are V cholerae database identified virulence genes. Three 
molecules of chorismate are converted to isochorismate by vibriobactin-specific isochorismate 
synthase (EC 5.4.4.2). The enzyme vibriobactin-specific isochorismatase (EC 3.3.2.1) converts 
isochorismate to three molecules of 2,3-dihydroxybenzoate (DHB). The VibB and VibE 
enzymes catalyse DHB to add the catechol moiety. VibF activates L-threonine converting it to a 
soluble product for transfer and attachment of DHB to the norspermindine backbone by amide 
bond formation catalysed by VibH. VibB, VibE , VibH and VibF are all used as a multi-protein 
complex to assemble the vibriobactin with VibE activating DHB to 2,3-dihydroxybenzoic acid 
(DBHA) to produce mature vibriobactin 239,240.  
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Chapter 6 : Conclusions 
        The number of orthologous gene pairs identified between bacterial strains mirrors the 
bacterial gene content across all three bacterial species. The number of genes under positive 
selection within each bacterial species does not mirror the gene content of the three bacterial 
species. The discord in gene numbers under positive selection in relation to bacterial gene 
content suggests that forces driving genome diversification between the three bacterial species 
are non-random. Factors that may influence genome diversification between H. pylori, N. 
meningitidis and V. cholerae include the integrity of DNA repair mechanisms, usage of de novo 
mutational strategies or contingency loci, environmental reservoirs that exert strong purifying 
selection to expunge mutations and sufficient time between divergence of bacterial strains for an 
accumulation of mutations to occur 78,93,95,96. 
        The relationship between positive selection and bacterial virulence is not well defined as 
not all genes under positive selection are known bacterial virulence genes and vice versa. Of the 
three bacterial species, only N. meningitidis has a statistically significant enrichment of 
virulence genes undergoing positive selection. Although H. pylori and V. cholerae known 
virulence genes are not statistically enriched for positive selection, both bacterial species do 
have virulence genes that are undergoing positive selection (Appendix B2). Both H. pylori and 
V. cholerae have more then twice the number of database identified virulence genes compared to 
N. meningitidis (Appendix B2). A larger sample size of virulence genes would ideally result in a 
larger statistically significant intersection between H. pylori and V. cholerae genes under 
positive selection and known virulence genes.  
        Statistical tests based on categorical data like gene counts are directly affected by the 
number of elements contained within each class such as the number of virulence genes and 
genes under positive selection and their resulting intersection. Virulence gene identification 
within a bacterial species is still incomplete and various definitions of bacterial virulence results 
in different virulence gene lists like those obtained from VFDB and MVirDB. In order for a 
bacterial gene to be categorised as a virulence gene, it must have some functional information 
linking that gene product to a virulence process. All database identified virulence genes for H. 
pylori and N. meningitidis have functional annotations while only 13 of 169 V. cholera database 
identified virulence genes do not have any functional annotations (Appendix B2). In contrast, a 
large number of genes under positive selection within H. pylori, N. meningitidis and V. cholerae 
are classified as hypothetical (81, 47 and 9 genes respectively, Appendix B1) because their 
biological functions are unknown. Application of high throughput genomic technologies like 
micro-arrays are identifying numerous genes with upregulated expressions under simulated 
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infection conditions whose biological functions are unknown and thus, are also annotated as 
hypothetical genes 224,225. As functional annotation of microbial genomes improve, gene counts 
of bacterial virulence genes identified are liable to increase and possibly result in a larger 
intersection with genes under positive selection. Hence, an absence of a statistically significant 
enrichment for H. pylori and V. cholerae virulence genes undergoing positive selection at the 
current level of gene functional annotation does not necessarily preclude the existence of a 
synergistic correlation between genes under positive selection and virulence genes. 
        In terms of physical properties, genes under positive selection in all three bacterial species 
are on average, longer then genomic and bacterial virulence genes and have different statistically 
significant distributions with the exception of N. meningitidis. Genes under positive selection 
have longer gene lengths due to the presence of more codons resulting in a higher probability of 
non-synonymous substitutions occurring. Virulence genes in all three bacterial species are on 
average, longer then the genomic mean gene length and follow different distributions that are 
statistically significant from the genomic gene length distribution. There is little literature to 
suggest a priori why virulence genes are on average, more likely to be longer then genomic 
mean length. In this regard, virulence genes and genes under positive selection from all three 
bacterial species have a similar physical property that differentiates them from the genomic gene 
length distribution. The %GC content distribution between gene lists for the three bacterial 
species is heterogeneous. N. meningitidis and V. cholerae genes under positive selection have 
different %GC distributions compared to their genomic distribution while both gene lists types 
in H. pylori follow a similar %GC distribution to that of its genome. N. meningitidis virulence 
genes are %GC poor compared to genes under positive selection and the genome mean (Table 
B4B, Appendix B4). V. cholerae genes under positive selection have a slightly higher %GC 
content compared to database identified virulence genes and the genomic mean. Hence, %GC 
content of the bacterial genomes and their respective gene lists are properties unique to each of 
the bacterial species. 
        An annotation bias for bacterial virulence genes exists as bacterial virulence genes are more 
likely to have a functional annotation then bacterial genes not known to be involved in virulence 
processes. The annotation bias of bacterial virulence genes is propagated through most 
functional annotation systems resulting in greater functional annotation coverage of bacterial 
virulence genes in comparison to genes under positive selection for all three bacterial species.  
        H. pylori, N. meningitidis and V. cholerae virulence genes and genes under positive 
selection have 34 GO terms in common at the current level of bacterial gene functional 
annotation. No statistical enrichment of common GO terms could be found for bacterial genes 
under positive selection indicating they could be involved in heterogeneous biological processes. 
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Alternatively, the lack of functional annotations for genes under positive selection in all three 
bacterial species may prevent those genes from forming functionally related groups resulting in 
a lack of statistical enrichment for any biological functional process. H. pylori and V. cholerae 
virulence genes and genes under positive selection share more GO terms pertaining to biological 
processes like chemo-taxis, cell motility and cell membrane structure then either bacterial 
species shares with N. meningitidis. The congruence of GO terms between H. pylori and V. 
cholerae gene lists may reflect gross similarities in lifestyles, both bacterial species are motile 
enteric pathogens which may use similar mechanisms to determine environmental gradients like 
pH, temperature, salinity and nutrient availability 6,71,76,78. N. meningitidis genes under positive 
selection and virulence genes have GO terms relating to the cell wall envelope, transport and 
secretion. H. pylori and N. meningitidis genes under positive selection share GO terms involved 
in DNA metabolism possibly due to the micro-organisms’ unique growth requirements and 
maintenance of genome homogeneity 5,38,69,153,168. GO annotation of bacterial gene lists indicates 
unequal virulence gene characterisation across all three bacterial species. GO terms present for 
virulence genes in one bacterial species are also present within another bacterial species, but 
those GO terms are not associated with any virulence genes in the latter bacterial species. 
Instead those bacterial virulence GO terms in one bacterial species are associated with genes 
under positive selection in another bacterial species. Hence, although they may be more 
biological processes shared by bacterial genes under positive selection and virulence genes then 
the 34 common GO terms suggests, unequal characterisation of virulence within each bacterial 
species means those common GO terms will not be found. Conversely, as the biological 
processes described by those GO terms exist in all three bacterial species, those biological 
processes might only be considered virulence associated in one of the bacterial species and not 
another, thereby providing a means to discriminate between species unique modes of 
pathogenicity.  
        Similar to GO annotations, COG annotation coverage of database identified virulence 
genes are greater compared to coverage of genes under positive selection. Alphabetical COG 
categories statistically enriched for virulence genes common to all three bacterial species include 
[N] cell motility and [U] intracellular trafficking and secretion indicating that some virulence 
processes are shared by the three bacterial species. A number of species unique alphabetical 
COG categories are also enriched for virulence genes such as [P] inorganic ion and transport for 
H. pylori, [M] cell wall / membrane biogenesis for N. meningitidis and [E] amino acid transport 
and metabolism for V. cholerae. No statistical enrichment for any alphabetical COG category 
could be found for H. pylori, N. meningitidis and V. cholerae genes under positive selection. Of 
the three bacterial species, only N. meningitidis database identified virulence genes and genes 
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under positive selection show a statistically significant association for the COG categories [M] 
cell wall / membrane biogenesis and [N] cell motility. 
        PSORTb is the only functional annotation system employed in this study that provides 
similar coverage for genes under positive selection and database identified virulence genes. 
PSORTb is able to achieve similar coverage for known virulence genes and genes under positive 
selection because it is a predictive classification system that utilises biological sequence features 
encoded within a protein sequence to predict a sub-cellular localisation sites and does not rely on 
pre-existing functional annotations. The cytoplasm and outer membrane subcellular localisation 
sites show a statistically significant enrichment for bacterial virulence genes in all three bacterial 
species. The extra-cellular PSORTb category shows a statistically significant enrichment for H. 
pylori and V. cholerae virulence genes indicating the secretion of factors like the H. pylori 
vacuolating cytotoxin or the cholera toxin into their surrounding environment plays a major 
roles in these bacterial species’ pathogenicity 6,71,76,78,81,92. The outer membrane subcellular 
localisation site is enriched for H. pylori and N. meningitidis virulence genes and genes under 
positive selection. Although the outer membrane subcellular localisation site is enriched for H. 
pylori and N. meningitidis virulence genes and genes under positive selection, no statistically 
significant association can be found between the two classes of genes when tested in unison. The 
lack of statistical association between H. pylori and N. meningitidis virulence genes and genes 
under positive selection might be because some of the outer membrane genes under positive 
selection in H. pylori and N. meningitidis are not virulence genes. Or alternatively, due to a lack 
of functional annotations for outer membrane genes under positive selection, they are not 
classified as virulence genes resulting in a lack of statistical association between the two gene 
classes for the outer membrane. In terms of species similarity, both H. pylori and N. meningitidis 
colonise and interact with their host environment through the use of cell surface proteins that 
mediate adhesion and epithelial cell interactions that are under host immune surveillance which 
exerts selective pressure for those outer membrane proteins to diversify 6,15,76,78,96. V. cholerae 
does not colonise human hosts and therefore may not have well developed factors that facilitate 
interactions as well as host immune evasion like H. pylori and N. meningitidis 6.  
        KEGG pathway maps show good concordance of virulence genes with some KEGG 
pathway maps like flagellar assembly and Type II and III secretion systems enriched for H. 
pylori, N. meningitidis and V. cholerae virulence genes. In some instances, KEGG pathway 
maps comprise exclusively of database identified virulence genes. No KEGG pathway maps 
were found to be statistically enriched for genes under positive selection in all three bacterial 
species which is unsurprising as only genes with known functions are placed in pathway maps. 
Species unique KEGG pathway maps such as epithelial cell signalling in H. pylori infection and 
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Type II secretion systems in N. meningitidis are virulence processes that contain both known 
virulence genes and genes under positive selection. Hence, genes under positive selection are 
involved in the same virulence processes as known virulence genes. 
        Metabolic pathway analysis of genes under positive selection and database identified 
virulence genes by BioCyc places more genes under positive selection in metabolic pathways 
compared to known virulence genes. The majority of N. meningitidis virulence genes appear to 
be involved in transport and adhesion as opposed to any known metabolic processes. Within H. 
pylori and N. meningitidis, known virulence genes and genes under positive selection form part 
of the same metabolic pathways, in some cases virulence genes involved in those metabolic 
pathways are under positive selection. Metabolic pathway analysis of H. pylori genes indentified 
two metabolic pathways common to genes under positive selection and known virulence genes 
that are not based on genes shared by both gene lists. One of the metabolic pathways, GDP-
Mannose Metabolism is involved in the fucosylation of LPS-O chains which enables Lewis 
antigen mimicry facilitating H. pylori adhesion to host epithelial cells, a biological process 
directly linked to gastritis 6,193-195. Metabolic pathway analysis reveals N. meningitidis known 
virulence genes under positive selection and linked to the cell membrane are surrounded by 
other cell membrane linked proteins that are also under positive selection, but due to a lack of 
functional annotation for these cell membrane linked proteins under positive selection, they are 
not identified as virulence genes.  
        Comparison of two metabolic pathways between H. pylori and V. cholerae reveals 
discrepancies between defined virulence processes between bacterial species. The urea 
degradation pathway within H. pylori produces ammonia to preserve cell homeostasis in low pH 
conditions 76,185,186. The ectoine biosynthesis pathway within V. cholerae produces ectoine from 
aspartate to also preserve cell homeostasis in highly saline conditions 222,223. Both metabolic 
pathways and end products are vital for H. pylori’s and V cholerae’s survival in their respective 
environmental niches and both metabolic pathways contain genes that are under positive 
selection 76,185,186,222,223. The only difference between the two analogous metabolic pathways is 
genes involved in the H. pylori urea degradation pathway are characterised as virulence genes 
while genes involved in the V. cholerae ectoine synthesis pathway are not characterised as 
virulence genes.  
           Species specific metabolic pathways for known virulence genes exists e.g. the urea 
degradation pathway in H. pylori, the sialic synthesising pathway in N. meningitidis and the 
vibriobactin synthesis pathway in V. cholerae. Metabolic pathway analysis of genes under 
positive selection show there are four metabolic pathways shared by all three bacterial species, 
of those four metabolic pathways, one (lysine biosynthesis I) is currently being investigated as 
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an antibacterial drug target 231. The substantial number of metabolic pathways containing H. 
pylori and N. meningitidis genes under positive selection and known virulence genes indicates 
bacterial genes under positive selection and known bacterial virulence genes can be grouped on 
a biological process level. 
        Assaying for positive selection using a variety of bacterial species demonstrates there are 
similar genes undergoing positive selection between bacterial species which are part of well 
characterised virulence processes. There are also classes of genes undergoing positive selection 
that are involved in species unique virulence processes. At the current level of functional 
annotation, statistical significance between genes under positive selection and bacterial virulence 
genes based on an intersection of common gene elements between both gene classes can not be 
determined, with the exception of N. meningitidis. The absence of any statistically significant 
intersection between genes under positive selection and known bacterial virulence genes when 
examined as separate entities does not preclude the existence of a relationship between positive 
selection and bacterial virulence. On a biological process level, genes under positive selection 
and known bacterial virulence genes have more in common with each other then if both gene 
classes are examined as separate, discrete entities. Numerous, well characterised bacterial 
virulence processes contain genes which are under positive selection as determined by their 
annotations and pathways they operate within. Genes and their products do not function in 
isolation within complex biological systems and well characterised virulence processes comprise 
of genes under positive selection. Therefore a relationship between positive selection and 
bacterial virulence can be determined on a biological process level, thereby establishing a link 
between nucleotide sequence diversity and bacterial virulence.  
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Appendix A1 
Positive Selection Pipeline PERL Scripts 
Fasta_split.pl 
#!/usr/bin/perl 
# Alan Christoffels- 14.01.99 
# fasta_split.pl - script to read in a fasta formatted file of sequences and 
# print out each sequence in a separate file where the file names are 
# sequencename.fasta 
use warnings; 
 
$/="\n>"; # set my deliminator to be a new line with a > fatsa header 
$file = $ARGV[0];  # specify the input file as the first file o the command line 
$dir = $ARGV[1];  # specify the output directory to write out the sequences 
$i= 0;    # initialise my counter to 0 
system "mkdir $dir";  # create my output directory specified on the command line 
open (FILE, "$file");  #open the input file 
while (<FILE>) {    # while in the input file 
  $i++;            # keep reading all the sequences 
  chop $_;         # remove stop codon * from end of sequence 
 
  if ($i > 1) {     # as soon as my sequence count reaches 1, add fasta headers 
    $_ = ">".$_; 
  } 
 
  if ($_=~/^>/) {    # pattern match for fasta headers 
    $_ =~/^>(\S+)\s+/;   # place gene accession into $_variable 
    $name = $1;   # name my sequence using the accession ID 
    $name =~ s/\|/_/g;   # substitute "pipes" for underscores 
    open (F, ">$dir/$name.fasta");  #open my command line specified output file 
    print F "$_\n";   # print my individual sequence file into a file named 
    close(F);    #after its accession ID with a .fasta file extension 
  } 
} 
close(FILE); 
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Ortho_BLAST.pl 
 
#! /usr/bin/perl 
# subroutine to parse BLAST results 
use warnings; 
 
if ($#ARGV < 2) {   #print warnings  on command line if I forget an input file 
  print "usage: ortho_BLAST.pl [input dir] [database1] [output dir]\n"; 
  exit; 
} 
 
$dir = $ARGV[0];    # intialise my input directory, database and output directory 
$dbase1 = $ARGV[1]; 
$outdir = $ARGV[2]; 
 
system "mkdir $outdir";   # unix system command to make my output directory 
open (CLUSTERS, ">clusters");   # print paired accessions to file called clusters 
 
opendir(DIR, "$dir");   # open my input directory to read sequence files 
@files = readdir(DIR);  # read sequence files 
foreach $file(@files) {  # for each sequence file read, run a BLAST using the 
  next unless (-f "$dir/$file"); 
  # unix system call and BLAST commands below 
  system "blastall -p blastp -d ./$dbase1 -i $dir/$file -v 1 -b 1 -F F > $outdir/$file.blast"; 
  parseBlast(); # call on my parseBlast sub-routine above to parse the BLAST results 
} 
 
sub parseBlast(){ 
  $count = 0;        # initialise counter to 0 
  open (BLAST, "$outdir/$file.blast");  # open the directory containing BLAST results 
  while (<BLAST>){ 
    s/\be\-/1e\-/g; 
    @array =split;   # place my BLAST output results into an array 
    if ($_ =~ /^Query\= /) { 
      $query = $array[1];   # place the accession of my query gene into an array 
    } 
    elsif ($_ =~ /^>(.+)/) {   # if my BLAST hit has more then 1 sequence 
      ++$count;                #then continue counting 
      if ($count == 1){ 
 $hit1 = $1; 
      } 
    } 
    elsif ($_ =~ /Expect = (\S+)/){ 
      if ($count == 1){ 
 $E1 = $1; 
      } 
    } 
 
    if ($_ =~ /Identities \= \d+\/\d+ \((\d+)\%.*\((\d+)\%\)/) { 
      if ($count == 1){ 
 $percent1 = $1; 
      } 
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    } 
    elsif ($_ =~ /No hits/)  { 
      $percent1 = 0; 
    } 
  } 
  close BLAST; 
  # print "$query $hit1 $E1 $percent1\n"; 
  # parse my BLAST results for and expectation score greeter then or equal to 1e10 
  # and greater then or equal to 50% coverage and similarity 
  # also create paired accession file clusters for reciprocal BLASTs 
  if ($E1 < 1E-10 && $percent1 >= 50){ 
    print CLUSTERS "$query $hit1\n"; 
  }else{ 
    system "rm -fr $outdir/$file.blast"; 
  } 
} 
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reciprocal_gene_ID.pl 
#!/usr/bin/perl 
use warnings; 
# initialise my paired accessions into variables 
my $acc1 = (); 
my $acc2 = (); 
my $acc3 = (); 
my $acc4 = (); 
# open my first paired accession file 
open(FILE1,$ARGV[0]) or die "Couldn’t open file 1\n"; 
 
while (<FILE1>) { 
  chomp; 
  @array1 = split;   # split on white space to get two accessions per line 
  my $acc1 = $array1[0];  #Strain A accession ID 
  my $acc2 = $array1[1];  #Strain B accession ID 
 
  open(FILE2,$ARGV[1]) or die "Couldn’t open file 1\n"; 
  while (<FILE2>) { 
    chomp; 
    @array2 = split; 
    my $acc3 = $array2[0];    # Strain B accession ID 
    my $acc4 = $array2[1];   # Strain A accession ID 
 
    if(($acc1 eq $acc4) && ($acc2 eq $acc3)){ # If the paired accession ID 
      print "$acc1 $acc3\n";    # from list 1 match list 2 then print orthologous 
    }                                 # paired accessions for use 
  } 
  close FILE2; 
} 
 
close FILE1; 
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accession_to_gene.pl 
#!/usr/bin/perl  
use warnings; 
 
if ($#ARGV < 3){ 
  die "\n\nusage: makeClusters.pl <blastclust_outfile> <DNA-table format> <PROTEIN-TABLE 
FORMAT> <output dir> \n\n\t\tNote: Sequence files in TABLE FORMAT eg. \nseq1  
AGTCCATTCCAGG\nseq2  AGTGGGGGCAGG\n"; 
} 
 
# initialise my variables 
$clusterfile = $ARGV[0];  # paired orthlogous accession ID list 
$dna = $ARGV[1];   # DNA sequences strain A and B in Table format 
$protein = $ARGV[2];   # Protein sequences strain A and B in Table format 
$outdir = $ARGV[3];   # Output directory 
 
system "mkdir $outdir";  # Unix system call to create output directory 
 
#Read DNA sequence and accession IDs into a hash table for quick retrieval 
open(DNA, "$dna"); 
%dna_seqs = (); 
while(<DNA>){ 
  @array1 = split; 
  $dna_seqs{$array1[0]} = $array1[1]; 
} 
close DNA; 
 
#Read protein sequence and accession IDs into a hash table for quick retrieval 
open(PROT, "$protein"); 
%prot_seqs = (); 
while(<PROT>){ 
  @array2 = split; 
  $prot_seqs{$array2[0]} = $array2[1]; 
} 
close PROT; 
 
#Grab each accession ID from paired accession cluster file and fetch 
#sequences from hash table using accession IDs as a key from hash tables 
#Write to a modified fasta file with each sequence on one line 
open(CLUSTS, "$clusterfile"); 
while(<CLUSTS>){ 
  @array = split; 
  $name1 = $array[0]; 
  $name2 = $array[1]; 
  ++$num; 
  $outfile = "cluster_" . "$num"; 
  # write out .dna amd .prot files into outfile in directory 
  mkdir("$outdir/$outfile",0777); 
  open(DNA_OUT, ">$outdir/$outfile/$outfile.dna"); 
  open(PROT_OUT, ">$outdir/$outfile/$outfile.prot"); 
  # pull out my DNA and amino acid sequences for the given accession ID key for strain A 
  foreach $name(@array){ 
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    if ($name =~ /$name1/){ 
      $dnaseq1 = $dna_seqs{$name}; 
      for ($i = 1, $i <= 3, ++$i) { 
 chop($dnaseq1);   # remove stop codons for CODEML 
      } 
      $dna1 = ">$name\n$dnaseq1\n"; 
      $prot1 = ">$name\n$prot_seqs{$name}\n"; 
    } 
    # pull out my DNA and amino acid sequences for the given accession ID key for 
    # strain B 
    elsif ($name =~ /$name2/){ 
      $dnaseq2 = $dna_seqs{$name}; 
      for ($i = 1, $i <= 3, ++$i) { 
 chop($dnaseq2); 
      } 
      $dna2 = ">$name\n$dnaseq2\n"; 
      $prot2 = ">$name\n$prot_seqs{$name}\n"; 
    } 
  } 
  #print my orthologous DNA sequences into a .dna file 
  #print my orthologous amino acid sequences in a .prot file 
  print DNA_OUT "$dna1$dna2"; 
  print PROT_OUT "$prot1$prot2"; 
  close DNA_OUT; 
  close PROT_OUT; 
} 
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In_frame_codon_align.pl 
#!/usr/bin/perl 
use warnings; 
 
$maindir = getcwd(); 
$dir = $ARGV[0]; 
# open my working directory with all the orthologous sequences identified by 
# reciporcal BLAST and pattern match for directories called cluster_ 
opendir(DIR, "$maindir/$dir") or die "can't opendir"; 
while (defined($nextdir = readdir(DIR))) { 
  if ($nextdir =~ /cluster_.+/) 
    { 
      print $nextdir; 
      in_frame_codon_align("$maindir/$dir/$nextdir"); 
    } 
} 
 
closedir(DIR); 
 
exit; 
#sub-routine to generate ClustalW alignments and in-frame codon alignments 
# and convert inframe codon aligned sequences into Phylip format 
sub in_frame_codon_align{ 
  my ($nextdir) = $_[0]; 
 
  print "**************** $nextdir\n"; 
  @dir_array = split(/\//, $nextdir); 
  $name = $dir_array[$#dir_array]; 
 
  #Run ClustalW for alignment of protein sequences using a unix system call 
  system("clustalw  -gapopen=40 -output=gde -outorder=input -outfile=$nextdir/$name.gde -
infile=$nextdir/$name.prot"); 
 
  #Run clustal for viewing alignment quality control checking 
  system ("clustalw -gapopen=40 -outorder=input -infile=$nextdir/$name.prot"); 
  # Run sed expressions to replace : and % characters from ClustalW alignmnets 
  # with and underscore and a fasta header 
  system ("sed 's/:/_/g' $nextdir/$name.dna > $nextdir/dna_file"); 
  system("sed 's/%/>/g' $nextdir/$name.gde > $nextdir/protalign; sed 's/:/_/g' $nextdir/$name.dna 
> $nextdir/dna_file; cat $nextdir/protalign $nextdir/dna_file > $nextdir/catted"); 
 
  #Use the ClustalW amino acid alignment as a template for EMBOSS's tranalign 
  #to place nucleotide codons onto amino acids generating in-frame codon alignments 
  #for CODEML. 
  system ("tranalign -asequence $nextdir/$name.dna -bsequence $nextdir/protalign -table 11 -
outseq $nextdir/pre_infile"); 
  #convert DNA alignment to Phylip format for CODEML using readseq 
  system("readseq -a -f=11 $nextdir/pre_infile > $nextdir/infile"); 
} 
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codeML.pl 
#!/usr/bin/perl 
use warnings; 
use Cwd; 
 
$maindir = getcwd(); 
# initialise my directory to be specified from the command line 
$dir = $ARGV[0]; 
# create a progress log to determine if all directories have been processed by 
# codeML 
open (LOG, ">progress.log_validation"); 
opendir(DIR, "$maindir/$dir") or die "can't opendir"; 
# Look for directories called cluster_ containing in-frame codon aligned files 
while (defined($nextdir = readdir(DIR))) { 
  if ($nextdir =~ /cluster_.+/) 
    { 
      print $nextdir; 
      run_codeML("$maindir/$dir/$nextdir"); 
    } 
} 
 
closedir(DIR); 
 
exit; 
# define my subroutine run_codeML to feed my infile to codeML and a pre-specifed 
# codeML control file specifying models M1a and M2a 
sub run_codeML{ 
  my ($nextdir) = $_[0]; 
 
  print "**************** $nextdir\n"; 
  @dir_array = split(/\//, $nextdir); 
 
  #temporarily copy Phylip format infile from working directory 
  system ("cp $nextdir/infile $maindir"); 
 
  #Run codeML 
  system ("codeml pipe.ctl"); 
 
  #move codeML results file to working directory 
  system ("mv outfile_results 2ML.ds 2ML.dn $nextdir"); 
  print LOG "$nextdir processed\n"; 
} 
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parse_codeML.pl 
#!/usr/bin/perl 
use warnings; 
 
$maindir = getcwd(); 
#Initialise my working directories and make an ouput directory containing parsed 
# CODEML results 
$dir = $ARGV[0]; 
$outdir = $ARGV[1]; 
system "mkdir $outdir"; 
opendir(DIR, "$maindir/$dir") or die "can't opendir"; 
while (defined($nextdir = readdir(DIR))) { 
  if ($nextdir =~ /cluster_.+/) 
    { 
      print $nextdir, "\n" ; 
      parse_codeml("$maindir/$dir/$nextdir", "$maindir/$outdir/$nextdir"); 
    } 
} 
 
closedir(DIR); 
 
exit; 
# Define my sub-routine to parse the CODEML results 
sub parse_codeml{ 
  # Create CODEML results in output directory maintaining the same directory 
  # structure as they were read in so I can track the cluster ID number 
  my ($nextdir) = $_[0]; 
  my ($outdir) = $_[1]; 
  my @accessions = () ; 
  # Open the CODEML results file 
  open(CODEML, "$nextdir/outfile") || next; 
 
  # Pattern match the CODEML results files for M1a and M2a reuslts and place into 
  # a hash for look up 
  while(<CODEML>) { 
    if(/^#\d:\s(.+)\n/){ 
      push(@accessions, $1) ; 
    } 
    @array = split; 
    if ($_ =~ /^Model\s[1|2]/){ 
      $w2 = $array[2] ; 
    } 
    elsif ($_ =~ /lnL/){ 
      chomp; 
      $ratio = $array[4]; 
      if(defined $w2){ 
 $hash{$w2} = $ratio ; 
      } 
    } 
  } 
  close CODEML; 
  # Determine if value of the LRT test is greater then 5.99 
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  # (P = 0.05 Chi-Square critical value with two degrees of freedom) 
  if(log_likelihood(\%hash) > 5.99){ 
    open(RESULT_FILE, ">>$outdir") || die "Can't create file $outdir"; 
    print RESULT_FILE "@accessions\n" ; 
    foreach (keys %hash){ 
      print RESULT_FILE "$_ $hash{$_}\n" ; 
    } 
    # If result of LRT greater then 5.99 then print paired accessions, Log liklihoods 
    # for M1a and M2a and LRT value to a reults file 
    print RESULT_FILE log_likelihood(\%hash), "\n" ; 
    close RESULT_FILE; 
  } 
} 
 
# Sub-routine to print paired accession IDs obtained from CODEML results file 
sub print_hash{ 
  my %hash = $_[0] ; 
  foreach (keys %hash){ 
    print "$_ $hash{$_}\n" ; 
  } 
} 
 
# Sub-routine to perform the LRT test on log liklihoods of M1a and M2a models. 
sub log_likelihood{ 
  my $hashref = $_[0] ; 
  my %hash = %$hashref ; 
  my $diff = 2*($hash{"PositiveSelection"} - ($hash{"NearlyNeutral"})) ; 
  return($diff) ; 
} 
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gene_annotation.pl 
#!/usr/bin/env perl 
use warnings; 
use File::Find; 
$annotation = shift;   # take in the genbank .ptt annotation file from the command line 
find(\&wanted, "."); # sub-routine for File::Find that specifies to look in the directory 
#being worked 
 
# Define my sub routine to open parsed codeML files and pattern 
# match accession IDs for strain A and B 
sub wanted { 
  my $file  = $_; 
  # "-d" option below confirms that file is NOT a directory 
  # if "-d" is true, then my "$_" is a directory, exit 
  return if -d $_; 
  return unless /^cluster_/;  # exit if no files named  "*cluster_*" exist 
  open FH, $file or die "Can not open file :-(", $!; 
  my $str = <FH>; 
  my ($acc) = $str =~ /(HP\w+)/; # finds the query accession number for H. pylori 26695 
# my ($acc) = $str =~ /(jhp\w+)/; # finds the query accession number for H. pylori J99 
# my ($acc) = $str =~ /(NMA\w+)/; # finds the query accession number for N. meningitidis 
Z2491 
# my ($acc) = $str =~ /(NMB\w+)/; # finds the query accession number for N. meningitidis 
MC58 
# my ($acc) = $str =~ /(VC\w+)/; # finds the query accession number for V. cholerae N16961 
# my ($acc) = $str =~ /(0395_\w+)/; # finds the query accession number for V. cholerae O395 
  close FH; 
  parse_annot_file($acc); 
} 
 
sub parse_annot_file { 
  # Find the query accession number in the annotation file specified on the command line 
  my ($acc) = @_; 
  open ANN, $annotation or die "Can not open file :-(", $!; 
  while ($line = <ANN>) { 
    print $line if $line =~ /$acc/;  # if my accession ID matches, print annotation file line 
  } 
} 
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Appendix A2                                      
Positive Selection Pipeline Documentation                       
Pre-processing of GenBank Files 
      Nucleotide sequences of the bacterial genes are extracted from their GenBank file using 
EMBOSS’s (Version 3.0.0) ExtractFeat utility with following commands: 
 
extractfeat [input GenBank file] -type gene –describe locus_tag –
osformat2 fasta –supper1 > [Output file name] 
 
      The resulting output file will contain gene sequences for the bacterial organism with fasta 
headers that look similar to the H pylori 26695 example shown below: 
 
>NC_000915_217_633 [gene] (locus_tag="HP0001") Helicobacter pylori 26695, 
complete genome. 
ATGGCGACACGAACTCAAGCCAGGGGGGCTGTGGTTGAATTGTTGTATGCGTTTGAGAGC 
GGTAATGAAGAAATTAAAAAAATCGCTTCTAGCATGTTAGAAGAAAAAAAGATTAAAAAC 
AACCAACTCGCTTTCGCTTTAAGCCTTTTTAATGGCGTGTTAGAAAAAATCAATGAAATT 
GACGCCCTCATCGAGCCGCATTTAAAAGACTGGGATTTCAAGCGATTAGGGAGCATGGAA 
AAGGCGATTTTACGCTTAGGAGCGTATGAAATTGGCTTCACGCCCACGCAAAACCCTATC 
ATCATCAATGAATGCATAGAGCTTGGCAAACTCTACGCTGAGCCTAACACCCCTAAATTT 
TTAAACGCTATCTTGGATTCTTTGAGCAAAAAGCTCACTCAAAAACCCTTGAATTGA 
 
  The fasta format headings for each gene need to be replaced for a number of reasons: 
1) To remove any special characters that may be wrongly interpreted by any of the 
applications in the pipeline e.g. formatDB, PAML, transeq, ClustalW. 
2) Truncate the header information to less then or equal to 10 characters as prerequisite for 
generating the Pyllip formatted files as input for PAML. 
3) Allow a standardized accessioning system that can be used for accession matching and 
parsing for subsequent analyses. 
 The fasta format headings are modified using the following sed regular expression: 
sed 's/NC_[0-9]*_[0-9]*_[0-9]* //g;s/\[gene]//g;s/locus_tag//g;s/Helicobacter 
pylori 26695, complete genome.//g;s/[(]//g;s/[)]//g;s/=//g;s/"//g' [infile] > 
[outfile] 
 
    The above sed regular expression results in the following output: 
>HP0001  
ATGGCGACACGAACTCAAGCCAGGGGGGCTGTGGTTGAATTGTTGTATGCGTTTGAGAGC 
GGTAATGAAGAAATTAAAAAAATCGCTTCTAGCATGTTAGAAGAAAAAAAGATTAAAAAC 
AACCAACTCGCTTTCGCTTTAAGCCTTTTTAATGGCGTGTTAGAAAAAATCAATGAAATT 
GACGCCCTCATCGAGCCGCATTTAAAAGACTGGGATTTCAAGCGATTAGGGAGCATGGAA 
AAGGCGATTTTACGCTTAGGAGCGTATGAAATTGGCTTCACGCCCACGCAAAACCCTATC 
ATCATCAATGAATGCATAGAGCTTGGCAAACTCTACGCTGAGCCTAACACCCCTAAATTT 
TTAAACGCTATCTTGGATTCTTTGAGCAAAAAGCTCACTCAAAAACCCTTGAATTGA 
 
 
 
 
 154 
     Quality control checks preformed to determine if EMBOSS’s ExtractFeat utility functions 
correctly include selecting 15 randomly chosen gene sequences from the unprocessed GenBank 
file and aligning those gene sequences with the corresponding gene sequences obtained by 
ExtracFeat to determine if there are any differences in nucleotide sequence length and 
characters. The two sets of sequences showed a 100% match.  
      Quality control checks using alignment methods to determine if the sed regular expression 
affected portions other then the fasta header were preformed, sequences pre and post sed fasta 
header modification displayed a 100% sequence match. 
        The result of the extraction and sed processing is a file of nucleotide sequences for each 
bacterial gene which contains the only gene’s accession ID as the fasta header. This gene 
accession ID is universally recognized by all databases and can be used for querying different 
resources such as NCBI’s Gene, PSORT, BioCyc etc. 
       The next step in pre-processing of the sequence files is to translate the extracted nucleotide 
fasta files into amino acid sequences to perform reciprocal BLASTs for orthologue identification 
and also use for generating in-frame codon alignments. EMBOSS’s TranSeq utility is used with 
the following commands: 
  
                 transeq [input_file] –table =11 > [output_file] 
 
       This will produce amino acid fasta sequences of the nucleotide sequences as shown below: 
>HP0001_1 
MATRTQARGAVVELLYAFESGNEEIKKIASSMLEEKKIKNNQLAFALSLFNGVLEKINEI 
DALIEPHLKDWDFKRLGSMEKAILRLGAYEIGFTPTQNPIIINECIELGKLYAEPNTPKF 
LNAILDSLSKKLTQKPLN* 
  
        The following sed regular expression is used to remove the “_1” suffix added by 
EMBOSS’s TranSeq utility as subsequent steps rely on pattern matching of the accession 
headers to obtain orthologous nucleotide sequences and align them to their amino acid 
counterparts for positive selection analysis. 
                                     s'/_1 $//g' [infile] > [outfile] 
  The following out-file will contain fasta sequences without the “_1” suffix as shown below: 
 >HP0001 
MATRTQARGAVVELLYAFESGNEEIKKIASSMLEEKKIKNNQLAFALSLFNGVLEKINEI 
DALIEPHLKDWDFKRLGSMEKAILRLGAYEIGFTPTQNPIIINECIELGKLYAEPNTPKF 
LNAILDSLSKKLTQKPLN* 
 
      Both the processed nucleotide and amino acid files contain all the genes for the bacterial 
strains’ genome in fasta format and are ready for use in the pipeline. 
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Creation of Sequence and BLAST Databases. 
        After pre-processing and obtaining the nucleotide and amino acid files for each of the 
bacterial strains, a sub-directory should be created which houses the sequences. 
       Two blast sub-directories should be created, each one housing a bacterial strain’s amino 
acid file. Two separate sub-directories should also be created that will each contain individual 
amino acid sequences in separate files. The Fasta_split.pl perl script written by Dr. Alan 
Christoffels takes the multi-sequence amino acid file created in the pre-processing step as input 
and writes out each amino acid fasta sequence into an individual file within a sub-directory 
created as output. The perl script is run as follows: 
   
         perl Fasta_split.pl [Input_file] [Output_directory] 
 
    To check if the Fasta_split.pl perl script functions correctly, the number of sequences in the 
original input file is counted using the following unix command: 
                                              grep “>” [Input_file] | wc -l 
  The number of individual sequence files within the sub-directory is also counted using the 
following unix command; 
                                                             ls | wc -l 
  In both instances, the number of fasta headers counted and the number of individual amino acid 
fasta files in the sub-directory created are the same. At the end of this step, they should be 2 sub-
directories, one for each bacterial strain which contains individual files for each amino acid 
sequence of a bacterial strain.  
      The next step is to create the BLAST databases of the sequences for each of the 2 bacterial 
strains. The amino acid file containing all the amino acid sequences should be copied into the 
separate BLAST sub-directories, 1 in each BLAST sub-directory. The amino acid sequences are 
formatted to create the BLAST databases using the following command: 
 
                                        formatdb –i [Input_File] –p T 
 
    After running fomatDB, the formatdb_log file should be checked to see how many sequences 
were formatted and if this number corresponds to the number of sequences contained with the 
amino acid file as a control check. 
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Identification of Orthologous Sequences 
     The ortho_BLAST.pl perl script was written which takes in as input each amino acid 
individual file in the sub-directory of amino acid sequences and BLASTs each sequence 
identifying the best hit and as output places the alignment in an individual file in another sub-
directory created specified by the user. The perl script is run as follows: 
 
perl orthoBLAST.pl [input_directory] [blast_directory1/file_name] 
[Output_directory]  
 
    The BLASTP parameters specified in the ortho_BLAST.pl perl script are ≥ 50 % identity 
and coverage, an expectation score of 1E-10 and a BLOSUM 62 matrix contained in the same 
directory the BLASTP searches are being conducted. In addition, ortho_BLAST.pl outputs a 
file called “clusters” which contains paired accessions of the best hit from genome A and 
genome B as shown below:  
jhp0049 HP0057 
jhp1311 HP1416 
jhp1368 HP1475 
jhp0151 HP0164 
jhp0602 HP0657 
jhp1414 HP1525 
jhp1470 HP1562 
jhp0254 HP0269 
jhp0705 HP0768 
jhp1066 HP1138 
jhp0300 HP0613 
 
At this point, multiple genes from strain A can have its best hit to a single database gene from 
strain B. Hence, the reciprocal best BLAST hit (RBH) method is used to identify orthologous 
genes. ortho_BLAST.pl should be opened in a text editor and the term “clusters” should be 
changed to “clusters_recip” or any other name other then clusters to ensure the first clusters file 
is not over-written. 
       ortho_BLAST.pl is re-run, this time reversing the input query sequences and the BLAST 
database, e.g if strain A formed the query and strain B formed the BLAST database, then strain 
B should know be the query and strain A the BLAST database. 
 This should provide a second list of paired accessions similar to the one shown below: 
HP0367 jhp1014 
HP0818 jhp0757 
HP1179 jhp1105 
HP0413 jhp0826 
HP0874 jhp0808 
HP1225 jhp1146 
HP0009 jhp1164 
HP0920 jhp0854 
HP1281 jhp1202 
HP0065 jhp0060 
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     The two sets of paired accession lists are to be parsed against each other using the 
reciprocal_gene_ID.pl perl script as follows: 
 
 perl reciprocal_gene_ID.pl [cluster_file_1] [cluster_file_2] > [output_file] 
 
     The output file specified by the user will contain paired accessions of the best reciprocal 
BLASTP hit for each gene of strain A and strain B which are orthologous.  
Creation of Sequence Files for Generating In-Frame Codon Alignments 
      The accession_to_gene.pl perl script is used to take as input the reciprocal paired accession 
file generated from the identification of orthologous sequences and matches them to the 
accessions for nucleotide and corresponding amino acid sequences from the Table formatted 
files and outputs the sequences to a pre-specified output directory. In the output directory, a 
number of subdirectories are created called cluster_No, one for each cluster of accessions from 
the input cluster file. In each cluster directory, there is a .dna and a .prot file, each containing 2 
orthologous sequences, one bacterial strain A and B.  The accession_to_gene.pl perl script used 
to generate these files is run as follows: 
 
perl accession_to_gene.pl [clusterfile] [DNA_table_format_file] [Protein_table 
_format_file] [Output_directory] 
Generation of In-Frame Codon Alignments 
     The .prot and .dna files in table format are used to generate in-frame codon alignments by the 
In_frame_codon_align.pl perl script. The perl script uses CLUSTALW to generate alignments 
between the nucleotide sequences in the .dna files and amino acid sequences in the .prot file and 
outputs them in GDE format alignment viewing. The aligned amino acid and nucleotide files are 
concatenated and EMBOSS’s TranAlign utility is used on these concatenated files to generate 
in-frame codon alignments based on the CLUSTALW (Version 1.83) alignments. The outputted 
in-frame codon aligned file is further processed by the ReadSeq programme called by 
In_frame_codon_align.pl to convert the out-putted in-frame codon aligned files into Phyllip 
format which is required as input to the PAML (Version 3.15) programme. The usage of the perl 
script is as follows: 
 
                           perl In_frame_codon_align.pl [input_dir] 
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Detection of Positive Selection 
      The codeML.pl perl script is run on the directory housing the files generated from the 
previous step. codeML.pl script opens the final input file for PAML, runs the CODEML module 
on each alignment using a pre-specified control file. The control file for PAML specifies that 
both the M1a and M2a model should be run on the in-frame codon alignments and the tree file 
to use. The control file should be located within the directory the codeML.pl script is being run 
in and have the same name as it is given within the perl script. The input file as well as the ouput 
results files for parsing CODEML results must be specified in the actual CODEML control file 
and in the perl script. The usage of the perl script is as follows: 
                               codeML.pl [input_directory]  
      The control file containing the parameters used and tree structure file are presented overleaf. 
The codeml run using the M1a (null model) and the M2a (selection model) takes on average 3 
minutes to process a file: That is 3mins x 1382 infiles = 4146 minutes / 60 = 69.1 hours / 24 = 
2.8 days to run for H pylori.   
The script will write the results in the file specified which in this case is the outfile with some 
ancillary result files called rst, rst1 and rub. The file called outfile is the main results files. 
Progress log for validation. The CODEML control file and tree file used are presented overleaf. 
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CODEML Control File 
      seqfile = infile * sequence data filename  
      treefile = stewart.trees      * tree structure file name 
      outfile = outfile           * main result file name 
 
        noisy = 9  * 0,1,2,3,9: how much rubbish on the screen 
      verbose = 2  * 0: concise; 1: detailed, 2: too much 
      runmode = 0  * 0: user tree;  1: semi-automatic;  2: automatic 
                   * 3: StepwiseAddition; (4,5):PerturbationNNI; -2: pairwise 
 
      seqtype = 1  * 1:codons; 2:AAs; 3:codons-->AAs 
    CodonFreq = 0  * 0:1/61 each, 1:F1X4, 2:F3X4, 3:codon table 
*        ndata = 10 
        clock = 0  * 0:no clock, 1:clock; 2:local clock; 3:CombinedAnalysis 
       aaDist = 0  * 0:equal, +:geometric; -:linear, 1-6:G1974,Miyata,c,p,v,a 
   aaRatefile = dat/jones.dat  * only used for aa seqs with model=empirical(_F) 
                   * dayhoff.dat, jones.dat, wag.dat, mtmam.dat, or your own 
 
        model = 0 
                   * models for codons: 
                       * 0:one, 1:b, 2:2 or more dN/dS ratios for branches 
                   * models for AAs or codon-translated AAs: 
                       * 0:poisson, 1:proportional, 2:Empirical, 3:Empirical+F 
                       * 6:FromCodon, 7:AAClasses, 8:REVaa_0, 9:REVaa(nr=189) 
 
      NSsites = 1 2  * 0:one w;1:neutral;2:selection; 3:discrete;4:freqs; 
                   * 5:gamma;6:2gamma;7:beta;8:beta&w;9:beta&gamma; 
                   * 10:beta&gamma+1; 11:beta&normal>1; 12:0&2normal>1; 
                   * 13:3normal>0 
 
        icode = 0  * 0:universal code; 1:mammalian mt; 2-10:see below 
        Mgene = 0 
                   * codon: 0:rates, 1:separate; 2:diff pi, 3:diff kapa, 4:all diff 
                   * AA: 0:rates, 1:separate 
 
   * fix_kappa = 0  * 1: kappa fixed, 0: kappa to be estimated 
    *    kappa = 2  * initial or fixed kappa 
   * fix_omega = 0  * 1: omega or omega_1 fixed, 0: estimate  
    *    omega = .4 * initial or fixed omega, for codons or codon-based AAs 
 
   * fix_alpha = 1  * 0: estimate gamma shape parameter; 1: fix it at alpha 
       * alpha = 0. * initial or fixed alpha, 0:infinity (constant rate) 
      * Malpha = 0  * different alphas for genes 
       * ncatG = 8  * # of categories in dG of NSsites models 
 
       * getSE = 0  * 0: don't want them, 1: want S.E.s of estimates 
* RateAncestor = 1  * (0,1,2): rates (alpha>0) or ancestral states (1 or 2) 
 
   Small_Diff = .5e-6 
    cleandata = 0  * remove sites with ambiguity data (1:yes, 0:no)? 
*  fix_blength = -1  * 0: ignore, -1: random, 1: initial, 2: fixed 
        method = 0   * 0: simultaneous; 1: one branch at a time 
 
* Genetic codes: 0:universal, 1:mammalian mt., 2:yeast mt., 3:mold mt., 
* 4: invertebrate mt., 5: ciliate nuclear, 6: echinoderm mt.,  
* 7: euplotid mt., 8: alternative yeast nu. 9: ascidian mt.,  
* 10: blepharisma nu. 
* These codes correspond to transl_table 1 to 11 of GENEBANK.   
Tree file 
2  1     (1,2); 
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Parsing Positive Selection Analysis Results 
        Once the PAML results have been generated, parse_codeML_LRT.pl is used to parse the 
results. codeML.pl parses the results outfile for the log likelihood scores of the M1a and M2a 
models and use those values to perform an Logliklihood ratio test which is a statistical test 
determining the goodness of fit for the sequence data to the CODEML specified models (the 
neutral and selection model in this case). The formula for the test is :  
LRT = 2*(lnL1-lnL2) 
1nL1 being the log-likelihood for M1a and 1nL2 being the log-likelihood for the M2a model. 
codeML.pl automatically calculates this value and will only output the results if the value is 
greater then 5.99 which is the value obtained from a Chi-Square table with 2 degrees of freedom 
at the 0.05 probability level. These parameters can be changed within codeML.pl. The 
codeML.pl perl script is run as follows: 
 
       perl codeML.pl [input directory] [output directory] 
Obtaining Bacterial Gene Annotations for genes under Positive Selection 
          In order to obtain the annotations for the result sequences, the .ptt files from the NCBI ftp 
directory was downloaded and parsed using gene_annotation.pl perl script. The 
gene_annotation.pl script and the .ptt file should be in the same directory as the CODEML 
results. The script will need to be run twice – once for each of the bacterial strains and for each 
run, the previous .ptt file and results file needs to be moved up one directory so as not to 
“confuse” the perl script, gene_annotation.pl is run as follows:  
 
perl gene_annotation.pl [GenBank annotation file] > [output file] 
 
Alternatively, the following unix command written in a bash shell can also be used to obtain 
bacterial gene annotations: 
 
for s in `grep START results_parse/cluster_* | cut -f2 -d" " | sed 
"s/[[:alpha:]]*//g"`; do grep $s hp_26695.ptt >>hhp_genes; done 
 
       The above unix command greps for the START position in a particular results file, splits the 
array on the second field based on space, a sed regular expression is used to remove any 
alphabetic characters before the start positions from the results file. The .ptt file saved as a .txt 
file is parsed against and the results are appended to file with the done command allowing the 
recursive processing of all the cluster files.  
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        The results are a series of gene list that have been identified as having sites under positive 
selection and can be used for analysis. 
        To copy the directories with all the orthlogous alignments and full CODEML results etc of 
genes found to be under positive selection for further analysis, the following perl “one-liner” is 
used: 
## Create a sequence_results directory in the Paml parsed results directory, copy and paste the 
one liner in the Paml parsed results directory. 
perl -e 'foreach(@ARGV){system("cp $_ $_.dat");system("mv *.dat sequence_results/");}' 
cluster_* 
 
 
External Dependencies / Applications. 
 
- Bacterial GenBank sequences and annotation files 
- EMBOSS 
- Formatdb 
- BLASTP version 2.2.4 [Aug-26-2002] or higher. 
- ClustalW version 1.83 
- Readseq  (Feb 1993) 
- PAML version 3.15, a control file and tree file. 
- Perl 
- Unix  
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Appendix A3A 
COG_parser.pl 
#!/usr/bin/perl 
use warnings; 
#Remove the first two line of the .ptt file or suppress warnings to avoid error messages which 
#does not affect the results of the parser 
#Open my file of paired accession IDs 
open(FILE1,$ARGV[0]) or die "Couldn’t open file 1\n"; 
 
while (<FILE1>) { 
 chomp; 
 @array1 = split; 
 my $acc1 = $array1[0]; 
#Open my GenBAnk COG annotation .ptt file 
open(FILE2,$ARGV[1]) or die "Couldn’t open file 2\n"; 
 while (<FILE2>) { 
 chomp; 
 @array2 = split /\t/;     #Split columns on tabs 
 my $acc_match = $array2[5]; # match my accession IDs to the sixth column in the table 
 my $cog_annot = $array2[7];  # place the eighth column of the array containing my COG 
annotations 
 if($acc1 eq $acc_match){     # provide a condition for matching accession IDs 
 print "$acc1\t";              # Print my accession ID 
 print "$acc_match\t";        # Print the accession ID matched in the .ptt COG file 
 print "$cog_annot\n";        # Print my matching COG annotation 
        } 
 } 
        close FILE2; 
 } 
close FILE1; 
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Appendix A3B 
PSORT_parser.pl 
#!/usr/bin/perl 
use warnings; 
 
# Open my file of paired Accession IDs 
open(FILE1,$ARGV[0]) or die "Couldn’t open file 1\n"; 
 
#Place my accession IDs into an array for matching 
while (<FILE1>) { 
chomp; 
@array1 = split; 
   my $acc1 = $array1[0]; 
 
#Open my PSORT annotation file 
open(FILE2,$ARGV[1]) or die "Couldn’t open file 2\n"; 
while (<FILE2>) { 
chomp; 
@array2 = split /\t/;     #split columns of tab delimniator 
 my $acc_match = $array2[3]; #define my accession IDs in the fourth column of the 
annotation file 
 my $protein_annot = $array2[1]; #define the protein annotation column in the array 
 my $localisation = $array2[5];  # define the subcellular localisation site column in the 
array 
 my $prediction_score = $array2[6]; # define the coumn with the PSORT score column in 
the array 
 if($acc1 eq $acc_match){  # condition, if accession IDs match then print the 
following fields. 
 print "$acc1\t"; 
 print "$acc_match\t"; 
 print "$protein_annot\t"; 
 print "$localisation\t"; 
 print "$prediction_score\n"; 
   } 
 } 
  close FILE2; 
 } 
 close FILE1; 
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Appendix A4 
Chi_Square R Functions 
One-Way Classification Chi-Square Test R Function 
 
        An R function written to conduct one way classification Chi-Square tests to determine if 
genes for a particular gene list (genes under positive selection or database identified virulence 
genes) are enriched for a certain functional annotation category is presented below: 
 
> one_way_classification_chi_function = function(gene_list_category_count, 
genome_gene_count_for_category, whole_gene_list_count, 
genome_count_of_all_genes_annot){ 
a1 = (gene_list_category_count) 
a2 = (genome_gene_count_for_category - gene_list_category_count) 
b1 = (whole_gene_list_count - gene_list_category_count) 
b2 = genome_count_of_all_genes_annot - (a1 + a2 + b1) 
row1 = c(a1,a2) 
row2 = c(b1,b2) 
contingency_table = rbind(row1,row2) 
print(contingency_table) 
print(chisq.test(contingency_table)) 
return(fisher.test(contingency_table)) 
} 
        Input to the one-way classification Chi-Square R function consists of gene counts for genes 
belonging to either the positive selection gene list or the database identified virulence genes, 
number of annotated gene list genes in that category, total number of gene list genes annotated 
by that system and the total number of genome genes annotated by that system. A listing of the 
input numbers is summarised below and overleaf.    
1) gene_list_category_count = count of gene list genes present in that particular functional 
annotation category. 
2) genome_gene_count_for_category = the total number of genome genes for a bacterial  
organism  placed within that particular functional annotation category. 
3) whole_gene_list_count = total number of gene list genes assigned to all functional annotation   
categories within that annotation system.  
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4) genome_count_of_all_genes_annot = number of genome genes for a species that have been 
classified into functional annotation categories within that annotation system. 
        The one-way Chi-Square classification R function uses gene counts provided by the user 
for annotation categories and systems to generate a 2 x 2 contingency table populated with the 
correct values for each cell, manual 2 x 2 contingency tables were constructed to double check 
the fidelity of the 2 x 2 contingency tables generated in R. A Chi-Square test with Yates 
continuity correction is performed on the 2 x 2 contingency tables and in cases where gene 
counts are below the recommended count of 5, a Fisher’s Exact Test is also conducted.  
 A worked example using the one-way classification Chi-Square R function is presented below 
for N. meningitidis genes under positive selection belonging to a COG category; 
Input Gene Counts: 
Total Number of N. meningitidis genes under positive selection belonging to COG category C 
(Energy production and conversion) = 11 genes 
Total Number of N. meningitidis genome genes placed in COG category C = 105 genes 
Total number of N. meningitidis genes under positive selection with COG annotations = 199 
genes 
Total number of N. meningitidis genome genes with COG annotations = 1356 genes 
 
>one_way_classification_chi_function(11,105,199,1356) 
     [,1] [,2] 
row1   11   94       # 2 x 2 contingency table generated for Chi-Square Test 
row2  188 1063 
        Pearson's Chi-squared test with Yates' continuity correction 
data:  contingency_table  
X-squared = 1.2599, df = 1, p-value = 0.2617   # Results of Chi-Square Test 
 
        Fisher's Exact Test for Count Data 
data:  contingency_table  
p-value = 0.2505          # Results for Fisher’s Exact Test 
alternative hypothesis: true odds ratio is not equal to 1  
95 percent confidence interval: 
 0.3133919 1.2698440  
sample estimates: 
odds ratio  
 0.661851 
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Two-Way Classification Chi-Square Test R Function 
        A two-way classification Chi-Square test was used to determine is database identified 
virulence genes and database identified virulence genes have a statistically significant 
intersection and association for a particular annotation category. The two-way classification Chi-
Square R function written is presented below: 
> two_way_classification_chi_function  = function(positive_selection_gene_count, 
virulence_gene_count, gene_list_intersection, genome_number){ 
a1 = (gene_list_intersection) 
a2 = (positive_selection_gene_count - gene_list_intersection) 
b1 = (virulence_gene_count - gene_list_intersection) 
b2 = genome_number-(a1+a2+b1) 
row1 = c(a1,a2) 
row2 = c(b1,b2) 
contingency_table = rbind(row1,row2) 
print(contingency_table) 
print(chisq.test(contingency_table)) 
return(fisher.test(contingency_table)) 
 
        Input gene numbers for the two-way classification Chi-Sqaure R function are as follows: 
1) positive_selection_gene_count = number of genes under positive selection in bacterial 
species 
2) virulence_gene_count = number of database identified virulence genes in bacterial 
species 
3) gene_list_intersection = number of database identified virulence genes that are under 
positive selection and belong an annotation category 
4) genome_number = number of genes in the genome that are annotated within a functional 
system. 
 
        The two-way classification Chi-Square R function uses the input gene numbers to 
generate a 2 x 2 contingency table which was double checked manually to ensure its 
correctness. A Chi-Square test is conducted on that 2 x 2 contingency table and in cases 
where gene counts are below 5, a Fisher’s Exact Test is conducted. A worked example using 
the two-way classification Chi-Square R function is presented overleaf. 
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Input Gene Numbers 
Number of N. meningitidis genes under positive selection = 218 genes 
Number of N. meningitidis database identified virulence genes = 68 genes 
Number of database identified virulence genes under positive selection (intersection between 
gene lists) = 14 genes  
Number of N. meningitidis genome genes = 2208 genes 
 
> two_way_classification_chi_function(218, 68, 14, 2208) 
     [,1] [,2] 
row1   14  204 
row2   54 1936    # 2 x 2 contingency table  
 
        Pearson's Chi-squared test with Yates' continuity correction 
data:  contingency_table  
X-squared = 7.8528, df = 1, p-value = 0.005074  # Results of Chi-Square Test 
 
 
        Fisher's Exact Test for Count Data 
data:  contingency_table  
p-value = 0.006048         # Results for Fisher’s Exact Test 
alternative hypothesis: true odds ratio is not equal to 1  
95 percent confidence interval: 
 1.238984 4.585353  
sample estimates: 
odds ratio  
  2.459031 
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Appendix B1 
Genes Under Positive Selection 
H. pylori Genes Under Positive Selection 
 
Table B1A (Part 1 of 7) : H. pylori Genes Under Positive Selection 
 
Cluster 
Identity 
H. pylori 
26695 
Accessions 
H. pylori 
J99 
Accessions 
Enterez Gene 
Name GenBank Annotation 
cluster_267 HP0022 jhp0020 eptA hypothetical protein 
cluster_844 HP0069 jhp0064 ureF urease accessory protein (ureF) 
cluster_688 HP0080 jhp0074  hypothetical protein 
cluster_919 HP0088 jhp0081 rpoD RNA polymerase sigma factor 
cluster_792 HP0102 jhp0094  hypothetical protein 
cluster_668 HP0120 jhp0110  hypothetical protein 
cluster_1007 HP0206 jhp0192  hypothetical protein 
cluster_1131 HP0238 jhp0223 proS prolyl-tRNA synthetase 
cluster_154 HP0252 jhp0237 omp7 outer membrane protein (omp7) 
cluster_1401 HP0258 jhp0242  hypothetical protein 
cluster_530 HP0298 jhp0283 dppA "dipeptide ABC transporter, 
periplasmic dipeptide-binding 
protein (dppA)" 
cluster_1155 HP0347 jhp0321  hypothetical protein 
cluster_1 HP0367 jhp1014  hypothetical protein 
cluster_32 HP0373 jhp1008  putative outer membrane protein 
cluster_105 HP0392 jhp0989 cheA histidine kinase (cheA) 
cluster_1343 HP0398 jhp0983  hypothetical protein 
cluster_1205 HP0462 jhp0414 hsdS type I restriction enzyme S protein 
(hsdS) 
cluster_936 HP0499 jhp0451 DR-
phospholipase 
A 
phospholipase A1 precursor (DR-
phospholipase A) 
cluster_817 HP0513 jhp0462  hypothetical protein 
cluster_640 HP0519 jhp0468  hypothetical protein 
cluster_1348 HP0547 jhp0495 cag26 / cagA cag pathogenicity island protein 
(cag26) 
cluster_344 HP0651 jhp0596 fucT (j99) "ALPHA (1,3)-
FUCOSYLTRANSFERASE" 
cluster_22 HP0675 jhp0617 xerC integrase/recombinase (xerC) 
cluster_414 HP0717 jhp0655 dnaX (j99) DNA polymerase III subunits 
gamma and tau 
cluster_53 HP0728 jhp0665  hypothetical protein 
cluster_884 HP0731 jhp0668  hypothetical protein 
cluster_207 HP0772 jhp0709 amiA N-acetylmuramoyl-L-alanine 
amidase (amiA) 
cluster_267 HP0022 jhp0020 eptA hypothetical protein 
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Table B1A (Part 2 of 7) : H. pylori Genes Under Positive Selection 
 
Cluster 
Identity 
H. pylori 
26695 
Accessions 
H. pylori 
J99 
Accessions 
Enterez 
Gene Name GenBank Annotation 
cluster_61 HP0887 jhp0819 vacA vacuolating cytotoxin 
cluster_974 HP0906 jhp0842  hypothetical protein 
cluster_1365 HP0958 jhp0892  hypothetical protein 
cluster_612 HP0973 jhp0907  hypothetical protein 
cluster_93 HP0996 jhp0942  hypothetical protein 
cluster_799 HP1017 jhp0406 rocE amino acid permease (rocE) 
cluster_439 HP1028 jhp0396  hypothetical protein 
cluster_720 HP1048 jhp0377 infB translation initiation factor IF-2 
cluster_528 HP1053 jhp0372 minC septum formation inhibitor 
cluster_466 HP1090 jhp0335 ftsK cell division protein (ftsK) 
cluster_349 HP1105 jhp1032  LPS biosynthesis protein 
cluster_287 HP1142 jhp1070  hypothetical protein 
cluster_533 HP1156 jhp1083 omp25 outer membrane protein (omp25) 
cluster_743 HP1157 jhp1084 omp26 outer membrane protein (omp26) 
cluster_1019 HP1177 jhp1103 omp27 outer membrane protein (omp27) 
cluster_1306 HP1243 jhp0833 omp28 / 
babA 
outer membrane protein (omp28) 
cluster_107 HP1250 jhp1171  hypothetical protein 
cluster_515 HP1252 jhp1173 oppA "oligopeptide ABC transporter, 
periplasmic oligopeptide-binding 
protein (oppA)" 
cluster_638 HP1284 jhp1204  hypothetical protein 
cluster_221 HP1329 jhp1249 czcA cation efflux system protein (czcA) 
cluster_750 HP1362 jhp1280 dnaB replicative DNA helicase 
cluster_1165 HP1364 jhp1282  "signal-transducing protein, histidine 
kinase" 
cluster_647 HP1433 jhp1326  hypothetical protein 
cluster_565 HP1470 jhp1363 polA DNA polymerase I (polA) 
cluster_1113 HP1550 jhp1449 SecD protein export protein SecD 
cluster_760 HP1568 jhp1476  hypothetical protein 
cluster_833 HP1587 jhp1493  hypothetical protein 
cluster_1327 HP0033 jhp0029 clpA ATP-dependent C1p protease (clpA) 
cluster_728 HP0037 jhp0033  NADH-ubiquinone oxidoreductase 
subunit 
cluster_935 HP0038 jhp0034 comB1 hypothetical protein 
cluster_356 HP0048 jhp0041 hypF transcriptional regulator (hypF) 
cluster_1389 HP0052 jhp0044  putative TYPE II DNA 
MODIFICATION ENZYME 
(METHYLTRANSFERASE) 
cluster_404 HP0060 jhp0054  hypothetical protein 
cluster_816 HP0062 jhp0057  hypothetical protein 
cluster_1025 HP0063 jhp0058  hypothetical protein 
cluster_11 HP0065 jhp0060  hypothetical protein 
cluster_789 HP0056 jhp0048 putA delta-1-pyrroline-5-carboxylate 
dehydrogenase 
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Table B1A (Part 3 of 7) : H. pylori Genes Under Positive Selection 
 
Cluster 
Identity 
H. pylori 
26695 
Accessions 
H. pylori 
J99 
Accessions 
Enterez 
Gene Name GenBank Annotation 
cluster_218 HP0066 jhp0061  conserved hypothetical ATP-binding 
protein 
cluster_519 HP0092 jhp0085 hsdM type II restriction enzyme M protein 
(hsdM) 
cluster_540 HP0099 jhp0091 tlpA methyl-accepting chemotaxis protein 
(tlpA) 
cluster_379 HP0100 jhp0092  hypothetical protein 
cluster_1003 HP0103 jhp0095 tlpB methyl-accepting chemotaxis protein 
(tlpB) 
cluster_1238 HP0110 jhp0102 grpE co-chaperone and heat shock protein 
(grpE) 
cluster_1369 HP0149 jhp0137  hypothetical protein 
cluster_795 HP0159 jhp0147 rfaJ "lipopolysaccharide 1,2-
glucosyltransferase (rfaJ)" 
cluster_1240 HP0167 jhp0153  hypothetical protein 
cluster_645 HP0170 jhp0156  hypothetical protein 
cluster_250 HP0175 jhp0161  cell binding factor 2 
cluster_73 HP0180 jhp0168 lnt apolipoprotein N-acyltransferase 
cluster_1314 HP0186 jhp0174  hypothetical protein 
cluster_924 HP0190 jhp0176  conserved hypothetical secreted 
protein 
cluster_1128 HP0191 jhp0177 frdB (j99) succinate dehydrogenase 
cluster_1397 HP0201 jhp0187 plsX fatty acid/phospholipid synthesis 
protein 
cluster_1034 HP0212 jhp0198 dapE (j99) succinyl-diaminopimelate 
desuccinylase 
cluster_21 HP0214 jhp0200 huNaDC-1 sodium-dependent transporter 
(huNaDC-1) 
cluster_1293 HP0226 jhp0211  hypothetical protein 
cluster_302 HP0234 jhp0219  hypothetical protein 
cluster_1336 HP0239 jhp0224 hemA glutamyl-tRNA reductase 
cluster_1063 HP0275 jhp0260 addB ATP-dependent nuclease (addB) 
cluster_488 HP0285 jhp0270  hypothetical protein 
cluster_1403 HP0304 jhp0289  hypothetical protein 
cluster_804 HP0308 jhp0293  hypothetical protein 
cluster_1015 HP0309 jhp0294  hypothetical protein 
cluster_887 HP0327 jhp0310 flaG flagellar protein G (flaG) 
cluster_1300 HP0329 jhp0312 nadE NH(3)-dependent NAD+ synthetase 
(nadE) 
cluster_491 HP0331 jhp0314 minD cell division inhibitor (minD) 
cluster_511 HP0338 jhp0320  hypothetical protein 
cluster_551 HP0350 jhp0324  hypothetical protein 
cluster_782 HP0358 jhp1022  hypothetical protein 
cluster_1043 HP0371 jhp1010 fabE / accB biotin carboxyl carrier protein (fabE) 
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Table B1A (Part 4 of 7) : H. pylori Genes Under Positive Selection 
 
Cluster 
Identity 
H. pylori 
26695 
Accessions 
H. pylori 
J99 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_446 HP0375 jhp1006  hypothetical protein 
cluster_1070 HP0378 jhp1003 ycf5 cytochrome c biogenesis protein (ycf5) 
cluster_162 HP0401 jhp0980 aroA 3-phosphoshikimate 1-carboxyvinyltransferase 
cluster_837 HP0417 jhp0967 metG methionine--tRNA ligase 
cluster_1046 HP0418 jhp0966  hypothetical protein 
cluster_449 HP0421 jhp0963 capJ type 1 capsular polysaccharide biosynthesis 
protein J (capJ) 
cluster_400 HP0465 jhp0417  hypothetical protein 
cluster_663 HP0479 jhp0431  hypothetical protein 
cluster_896 HP0486 jhp0438  hypothetical protein 
cluster_1001 HP0508 jhp0458  hypothetical protein 
cluster_219 HP0517 jhp0466 era GTP-binding protein Era 
cluster_92 HP0535 jhp0483 cag14 cag pathogenicity island protein (cag14) 
cluster_147 HP0554 jhp0501  hypothetical protein 
cluster_980 HP0558 jhp0505 fabB 3-oxoacyl-(acyl carrier protein) synthase 
cluster_793 HP0563 jhp0510  hypothetical protein 
cluster_615 HP0569 jhp0516 gtp1 GTP-binding protein (gtp1) 
cluster_275 HP0586 jhp0534  hypothetical protein 
cluster_618 HP0615 jhp0558 lig DNA ligase 
cluster_822 HP0616 jhp0559 cheV chemotaxis protein (cheV) 
cluster_1032 HP0617 jhp0560 aspS aspartyl-tRNA synthetase 
cluster_1241 HP0618 jhp0561 adk adenylate kinase 
cluster_1058 HP0623 jhp0567 murC UDP-N-acetylmuramate--L-alanine ligase 
cluster_878 HP0629 jhp0572  hypothetical protein 
cluster_1291 HP0630 jhp0573 mda66 modulator of drug activity (mda66) 
cluster_98 HP0638 jhp0581 omp13 outer membrane protein (omp13) 
cluster_300 HP0639 jhp0582  hypothetical protein 
cluster_544 HP0652 jhp0597 serB phosphoserine phosphatase (serB) 
cluster_1168 HP0655 jhp0600  protective surface antigen D15 
cluster_853 HP0679 jhp0620 wbpB lipopolysaccharide biosynthesis protein (wbpB) 
cluster_462 HP0683 jhp0624 glmU UDP-N-acetylglucosamine pyrophosphorylase 
(glmU) 
cluster_1134 HP0745 jhp0682  hypothetical protein 
cluster_531 HP0749 jhp0686 ftsX cell division membrane protein (ftsX) 
cluster_348 HP0754 jhp0691  hypothetical protein 
cluster_600 HP0768 jhp0705 moaA molybdenum cofactor biosynthesis protein A 
cluster_469 HP0786 jhp0723 secA translocase 
cluster_286 HP0791 jhp0727 cadA / 
hmcT 
"cadmium-transporting ATPase, P-type (cadA)" 
cluster_696 HP0690 jhp0638 fadA / 
thl 
acetyl coenzyme A acetyltransferase (thiolase) 
(fadA) 
cluster_388 HP0710 jhp0649  putative Outer membrane protein 
cluster_699 HP0737 jhp0674 pgpA PHOSPHATIDYLGLYCEROPHOSPHATASE A 
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Table B1A (Part 5 of 7) : H. pylori Genes Under Positive Selection 
 
Cluster 
Identity 
H. pylori 
26695 
Accessions 
H. pylori 
J99 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_160 HP0806 jhp0742  hypothetical protein 
cluster_575 HP0808 jhp0744 acpS 4'-phosphopantetheinyl transferase 
cluster_783 HP0809 jhp0745 fliL flagellar basal body-associated protein 
cluster_1199 HP0810 jhp0746  hypothetical protein 
cluster_395 HP0813 jhp0749  hypothetical protein 
cluster_1044 HP0822 jhp0761 hom homoserine dehydrogenase 
cluster_447 HP0826 jhp0765 lex2B lipooligosaccharide 5G8 epitope biosynthesis-
associated protein (lex2B) 
cluster_1118 HP0841 jhp0779 dfp phosphopantothenoylcysteine 
synthase/decarboxylase 
cluster_514 HP0845 jhp0783 thiM 
(j99) 
hydroxyethylthiazole kinase 
cluster_726 HP0846 jhp0784 hsdR type I restriction enzyme R protein (hsdR) 
cluster_534 HP0851 jhp0787  hypothetical protein 
cluster_764 HP0859 jhp0793 rfaD / 
gmhD 
ADP-L-glycero-D-mannoheptose-6-epimerase 
(rfaD) 
cluster_1384 HP0861 jhp0795  hypothetical protein 
cluster_373 HP0863 jhp0797  hypothetical protein 
cluster_424 HP0876 jhp0810 frpB iron-regulated outer membrane protein (frpB) 
cluster_1073 HP0885 jhp0817 mviN virulence factor mviN protein (mviN) 
cluster_893 HP0890 jhp0823  hypothetical protein 
cluster_706 HP0896 jhp1164 omp19 / 
babB 
outer membrane protein (omp19) 
cluster_1119 HP0898 jhp0835 hypD hydrogenase expression/formation protein 
(hypD) 
cluster_165 HP0909 jhp0845  hypothetical protein 
cluster_787 HP0911 jhp0847 rep "rep helicase, single-stranded DNA-dependent 
ATPase (rep)" 
cluster_998 HP0912 jhp0848 omp20 / 
hopC 
outer membrane protein (omp20) 
cluster_1206 HP0913 jhp0849 omp21 / 
hopB 
outer membrane protein (omp21) 
cluster_216 HP0921 jhp0855 gap glyceraldehyde-3-phosphate dehydrogenase 
(gap) 
cluster_637 HP0923 jhp0857 omp22 outer membrane protein (omp22) 
cluster_294 HP0940 jhp0875 yckK "amino acid ABC transporter, periplasmic 
binding protein (yckK)" 
cluster_110 HP0946 jhp0880  hypothetical protein 
cluster_146 HP0959 jhp0893  hypothetical protein 
cluster_220 HP0978 jhp0912 ftsA cell division protein (ftsA) protein 
cluster_1399 HP1013 jhp0410 dapA dihydrodipicolinate synthase 
cluster_1319 HP1044 jhp0380  hypothetical protein 
cluster_756 HP1060 jhp0365  sec-independent translocase 
cluster_593 HP1016 jhp0407 pgsA phosphatidylglycerophosphate synthase (pgsA) 
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Table B1A (Part 6 of 7) : H. pylori Genes Under Positive Selection 
 
Cluster 
Identity 
H. pylori 
26695 
Accessions 
H. pylori 
J99 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_200 HP1020 jhp0404 ispDF "bifunctional 2-C-methyl-D-erythritol 4-
phosphate cytidylyltransferase/2-C-methyl-D-
erythritol 2,4-cyclodiphosphate synthase protein" 
cluster_23 HP1026 jhp0398  conserved hypothetical helicase-like protein 
cluster_674 HP1035 jhp0389 flhF flagellar biosynthesis protein 
cluster_1295 HP1038 jhp0386 aroD 3-dehydroquinate dehydratase 
cluster_964 HP1061 jhp0364  hypothetical protein 
cluster_626 HP1079 jhp0346  hypothetical protein 
cluster_856 HP1086 jhp0339 tly / 
hlyA 
hemolysin (tly) 
cluster_1065 HP1087 jhp0338 ribF 
(j99) 
hypothetical protein 
cluster_677 HP1091 jhp0334 kgtP alpha-ketoglutarate permease (kgtP) 
cluster_780 HP1113 jhp1040 omp24 outer membrane protein (omp24) 
cluster_208 HP1123 jhp1052 slyD "peptidyl-prolyl cis-trans isomerase, FKBP-type 
rotamase (slyD)" 
cluster_311 HP1149 jhp1076  hypothetical protein 
cluster_1342 HP1153 jhp1080  valyl-tRNA synthetase 
cluster_332 HP1155 jhp1082 murG N-acetylglucosaminyl transferase 
cluster_1178 HP1165 jhp1092 tetA "tetracycline resistance protein tetA(P), putative" 
cluster_1200 HP1171 jhp1098 glnQ "glutamine ABC transporter, ATP-binding protein 
(glnQ)" 
cluster_34 HP1185 jhp1111  sugar efflux transporter 
cluster_125 HP1200 jhp1123 rplJ 50S ribosomal protein L10 
cluster_1021 HP1223 jhp1144  hypothetical protein 
cluster_240 HP1232 jhp1153 folP dihydropteroate synthase (folP) 
cluster_865 HP1235 jhp1156  hypothetical protein 
cluster_684 HP1240 jhp1161 maf Maf-like protein 
cluster_894 HP1241 jhp1162 alaS alanyl-tRNA synthetase 
cluster_292 HP1245 jhp1166 ssb single-strand DNA-binding protein 
cluster_934 HP1254 jhp1175 bioC biotin synthesis protein (bioC) 
cluster_1139 HP1255 jhp1176 secG protein-export membrane protein 
cluster_335 HP1258 jhp1179  conserved hypothetical mitochondrial protein 4 
cluster_1414 HP1275 jhp1196  phosphomannomutase 
cluster_403 HP1277 jhp1198 trpA "tryptophan synthase, alpha subunit (trpA)" 
cluster_815 HP1279 jhp1200 trpC bifunctional indole-3-glycerol phosphate 
synthase/phosphoribosylanthranilate isomerase 
cluster_1262 HP1333 jhp1253  hypothetical protein 
cluster_959 HP1363 jhp1281  hypothetical protein 
cluster_1368 HP1365 jhp1443  response regulator 
cluster_664 HP1290 jhp1210 pnuC nicotinamide mononucleotide transporter (pnuC) 
cluster_1366 HP1309 jhp1229 rplN 50S ribosomal protein L14 
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Table B1A (Part 7 of 7) : H. pylori Genes Under Positive Selection 
 
Cluster 
Identity 
H. pylori 
26695 
Accessions 
H. pylori 
J99 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_541 HP1361 jhp1279 comE3 
/ 
comEC 
competence locus E (comE3) 
cluster_1393 HP1371 jhp1285  type III restriction enzyme R protein 
cluster_17 HP1384 jhp1441  hypothetical protein 
cluster_458 HP1392 jhp1435  fibronectin/fibrinogen-binding protein 
cluster_481 HP1399 jhp1427 rocF arginase (rocF) 
cluster_733 HP1402 jhp1424 hsdR type I restriction enzyme R protein (hsdR) 
cluster_343 HP1407 jhp1299 rbn 
(j99) 
hypothetical protein 
cluster_1422 HP1424 jhp1319  hypothetical protein 
cluster_823 HP1428 jhp1325  hypothetical protein 
cluster_1033 HP1429 jhp1324 kpsF polysialic acid capsule expression protein (kpsF) 
cluster_20 HP1430 jhp1323  conserved hypothetical ATP-binding protein 
cluster_926 HP1453 jhp1346  hypothetical protein 
cluster_986 HP1472 jhp1365 mod type IIS restriction enzyme M protein (mod) 
cluster_800 HP1478 jhp1371 uvrD / 
rep 
DNA helicase II (uvrD) 
cluster_827 HP1484 jhp1377  hypothetical protein 
cluster_882 HP1497 jhp1390 pth peptidyl-tRNA hydrolase 
cluster_329 HP1503 jhp1396 copA / 
fixI 
"cation-transporting ATPase, P-type (copA)" 
cluster_947 HP1506 jhp1399 gltS glutamate permease (gltS) 
cluster_1357 HP1508 jhp1401  ferrodoxin-like protein 
cluster_179 HP1521 jhp1410 res type III restriction enzyme R protein (res) 
cluster_830 HP1530 jhp1418 punB purine nucleoside phosphorylase (punB) 
cluster_467 HP1541 jhp1458 trcF / 
mfd 
transcription-repair coupling factor (trcF) 
cluster_1091 HP1544 jhp1455 tagE toxR-activated gene (tagE) 
cluster_1299 HP1545 jhp1454 folC folylpolyglutamate synthase (folC) 
cluster_308 HP1553 jhp1446 pcrA 
(j99) 
helicase 
cluster_1360 HP1564 jhp1472  outer membrane protein 
Table B1A :  H. pylori strains 26695 (HP) and J99 (jhp) orthologous genes pairs found to be 
under positive selection after curation of alignments for frameshifts together with their GenBank 
annotations. Genes highlighted in bold italics are database identified virulence genes under 
positive selection. 
 
 
 
 
 
 
 
 
 
 
 
 175 
N. meningitidis Genes Under Positive Selection   
 
Table B1B (Part 1 of 7) : N. meningitidis Genes Under Positive Selection 
 
Cluster 
Identity 
N. 
meningitidis 
MC58 
Accessions 
N. 
meningitidis 
Z2491 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_1218 NMB0004 NMA0251  EpiH/GdmH-related protein 
cluster_1793 NMB0012 NMA0259  putative transmembrane transport protein 
cluster_1556 NMB0018 NMA0264 pilE pilin PilE 
cluster_305 NMB0032 NMA0277  putative lipoprotein 
cluster_617 NMB0199 NMA0069 lpxB lipid-A-disaccharide synthase 
cluster_754 NMB0270 NMA2216  putative bioH protein 
cluster_1009 NMB0271 NMA2215  hypothetical protein 
cluster_599 NMB0341 NMA2146  "Neisseria-specific antigen protein, TspA" 
cluster_928 NMB0401 NMA2084 putA proline dehydrogenase 
cluster_1720 NMB0460 NMA2025 tbp2 / 
tbpB 
transferrin-binding protein 2 
cluster_414 NMB0462 NMA2023 potD-1 
(mc58) 
"spermidine/putrescine ABC transporter, 
periplasmic spermidine/putrescine-binding 
protein" 
cluster_1461 NMB0506 NMA0692  hypothetical protein 
cluster_862 NMB0598 NMA0802  Maf/YceF/YhdE family protein 
cluster_1107 NMB0741 NMA0954  hypothetical protein 
cluster_796 NMB0887 NMA1107  putative type IV pilus assembly protein PilV 
cluster_1053 NMB0888 NMA1108  putative membrane protein 
cluster_1060 NMB0990 NMA1191  hypothetical protein 
cluster_1591 NMB0992 NMA1200 hsf 
(mc58) 
adhesin 
cluster_1599 NMB1041 NMA1445  GTP-binding protein 
cluster_1580 NMB1194 NMA1367 cysG-2 / 
cysG 
siroheme synthase 
cluster_523 NMB1293 NMA1503  hypothetical protein 
cluster_385 NMB1314 NMA1527 ftsK-2 
(mc58) 
cell division protein FtsK 
cluster_1466 NMB1374 NMA1588 truB tRNA pseudouridine synthase B 
cluster_870 NMB1559 NMA1747 gshB glutathione synthetase 
cluster_627 NMB1564 NMA1753  hypothetical protein 
cluster_1246 NMB1585 NMA1774  "transcriptional regulator, MarR family" 
cluster_1250 NMB1631 NMA1795  hypothetical protein 
cluster_992 NMB1687 NMA1946  hypothetical protein 
cluster_1254 NMB1688 NMA1947 ansA / 
ans 
L-asparaginase I 
cluster_1527 NMB1735 NMA1991 relA GTP pyrophosphokinase 
cluster_1529 NMB1791 NMA0672 cafA cytoplasmic axial filament protein 
cluster_1467 NMB1825 NMA0634  hypothetical protein 
cluster_798 NMB1699 NMA1955  hypothetical protein 
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Table B1B (Part 2 of 7) : N. meningitidis Genes Under Positive Selection 
 
Cluster 
Identity 
N. 
meningitidis 
MC58 
Accessions 
N. 
meningitidis 
Z2491 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_1231 NMB1830 NMA0625  putative phosphoglycolate phosphatase 
cluster_260 NMB1846 NMA0611  Mrp/NBP35 family protein 
cluster_232 NMB1896 NMA0560 dpnC / 
drg 
type II restriction enzyme DpnI 
cluster_1418 NMB1915 NMA0540  hypothetical protein 
cluster_1739 NMB1929 NMA0524 lgtA lacto-N-neotetraose biosynthesis glycosyl 
transferase LgtA 
cluster_1105 NMB1958 NMA0493  putative thioredoxin 
cluster_1156 NMB1970 NMA0477  putative para-aminobenzoate synthetase 
component I/4-amino-4-deoxychorismate 
lyase 
cluster_1744 NMB1985 NMA0457 hap / 
iga2 
IgA-specific serine endopeptidase 
cluster_1547 NMB1997 NMA0444 gloB 
(mc58) 
hydroxyacylglutathione hydrolase 
cluster_1317 NMB2051 NMA0385 petC "ubiquinol--cytochrome c reductase, 
cytochrome c1" 
cluster_1614 NMB2105 NMA0324 mafB mafB protein 
cluster_421 NMB2132 NMA0299  transferrin-binding protein-related protein 
cluster_449 NMB0008 NMA0255  putative cell division protein FtsX 
cluster_1088 NMB0029 NMA0274 hprA 
(mc58) 
glycerate dehydrogenase 
cluster_116 NMB0050 NMA0220  putative integral membrane protein 
cluster_770 NMB0071 NMA0198 ctrA capsule polysaccharide export outer 
membrane protein CtrA 
cluster_1027 NMB0072 NMA0197 ctrB capsule polysaccharide export inner-
membrane protein CtrB 
cluster_1559 NMB0074 NMA0195 ctrD capsule polysaccharide export ATP-
binding protein CtrD 
cluster_37 NMB0088 NMA0178  putative outer membrane protein P1 
cluster_705 NMB0105 NMA0169  PhnO-related protein 
cluster_1802 NMB0115 NMA0159 ntrX 
(mc58) 
nitrogen assimilation regulatory protein 
NtrX 
cluster_226 NMB0116 NMA0158 dprA DNA processing chain A 
cluster_777 NMB0174 NMA0094 valS valyl-tRNA synthetase 
cluster_809 NMB0180 NMA0087 lpxD UDP-3-O-[3-hydroxymyristoyl] 
glucosamine N-acyltransferase 
cluster_589 NMB0192 NMA0075 rnhB ribonuclease HII 
cluster_341 NMB0198 NMA0070 rluC ribosomal large subunit pseudouridine 
synthase C 
cluster_1472 NMB0204 NMA0065  putative lipoprotein 
cluster_749 NMB0214 NMA0054 prlC oligopeptidase A 
cluster_893 NMB0246 NMA0014 nuoF "NADH dehydrogenase I, F subunit" 
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Table B1B (Part 3 of 7) : N. meningitidis Genes Under Positive Selection 
 
Cluster 
Identity 
N. 
meningitidis 
MC58 
Accessions 
N. 
meningitidis 
Z2491 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_946 NMB0259 NMA2228 nuoN NADH dehydrogenase subunit N 
cluster_163 NMB0262 NMA2225 xseB "exodeoxyribonuclease, small subunit" 
cluster_433 NMB0263 NMA2224  ribosome-associated GTPase 
cluster_716 NMB0264 NMA2223  "ABC transporter, ATP-binding protein" 
cluster_1509 NMB0267 NMA2219  putative periplasmic protein 
cluster_1780 NMB0314 NMA2173  hypothetical protein 
cluster_295 NMB0334 NMA2154 pgi-1 / 
pgi2 
glucose-6-phosphate isomerase 
cluster_571 NMB0335 NMA2153 dapD "2,3,4,5-tetrahydropyridine-2,6-
dicarboxylate N-succinyltransferase" 
cluster_628 NMB0348 NMA2139  hypothetical protein 
cluster_897 NMB0349 NMA2138  glutamyl-tRNA synthetase 
cluster_372 NMB0353 NMA2134  hypothetical protein 
cluster_440 NMB0366 NMA2122  hypothetical protein 
cluster_1373 NMB0394 NMA2090 nadA quinolinate synthetase 
cluster_139 NMB0405 NMA2080 comM 
(mc58) 
competence protein ComM 
cluster_1519 NMB0416 NMA2068 murF "UDP-N-acetylmuramoylalanyl-D-
glutamyl-2,6-diaminopimelate--D-alanyl-D-
alanyl ligase" 
cluster_1084 NMB0433 NMA2052 acnA aconitate hydratase 
cluster_1404 NMB0447 NMA2038 recO DNA repair protein RecO 
cluster_1429 NMB0453 NMA2032 mutT mutT protein 
cluster_112 NMB0455 NMA2030  hypothetical protein 
cluster_144 NMB0461 NMA2024 tbp1 / 
tbpA 
transferrin-binding protein 1 
cluster_1524 NMB0472 NMA2013 bioF 8-amino-7-oxononanoate synthase 
cluster_1323 NMB0530 NMA0708  beta-hexosaminidase 
cluster_1590 NMB0531 NMA0709  putative integral membrane protein 
cluster_1616 NMB0538 NMA0717  hypothetical protein 
cluster_858 NMB0541 NMA0720  hypothetical protein 
cluster_67 NMB0545 NMA0724  hypothetical protein 
cluster_612 NMB0547 NMA0726  type IV pilin protein 
cluster_1532 NMB0575 NMA0759 gcvH glycine cleavage system protein H 
cluster_1439 NMB0602 NMA0806 hitA 
(mc58) 
hitA protein 
cluster_838 NMB0638 NMA0848 galU UTP--glucose-1-phosphate 
uridylyltransferase 
cluster_1040 NMB0682 NMA0884 pyrC dihydroorotase 
cluster_813 NMB0688 NMA0890 trpF N-(5'-phosphoribosyl)anthranilate 
isomerase 
cluster_1598 NMB0690 NMA0892 purF amidophosphoribosyltransferase 
cluster_1807 NMB0622 NMA0830 lolA outer membrane lipoprotein carrier protein 
cluster_163 NMB0262 NMA2225 xseB "exodeoxyribonuclease, small subunit" 
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Table B1B (Part 4 of 7) : N. meningitidis Genes Under Positive Selection 
 
Cluster 
Identity 
N. 
meningitidis 
MC58 
Accessions 
N. 
meningitidis 
Z2491 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_566 NMB0693 NMA0896 folC folylpolyglutamate synthase/dihydrofolate 
synthase 
cluster_100 NMB0700 NMA0905 iga IgA-specific serine endopeptidase 
cluster_649 NMB0702 NMA0906 comA competence protein ComA 
cluster_787 NMB0728 NMA0937 pheT phenylalanyl-tRNA synthetase beta subunit 
cluster_1848 NMB0731 NMA0941  hypothetical protein 
cluster_817 NMB0734 NMA0944  hypothetical protein 
cluster_843 NMB0740 NMA0952 recN DNA repair protein RecN 
cluster_1211 NMB0767 NMA0978 pfs 5-methylthioadenosine nucleosidase/S-
adenosylhomocysteine nucleosidase 
cluster_1746 NMB0769 NMA0980  DNA polymerase III subunit delta 
cluster_721 NMB0771 NMA0982  hypothetical protein 
cluster_476 NMB0777 NMA0988  uroporphyrinogen-III synthetase 
cluster_1014 NMB0779 NMA0990  hypothetical protein 
cluster_1816 NMB0781 NMA0991 hemE uroporphyrinogen decarboxylase 
cluster_509 NMB0783 NMA0993  hypothetical protein 
cluster_790 NMB0784 NMA0994  putative phage shock protein E precursor 
cluster_1048 NMB0785 NMA0995 recB exodeoxyribonuclease V 135 KD 
polypeptide 
cluster_1713 NMB0809 NMA1019  hypothetical protein 
cluster_690 NMB0811 NMA1021 murB UDP-N-acetylpyruvoylglucosamine 
reductase 
cluster_1 NMB0834 NMA1814  "transposase, IS30 family" 
cluster_1344 NMB0839 NMA1048 pmbA pmbA protein 
cluster_299 NMB0841 NMA1051  putative membrane protein 
cluster_1658 NMB0852 NMA1063  GTP-binding protein EngA 
cluster_351 NMB0854 NMA1065 hisS histidyl-tRNA synthetase 
cluster_140 NMB0866 NMA1084  putative periplasmic protein 
cluster_175 NMB0872 NMA1090  putative periplasmic protein 
cluster_446 NMB0873 NMA1091 lolB outer membrane lipoprotein LolB precursor 
cluster_1823 NMB0884 NMA1104 sodB superoxide dismutase 
cluster_517 NMB0886 NMA1106 fimT fimbrial protein FimT 
cluster_117 NMB0962 NMA1159 uvrA excinuclease ABC subunit A 
cluster_1798 NMB0980 NMA1177 pntA NAD(P) transhydrogenase subunit alpha 
cluster_222 NMB0981 NMA1179 serB phosphoserine phosphatase 
cluster_1832 NMB0987 NMA1303  putative N-acetylmuramoyl-L-alanine 
amidase 
cluster_1617 NMB0999 NMA1207  NifR3/SMM1 family protein 
cluster_196 NMB1024 NMA1464  hypothetical protein 
cluster_1348 NMB0895 NMA1114  hypothetical protein 
cluster_1320 NMB0935 NMA1130 miaA tRNA delta(2)-isopentenylpyrophosphate 
transferase 
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Table B1B (Part 5 of 7) : N. meningitidis Genes Under Positive Selection 
 
Cluster 
Identity 
N. 
meningitidis 
MC58 
Accessions 
N. 
meningitidis 
Z2491 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_234 NMB1030 NMA1457  hypothetical protein 
cluster_814 NMB1039 NMA1447  hypothetical protein 
cluster_1104 NMB1046 NMA1440 thrC threonine synthase 
cluster_75 NMB1055 NMA1254 glyA serine hydroxymethyltransferase 
cluster_368 NMB1062 NMA1261  putative integral membrane protein 
cluster_1706 NMB1067 NMA1266 ftsK-1 
(mc58) 
cell division protein FtsK 
cluster_1545 NMB1085 NMA1864  putative N-acetylmuramoyl-L-alanine 
amidase 
cluster_541 NMB1094 NMA1313  hypothetical protein 
cluster_404 NMB1115 NMA1325  putative tail fibre protein 
cluster_209 NMB1183 NMA1356 mpl-2 / 
mpl 
UDP-N-acetylmuramate:L-alanyl-gamma-
D-glutamyl-meso-diaminopimelate ligase 
cluster_1821 NMB1189 NMA1362 cysI-2 / 
cysI 
"sulfite reductase hemoprotein, beta-
component" 
cluster_514 NMB1190 NMA1363 cysJ-2 / 
cysJ 
"sulfite reductase (NADPH) flavoprotein, 
alpha component" 
cluster_1082 NMB1199 NMA1370 typA GTP-binding protein TypA 
cluster_1582 NMB1240 NMA1409  "ABC transporter, ATP-binding protein" 
cluster_303 NMB1249 NMA1418  putative nitrate/nitrite sensory protein NarX 
cluster_1637 NMB1253 NMA1424  hypothetical protein 
cluster_1526 NMB1284 NMA1494  hypothetical protein 
cluster_1164 NMB1310 NMA1524 gcpE 4-hydroxy-3-methylbut-2-en-1-yl 
diphosphate synthase 
cluster_1799 NMB1331 NMA1545 uvrB excinuclease ABC subunit B 
cluster_1293 NMB1336 NMA1550  hypothetical protein 
cluster_859 NMB1353 NMA1565  aldehyde dehydrogenase family protein 
cluster_1437 NMB1368 NMA1580  putative ATP-dependent RNA helicase 
cluster_672 NMB1371 NMA1584 argD bifunctional N-succinyldiaminopimelate-
aminotransferase/acetylornithine 
transaminase protein 
cluster_1125 NMB1400 NMA1620  ABC transporter family protein 
cluster_1733 NMB1421 NMA1633  nifR3 protein 
cluster_193 NMB1429 NMA1642 porA outer membrane protein PorA 
cluster_1269 NMB1432 NMA1644 aroA 3-phosphoshikimate 1-
carboxyvinyltransferase 
cluster_1841 NMB1440 NMA1652  hypothetical protein 
cluster_20 NMB1447 NMA1660 rep ATP-dependent DNA helicase 
cluster_365 NMB1467 NMA1679 ppx 
(gppA-
z2491) 
exopolyphosphatase 
 
 
 
 
 
 
 180 
Table B1B (Part 6 of 7) : N. meningitidis Genes Under Positive Selection 
 
Cluster 
Identity 
N. 
meningitidis 
MC58 
Accessions 
N. 
meningitidis 
Z2491 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_1845 NMB1497 NMA1700  TonB-dependent receptor 
cluster_76 NMB1506 NMA1707 argS arginyl-tRNA synthetase 
cluster_1546 NMB1536 NMA1735 secA translocase 
cluster_1046 NMB1540 NMA1739 lbpA lactoferrin-binding protein A 
cluster_1339 NMB1548 NMA1797  putative tspB protein 
cluster_1629 NMB1555 NMA1743 fadD-2 / 
fadD 
long-chain-fatty-acid--CoA ligase 
cluster_1157 NMB1566 NMA1755 purN phosphoribosylglycinamide 
formyltransferase 
cluster_1451 NMB1573 NMA1762 argF "ornithine carbamoyltransferase, catabolic" 
cluster_511 NMB1595 NMA1788 alaS alanyl-tRNA synthetase 
cluster_1314 NMB1644 NMA1898  hypothetical protein 
cluster_61 NMB1705 NMA1959 rfaK "alpha-1,2-N-acetylglucosamine 
transferase" 
cluster_1162 NMB1715 NMA1969 mtrD multiple transferable resistance system 
protein MtrD 
cluster_114 NMB1718 NMA1972  hypothetical protein 
cluster_932 NMB1720 NMA1974 recC exodeoxyribonuclease V 125 kD 
polypeptide 
cluster_1192 NMB1721 NMA1975  hypothetical protein 
cluster_1227 NMB1784 NMA0681  hypothetical protein 
cluster_1294 NMB1797 NMA0665  penicillin-binding protein 3 
cluster_95 NMB1814 NMA0647 aroB 3-dehydroquinate synthase 
cluster_361 NMB1815 NMA0646  hypothetical protein 
cluster_913 NMB1817 NMA0644 ribD riboflavin biosynthesis protein RibD 
cluster_120 NMB1820 NMA0639 pglB pilin glycosylation protein PglB 
cluster_673 NMB1822 NMA0637 pglD pilin glycosylation protein PglD 
cluster_156 NMB1827 NMA0632 dnaE "DNA polymerase III, alpha subunit" 
cluster_190 NMB1833 NMA0622 ileS isoleucyl-tRNA synthetase 
cluster_744 NMB1835 NMA0620 tyrS tyrosyl-tRNA synthetase 
cluster_497 NMB1840 NMA0616  hypothetical protein 
cluster_1098 NMB1855 NMA0602 carB "carbamoyl-phosphate synthase, large 
subunit" 
cluster_1149 NMB1868 NMA0588 xerC integrase/recombinase XerC 
cluster_711 NMB1885 NMA0572 pcm protein-L-isoaspartate O-methyltransferase 
cluster_501 NMB1897 NMA0559 leuS leucyl-tRNA synthetase 
cluster_865 NMB1907 NMA0548 yidC putative inner membrane protein translocase 
component YidC 
cluster_1129 NMB1908 NMA0547  hypothetical protein 
cluster_73 NMB1910 NMA0545  hypothetical protein 
cluster_363 NMB1871 NMA0585  hypothetical protein 
cluster_916 NMB1873 NMA0583  "putative DNA polymerase, bacteriophage-
type" 
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Table B1B (Part 7 of 7) : N. meningitidis Genes Under Positive Selection 
 
Cluster 
Identity 
N. 
meningitidis 
MC58 
Accessions 
N. 
meningitidis 
Z2491 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_366 NMB1918 NMA0536  acyl-carrier-protein S-malonyltransferase 
cluster_647 NMB1919 NMA0535  "ABC transporter, ATP-binding protein" 
cluster_1475 NMB1928 NMA0525 lgtB lacto-N-neotetraose biosynthesis glycosyl 
transferase LgtB 
cluster_1846 NMB1948 NMA0504  "ABC transporter, ATP-binding protein" 
cluster_624 NMB1969 NMA0478  putative serotype-1-specific antigen 
cluster_103 NMB1973 NMA0472 groES co-chaperonin GroES 
cluster_1449 NMB1978 NMA0466 cyaY frataxin-like protein 
cluster_949 NMB1982 NMA0462 polA DNA polymerase I 
cluster_436 NMB1987 NMA0454 thdF tRNA modification GTPase 
cluster_474 NMB1993 NMA0448  "iron(III) ABC transporter, ATP-binding 
protein" 
cluster_1274 NMB1996 NMA0445 purL phosphoribosylformylglycinamidine 
synthase 
cluster_662 NMB2024 NMA0416  hypothetical protein 
cluster_1756 NMB2034 NMA0404  putative 1-acyl-sn-glycerol-3-phosphate 
acyltransferase 
cluster_448 NMB2036 NMA0402 truA tRNA pseudouridine synthase A 
cluster_1255 NMB2039 NMA0398 porB major outer membrane protein PIB 
cluster_214 NMB2041 NMA0394  thiamin pyrophosphokinase-related protein 
cluster_853 NMB2062 NMA0373 thiF thiF protein 
cluster_636 NMB2074 NMA0358  hypothetical protein 
cluster_906 NMB2075 NMA0357  BirA protein/Bvg accessory factor 
cluster_1693 NMB2078 NMA0353  hypothetical protein 
cluster_490 NMB2099 NMA0330  hypothetical protein 
Table B1B : Genes under positive selection between N. meningitidis strains MC58 (NMB) and 
Z2491 (NMA) after curation of alignments for frameshifts. Genes highlighted in bold italics are 
database identified virulence genes under positive selection. 
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V. cholerae Genes Under Positive Selection 
 
Table B1C (Part 1 of 1) : V. cholerae Genes Under Positive Selection 
 
Cluster 
Identity 
V. cholerae 
N16961 
Accessions 
V. cholerae O395 
Accessions 
Enterez 
Gene 
Name 
GenBank Annotation 
cluster_1096 VC0212 VC0395_A2591 msbB 
(O395) 
lipid A biosynthesis lauroyl 
acyltransferase 
cluster_606 VC0370 VC0395_A2781  hypothetical protein 
cluster_492 VC0460 VC0395_A0012 proC 
(O395) 
pyrroline-5-carboxylate reductase 
cluster_2309 VC0694 VC0395_A0225  hypothetical protein 
cluster_2274 VC0837 VC0395_A0362 tcpF 
(O395) 
toxin co-regulated pilus biosynthesis 
protein F 
cluster_1375 VC1460 VC0395_A1063  hypothetical protein 
cluster_1683 VC1492 VC0395_A1099  hypothetical protein 
cluster_3151 VC1688 VC0395_A1293  hypothetical protein 
cluster_1570 VC1987 VC0395_A1572  "outer membrane lipoprotein Slp, 
putative" 
cluster_1299 VC2107 VC0395_A1691  aspartate-semialdehyde dehydrogenase 
cluster_826 VC2414 VC0395_A1990 aceE "pyruvate dehydrogenase, E1 component" 
cluster_155 VC2450 VC0395_A2028 mazG 
(O395) 
mazG protein 
cluster_217 VC2503 VC0395_A2085 valS valyl-tRNA synthetase 
cluster_2810 VC2610 VC0395_A2188  hypothetical protein 
cluster_2306 VC2712 VC0395_A2284  xanthine/uracil permease family protein 
cluster_3244 VC2758 VC0395_A2534 fadB "fatty oxidation complex, alpha subunit" 
cluster_1734 VC2761 VC0395_A2531  multidrug resistance protein 
cluster_580 VCA0082 VC0395_0058  "transcriptional regulator, LysR family" 
cluster_3098 VCA0382 VC0395_0855  hypothetical protein 
cluster_1192 VCA0849 VC0395_0388  hypothetical protein 
cluster_582 VCA0994 VC0395_0243  hypothetical protein 
cluster_771 VCA1062 VC0395_0180 potE putrescine-ornithine antiporter 
cluster_3419 VCA1073 VC0395_0169 putA "proline dehydrogenase/delta-1-pyrroline-
5-carboxylate dehydrogenase, authentic 
point mutation" 
Table B1C : Genes under positive selection between V. cholerae strains N16961 (VC and VCA) 
and O395 (VC_0395) after curation of alignments for frameshifts. Database identified virulence 
genes under positive selection are highlighted in bold italics. 
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Appendix B2 
Database Identified Virulence Genes 
H. pylori Database Identified Virulence Genes 
Table B2A (Part 1 of 4) H. pylori Database Identified Virulence Genes 
H. pylori Gene 
Accession Gene Name GenBank Annotation 
HP0009 omp1 outer membrane protein 
HP1129 - biopolymer transport protein (exbD) 
HP0824 - thioredoxin (trxA) 
HP0071 - urease accessory protein (ureI) 
HP0522 - cag pathogenicity island protein (cag3) 
HP0220 - cysteine desulfurase 
HP0887 - vacuolating cytotoxin 
HP1238 - aliphatic amidase (aimE) 
HP0529 - cag pathogenicity island protein (cag9) 
HP1340 - biopolymer transport protein (exbD) 
HP0535 - cag pathogenicity island protein (cag14) 
HP0638 - outer membrane protein (omp13) 
HP0797 - flagellar sheath adhesin hpaA 
HP0439 - hypothetical protein 
HP0541 - cag pathogenicity island protein (cag20) 
HP0246 - flagellar P-ring protein precursor 
HP0753 - flagellar protein FliS 
HP1419 - flagellar biosynthesis protein 
HP1475 - phosphopantetheine adenylyltransferase 
HP0915 - iron-regulated outer membrane protein (frpB) 
HP1077 - nickel transport protein (nixA) 
HP1027 - ferric uptake regulation protein (fur) 
HP0825 - thioredoxin reductase (trxB) 
HP0072 - urease beta subunit (urea amidohydrolase) (ureB) 
HP0523 - cag pathogenicity island protein (cag4) 
HP0221 - nifU-like protein 
HP0380 - glutamate dehydrogenase 
HP0888 - "iron(III) dicitrate ABC transporter, ATP-binding 
protein (fecE)" 
HP0039m  - Component of conjugal plasmid transfer system  
HP0393  - chemotaxis protein (cheV)  
HP0542  - cag pathogenicity island protein (cag21)2  
HP1400  - iron(III) dicitrate transport protein (fecA)  
HP0651  - fucosyltransferase 
HP1341 - siderophore-mediated iron transport protein (tonB) 
HP0536 - cag pathogenicity island protein (cag15) 
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Table B2A (Part 2 of 4) H. pylori Database Identified Virulence Genes 
H. pylori Gene 
Accession Gene Name GenBank Annotation 
HP0601 - flagellin 
HP0807 - iron(III) dicitrate transport protein (fecA) 
HP0459 - virB4 homolog (virB4) 
HP1174 - glucose/galactose transporter (gluP) 
HP1585 - flagellar basal-body rod protein (flgG) 
HP0876 - iron-regulated outer membrane protein (frpB) 
HP0067 - urease accessory protein (ureH) 
HP1130 - biopolymer transport protein (exbB) 
HP0017 - virB4 homolog (virB4) 
HP0073 - urease alpha subunit (ureA) (urea 
amidohydrolase) 
HP0524 - cag pathogenicity island protein (cag5) 
HP0279 - lipopolysaccharide heptosyltransferase-1 (rfaC) 
HP0325 - flagellar L-ring protein precursor 
HP0786 - translocase 
HP0889 - "iron(III) dicitrate ABC transporter, permease 
protein (fecD)" 
HP0530 - cag pathogenicity island protein (cag10) 
HP1399 - arginase (rocF) 
HP1445 - biopolymer transport protein (exbB) 
HP0537 - cag pathogenicity island protein (cag16) 
HP0235 - conserved hypothetical secreted protein 
HP0543 - cag pathogenicity island protein (cag22) 
HP0042 - trbI protein 
HP1420 - flagellum-specific ATP synthase 
HP1119 - flagellar hook-associated protein 
HP0870 - flagellar hook protein 
HP0512 - glutamine synthetase (glnA) 
HP0068 - urease accessory protein (ureG) 
HP0525 - virB11 homolog 
HP0684 fliP flagellar biosynthesis protein 
HP0326  - CMP-N-acetylneuraminic acid synthetase 
(neuA) 
HP0531  - cag pathogenicity island protein (cag11) 
HP1446  - biopolymer transport protein (exbD) 
HP1041  - flagellar biosynthesis protein 
HP0538  - cag pathogenicity island protein (cag17) 
HP0441  - VirB4 homolog 
HP0037  - NADH ubiquinone oxidoreductase subunit 
HP0544  - cag pathogenicity island protein (cag23) 
HP1561  - "iron(III) ABC transporter, periplasmic iron-
binding protein (ceuE)" 
HP0043  - mannose-6-phosphate isomerase (pmi) or (algA) 
HP1035 - flagellar biosynthesis protein 
 
 
 
 
 
 185 
Table B2A (Part 3 of 4) H. pylori Database Identified Virulence Genes 
H. pylori Gene 
Accession Gene Name GenBank Annotation 
HP0653 - nonheme iron-containing ferritin (pfr) 
HP0351 - flagellar M-ring protein 
HP1067 - chemotaxis protein (cheY) 
HP0159 - "lipopolysaccharide 1,2-glucosyltransferase 
(rfaJ)" 
HP1421 - conjugative transfer regulon protein (trbB) 
HP0815 - flagellar motor protein 
HP0616 - chemotaxis protein (cheV) 
HP0069 - urease accessory protein (ureF) 
HP0115 - Flagellin 
HP0679 - lipopolysaccharide biosynthesis protein (wbpB) 
HP1490 - hypothetical protein 
HP0725 omp17 outer membrane protein 
HP1086 - hemolysin (tly) 
HP0019 - chemotaxis protein (cheV) 
HP0526 - cag pathogenicity island protein (cag6) 
HP0178 - spore coat polysaccharide biosynthesis protein 
E 
HP0685 - flagellar biosynthetic protein (fliP) 
HP1092 - flagellar basal-body rod protein (flgG) 
HP0532 - cag pathogenicity island protein (cag12) 
HP0539 - cag pathogenicity island protein (cag18) 
HP0038 - DNA transformation competancy (J99 
annotation) 
HP0545 - cag pathogenicity island protein (cag24) 
HP0243 - neutrophil activating protein (napA) 
(bacterioferritin) 
HP1562 - "iron(III) ABC transporter, periplasmic iron-
binding protein (ceuE)" 
HP0044 - GDP-D-mannose dehydratase (rfbD) 
HP1512 - iron-regulated outer membrane protein (frpB) 
HP0352 - flagellar motor protein 
HP0912 - outer membrane protein (omp20) 
HP0816 - flagellar motor protein 
HP0520 - cag pathogenicity island protein (cag1) 
HP1030  - flagellar motor switch protein 
HP0527  - cag pathogenicity island protein (cag7) 
HP1339  - biopolymer transport protein (exbB) 
HP0686  - iron(III) dicitrate transport protein (fecA) 
HP0390  - adhesin-thiol peroxidase (tagD)) 
HP0294  - aliphatic amidase (aimE) 
HP1557  - flagellar basal body protein 
HP0546  - cag pathogenicity island protein (cag25) 
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Table B2A (Part 4 of 4) H. pylori Database Identified Virulence Genes 
H. pylori Gene 
Accession Gene Name GenBank Annotation 
HP1563 - alkyl hydroperoxide reductase (tsaA) 
HP0045 - nodulation protein (nolK) 
HP0353 - flagellar assembly protein 
HP0907 - flagellar biosynthesis protein 
HP0867 lpxB lipid-A-disaccharide synthase 
HP0913 - outer membrane protein (omp21) 
HP0160 - conserved hypothetical secreted protein 
HP0770 - flagellar biosynthesis protein 
HP0070 - urease accessory protein (ureE) 
HP0173 - flagellar biosynthesis protein 
HP1031 - flagellar motor switch protein 
HP0379 - fucosyltransferase 
HP0528 - cag pathogenicity island protein (cag8) 
HP0584 - flagellar motor switch protein 
HP0687 - iron(II) transport protein (feoB) 
HP1243 - outer membrane protein (omp28) 
HP0534 - cag pathogenicity island protein (cag13) 
HP0289 - toxin-like outer membrane protein 
HP0391 - purine-binding chemotaxis protein (cheW) 
HP0540 - cag pathogenicity island protein (cag19) 
HP0136 - bacterioferritin comigratory protein (bcp) 
HP1558 - flagellar basal body rod protein 
HP0547 - cag pathogenicity island protein (cag26) 
HP0752 - flagellar hook-associated protein 
HP0360 - UDP-glucose 4-epimerase 
HP0896 - outer membrane protein (omp19) 
HP0127 - outer membrane protein (omp4) 
HP0722 omp16 outer membrane protein 
HP0093 - hypothetical protein 
HP0751 - flagellar protein FlaG 
HP0295 - flagellar hook-associated protein 
HP0327 - flagellar protein G (flaG) 
HP1032 - flagellar biosynthesis sigma factor FliA 
HP0809 - flagellar basal body-associated protein 
HP0908 - flagellar hook protein 
HP1274  - paralysed flagella protein (pflA) 
HP1477  - flagellar basal body P-ring biosynthesis protein 
HP1559  - flagellar basal body rod protein 
HP1575  - "ABC transporter, putative" 
Table B2A : H. pylori database identified virulence genes and their GenBank annotations. H. 
pylori database identified virulence genes under positive selection are highlighted in bold italics.
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N. meningitidis Database Identified Virulence Genes 
 
Table B2B (Part 1 of 2) N. meningitidis Database Identified Virulence Genes 
N. meningitidis 
Gene Accession Gene Name GenBank Annotation 
NMA0049 -  RNA polymerase sigma factor 
NMA0185 -  capsule polysaccharide modification protein 
NMA0186 -  capsule polysaccharide modification protein 
NMA0195 -  capsule polysaccharide export ATP-binding protein 
NMA0196 -  capsule polysaccharide export inner-membrane protein 
NMA0197 -  capsule polysaccharide export inner-membrane protein 
NMA0198 -  capsule polysaccharide export outer membrane protein 
NMA0199 -  putative UDP-N-acetyl-D-glucosamine 2-epimerase 
NMA0200 -  putative capsule biosynthesis protein 
NMA0201 -  putative capsule biosynthesis protein 
NMA0202 -  putative capsule biosynthesis protein 
NMA0218 -  putative pilus retraction protein 
NMA0219 -  pilT-like protein 
NMA0243 -  lipopolysaccharide heptosyltransferase I 
NMA0264 -  fimbrial protein precursor (pilin) 
NMA0265 -  pilS1 
NMA0266 -  pilS2 
NMA0267 -  pilS3 
NMA0268 -  pilS4 
NMA0269 -  pilS5 
NMA0270 -  pilS6 
NMA0271 -  pilS7 
NMA0272 -  truncated pilin 
NMA0293 -  pseudogene (pilus-associated protein) 
NMA0398 -  "porin, major outer membrane protein P.I" 
NMA0453 -  putative iron-regulated outer membrane protein 
NMA0457 -  IgA-specific serine endopeptidase 
NMA0474 -  haemoglobin-haptoglobin-utilization protein 
NMA0475 -  haemoglobin-haptoglobin-utilization protein 
NMA0524 -  lacto-N-neotetraose biosynthesis glycosyl tranferase 
NMA0525 -  lacto-N-neotetraose biosynthesis glycosyl tranferase 
NMA0527 -  lacto-N-neotetraose biosynthesis glycosyl tranferase 
NMA0609 -  pilus-associated protein 
NMA0650 -  pilus secretin 
NMA0652 -  pilus assembly protein  
NMA0653 -  putative pilus assembly protein 
NMA0654 -  putative pilus assembly protein 
NMA0842 -  putative iron-uptake permease ATP-binding protein 
NMA0651 -  pilus assembly protein 
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Table B2B (Part 2 of 2) N. meningitidis Database Identified Virulence Genes 
N. meningitidis 
Gene Accession Gene Name N. meningitidis Gene Accession 
NMA0843 -  putative iron-uptake permease inner membrane 
protein 
NMA0844 -  major ferric iron binding protein 
NMA0905 -  IgA1 protease 
NMA0979 -  putative pilus retraction protein 
NMA1110 -  putative pilin 
NMA1118 -  "CMP-N-acetylneuraminate-beta-galactosamide-
alpha- 2,3-sialyltransferase" 
NMA1251 -  outer membrane protein precursor 
NMA1523 -  putative lipoprotein 
NMA1626 -  putative RTX-family exoprotein 
NMA1642 -  "porin, class I outer membrane protein" 
NMA1676 -  opacity protein 
NMA1727 -  ADP-heptose:LPS heptosyltransferase II 
NMA1739 -  lactoferrin binding protein A 
NMA1740 -  lactoferrin-binding protein 
NMA1890 -  opacity protein 
NMA1925 -  haemoglobin recepto 
NMA1958 -  "beta-1,4-glucosyltransferase" 
NMA1959 -  "alpha 1,2 N-acetylglucosamine transferase" 
NMA1983 -  biopolymer transport protein 
NMA1985 -  TonB protein 
NMA1995 -  periplasmic type I secretion system protein 
NMA2024 -  transferrin-binding protein A 
NMA2025 -  transferrin-binding protein B 
NMA2043 -  opacity protein 
NMA2113 -  adhesin MafB2 
NMA2155 -  pilus-assembly protein 
NMA2156 -  type IV prepilin leader peptidase 
NMA2159 -  type IV pilus assembly protein 
Table B2B : N. meningitidis database identified virulence genes and their GenBank annotations. 
N. meningitidis database identified virulence genes under positive selection are highlighted in 
bold italics. 
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V. cholerae Database Identified Virulence Genes 
 
Table B2C (Part 1 of 4) V. cholerae Database Identified Virulence Genes 
V. cholerae Gene 
Accession Gene Name GenBank Annotation 
VC0398 - regulatory protein CsrD 
VC0399 - MSHA biogenesis protein MshI 
VC0400 - MSHA biogenesis protein MshJ 
VC0401 - MSHA biogenesis protein MshK 
VC0402 - MSHA biogenesis protein MshL 
VC0403 - MSHA biogenesis protein MshM 
VC0404 - MSHA biogenesis protein MshN 
VC0405 - MSHA biogenesis protein MshE 
VC0406 - MSHA biogenesis protein MshG 
VC0407 - MSHA biogenesis protein MshF 
VC0408 - MSHA pilin protein MshB 
VC0409 - MSHA pilin protein MshA 
VC0410 - MSHA pilin protein MshC 
VC0411 - MSHA pilin protein MshD 
VC2423 - fimbrial protein 
VC2424 - type IV pilus assembly protein PilB 
VC2425 - type IV pilin biogenesis protein PilC 
VC2426 - leader peptidase PilD 
VC0918 wecC UDP-N-acetyl-D-mannosamine dehydrogenase 
VC0917 - UDP-N-acetylglucosamine 2-epimerase 
VC0263 - "galactosyl-transferase, putative" 
VC0260 - mannosyl-transferase 
VC0934 - "capsular polysaccharide biosynthesis 
glycosyltransferase, putative" 
VC0935 - hypothetical protein 
VC0936 - polysaccharide export-related protein 
VC0937 - "exopolysaccharide biosynthesis protein, putative" 
VC0927 - UDP-N-acetyl-D-mannosamine transferase 
VC2187 - flagellin 
VC2190 flgL flagellar hook-associated protein FlgL 
VC2191 flgK flagellar hook-associated protein FlgK 
VC2192 flgJ flagellar rod assembly protein/muramidase FlgJ 
VC2194 flgH flagellar basal body L-ring protein 
VC2195 flgG flagellar basal body rod protein FlgG 
VC2196 flgF flagellar basal body rod protein FlgF 
VC2197 flgE flagellar hook protein FlgE 
VC2198 flgD flagellar basal body rod modification protein 
VC2199 flgC flagellar basal body rod protein FlgC 
VC2200 flgB flagellar basal body rod protein FlgB 
VC2201 - chemotaxis protein methyltransferase CheR 
VC2202 - chemotaxis protein CheV 
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Table B2C (Part 2 of 4) V. cholerae Database Identified Virulence Genes 
V. cholerae Gene 
Accession Gene Name GenBank Annotation 
VC2203 flgA flagellar basal body P-ring biosynthesis protein FlgA 
VC2204 - "negative regulator of flagellin synthesis FlgM, putative" 
VC2205 - hypothetical protein 
VC2120 flhB flagellar biosynthesis protein FlhB 
VC2121 fliR flagellar biosynthesis protein FliR 
VC2122 fliQ flagellar biosynthesis protein FliQ 
VC2123 fliP flagellar biosynthesis protein FliP 
VC2124 - flagellar protein FliO 
VC2125 fliN flagellar motor switch protein 
VC2126 fliM flagellar motor switch protein FliM 
VC2127 fliL flagellar basal body-associated protein FliL 
VC2128 - "flagellar hook-length control protein FliK, putative" 
VC2129 fliJ flagellar biosynthesis chaperone 
VC2130 fliI flagellum-specific ATP synthase 
VC2131 fliH flagellar assembly protein H 
VC2132 fliG flagellar motor switch protein G 
VC2133 fliF flagellar MS-ring protein 
VC2134 fliE flagellar hook-basal body protein FliE 
VC2135 - sigma-54 dependent response regulator 
VC2136 - sensory box sensor histidine kinase 
VC2137 - sigma-54 dependent transcriptional activator 
VC2138 fliS flagellar protein FliS 
VC2139 - "flagellar rod protein FlaI, putative" 
VC2140 fliD flagellar capping protein 
VC2141 - flagellar protein FlaG 
VC2142 - flagellin 
VC2143 - flagellin 
VC2144 - flagellin 
VC2059 - purine-binding chemotaxis protein CheW 
VC2062 - chemotaxis-specific methylesterase 
VC2063 - chemotaxis protein CheA 
VC2064 - chemotaxis protein CheZ 
VC2065 - chemotaxis protein CheY 
VC2066 fliA flagellar biosynthesis sigma factor 
VC2067 - MinD-related protein 
VC2068 flhF flagellar biosynthesis regulator FlhF 
VC2069 flhA flagellar biosynthesis protein FlhA 
VC0892 - flagellar motor protein PomA 
VC0893 motB flagellar motor protein MotB 
VC1008 - sodium-type flagellar protein MotY 
VC2601 - sodium-type flagellar protein MotX 
VCA0112 - hypothetical protein 
VCA0865 - hemagglutinin/protease 
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Table B2C (Part 3 of 4) V. cholerae Database Identified Virulence Genes 
V. cholerae Gene 
Accession Gene Name GenBank Annotation 
VC1784 - neuraminidase 
VC0475 - enterobactin receptor protein 
VCA0576 - heme transport protein HutA 
VCA0064 - "TonB system receptor, putative" 
VCA0625 - TonB receptor-related protein 
VC0776 - iron-enterobactin transporter periplasmic binding protein 
VC0777 - "ferric vibriobactin ABC transporter, permease protein" 
VC0778 - "ferric vibriobactin ABC transporter, permease protein" 
VC0779 - "ferric vibriobactin ABC transporter, ATP-binding 
protein" 
VCA0227 - "iron(III) ABC transporter, periplasmic iron-compound-
binding protein" 
VCA0228 - "iron(III) ABC transporter, permease protein" 
VCA0229 - "iron(III) ABC transporter, permease protein" 
VCA0230 - "iron(III) ABC transporter, ATP-binding protein" 
VC0771 - vibriobactin-specific isochorismatase 
VC0772 - "vibriobactin-specific 2,3-dihydroxybenzoate-AMP 
ligase" 
VC0773 - vibriobactin-specific isochorismate synthase 
VC0774 - "2,3-dihydroxybenzoate-2,3-dehydrogenase" 
VC0775 - "vibriobactin synthesis protein, putative" 
VC0780 - vibriobactin synthase component D 
VC2209 vibF nonribosomal peptide synthetase VibF 
VC2210 - vibriobactin utilization protein ViuB 
VC2211 - ferric vibriobactin receptor 
VC0557 - S-ribosylhomocysteinase 
VCA0523 - hypothetical protein 
VC2723 - general secretion pathway protein N 
VC2724 - cholera toxin secretion protein EpsM 
VC2725 - general secretion pathway protein L 
VC2726 - general secretion pathway protein K 
VC2727 - general secretion pathway protein J 
VC2728 - general secretion pathway protein I 
VC2729 - general secretion pathway protein H 
VC2730 - general secretion pathway protein G 
VC2731 - general secretion pathway protein F 
VC2732 - general secretion pathway protein E 
VC2734 - general secretion pathway protein C 
VC1415  - hcp protein 
VCA0017  - hcp protein 
VC1416  - vgrG protein 
VCA0018  - vgrG protein 
VCA0123  - vgrG protein 
VCA0110  - hypothetical protein 
VCA0111  - hypothetical protein 
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Table B2C (Part 4 of 4) V. cholerae Database Identified Virulence Genes 
V. cholerae Gene 
Accession Gene Name GenBank Annotation 
VCA0113 - hypothetical protein 
VCA0114 - hypothetical protein 
VCA0115 - hypothetical protein 
VCA0116 - clpB protein 
VCA0118 - hypothetical protein 
VCA0119 - hypothetical protein 
VCA0120 - IcmF-related protein 
VCA0218 - thermolabile hemolysin 
VCA0219 - haemolysin 
VC0827 - toxin co-regulated pilus biosynthesis protein H 
VC0833 - toxin co-regulated pilus biosynthesis protein D 
VC0640 secG preprotein translocase subunit SecG 
VC1459 - accessory cholera enterotoxin 
VC2193 flgI flagellar basal body P-ring protein 
VC0828 - toxin co-regulated pilin 
VC0834 - toxin co-regulated pilus biosynthesis protein S 
VC1447 - RTX toxin transporter 
VC0840 - accessory colonization factor AcfB 
VC0744 secF preprotein translocase subunit SecF 
VCA0117 - sigma-54 dependent transcriptional regulator 
VC2188 - flagellin 
VC0829 - toxin co-regulated pilus biosynthesis protein B 
VC0835 - toxin co-regulated pilus biosynthesis protein T 
VC1448 - RTX toxin transporter 
VC0841 - accessory colonization factor AcfC 
VC1473 - hypothetical protein 
VC0836 - toxin co-regulated pilus biosynthesis protein E 
VC0830 - toxin co-regulated pilus biosynthesis protein Q 
VC0837 - toxin co-regulated pilus biosynthesis protein F 
VC1456 - "cholera enterotoxin, B subunit" 
VC0825 - toxin co-regulated pilus biosynthesis protein I 
VC0831 - toxin co-regulated pilus biosynthesis outer membrane 
protein C 
VC0838 - TCP pilus virulence regulatory protein 
VC1450 - RTX toxin activating protein 
VC0844 - accessory colonization factor AcfA 
VC1457  - "cholera enterotoxin, A subunit" 
VC0826  - toxin co-regulated pilus biosynthesis protein P 
VC0832  - toxin co-regulated pilus biosynthesis protein R 
VC0839  - leader peptidase TcpJ 
VC1451  - RTX toxin RtxA 
VC0845  - hypothetical protein 
VC1458  - zona occludens toxin 
Table B2C : V. cholerae database identified virulence genes and their GenBank annotations. V. 
cholerae database identified virulence genes under positive selection are highlighted in bold 
italics. 
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Appendix B3 
Statistical Testing for Association between Genes Under Positive 
Selection and Database Identified Virulence Genes 
 
H pylori 
 
> two_way_classification_chi_function (230,153,22,1535) 
     row1 row2 
[1,]   22  131 
[2,]  208 1174 
 
        Pearson's Chi-squared test with Yates' continuity correction 
 
data:  contingency_table  
X-squared = 0.0103, df = 1, p-value = 0.9192 
 
 
        Fisher's Exact Test for Count Data 
 
data:  contingency_table  
p-value = 0.9052 
alternative hypothesis: true odds ratio is not equal to 1  
95 percent confidence interval: 
 0.560765 1.539217  
sample estimates: 
odds ratio  
 0.9478948 
 
N meningitidis 
 
> two_way_classification_chi_function(218, 68, 14, 2208) 
     [,1] [,2] 
row1   14  204 
row2   54 1936 
 
        Pearson's Chi-squared test with Yates' continuity correction 
 
data:  contingency_table  
X-squared = 7.8528, df = 1, p-value = 0.005074 
 
 
        Fisher's Exact Test for Count Data 
 
data:  contingency_table  
p-value = 0.006048 
alternative hypothesis: true odds ratio is not equal to 1  
95 percent confidence interval: 
 1.238984 4.585353  
sample estimates: 
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odds ratio  
  2.459031  
 
V cholerae 
 
> two_way_classification_chi_function (23,169,1,3998) 
     row1 row2 
[1,]    1  168 
[2,]   22 3807 
 
        Pearson's Chi-squared test with Yates' continuity correction 
 
data:  contingency_table  
X-squared = 0.2409, df = 1, p-value = 0.6236 
 
 
        Fisher's Exact Test for Count Data 
 
data:  contingency_table  
p-value = 1 
alternative hypothesis: true odds ratio is not equal to 1  
95 percent confidence interval: 
 0.02481221 6.45051469  
sample estimates: 
odds ratio  
  1.030033  
 
Warning message: 
In chisq.test(contingency_table) : 
  Chi-squared approximation may be incorrect 
 
Statistical Testing For Virulence Gene Database Bias 
 
H pylori MVirDB 
 
two_way_classification_chi_function (230,138,19,1535) 
     row1 row2 
[1,]   19  119 
[2,]  211 1186 
 
        Pearson's Chi-squared test with Yates' continuity correction 
 
data:  contingency_table  
X-squared = 0.0867, df = 1, p-value = 0.7685 
 
H pylori VFDB 
 
two_way_classification_chi_function (230,87,13,1535) 
     row1 row2 
[1,]   13   74 
[2,]  217 1231 
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        Pearson's Chi-squared test with Yates' continuity correction 
 
data:  contingency_table  
X-squared = 0.0206, df = 1, p-value = 0.8858 
 
N meningitidis MVirDB 
 
two_way_classification_chi_function (218,37,12,2208) 
     row1 row2 
[1,]   12   25 
[2,]  206 1965 
 
        Pearson's Chi-squared test with Yates' continuity correction 
 
data:  contingency_table  
X-squared = 19.0206, df = 1, p-value = 1.293e-05 
 
N meningitidis VFDB 
 
two_way_classification_chi_function (218,68,14,2208) 
     row1 row2 
[1,]   14   54 
[2,]  204 1936 
 
        Pearson's Chi-squared test with Yates' continuity correction 
 
data:  contingency_table  
X-squared = 7.8528, df = 1, p-value = 0.005074 
 
V cholerae MVirDB 
two_way_classification_chi_function (23,33,1,3998) 
     [,1] [,2] 
row1    1   22 
row2   32 3943 
 
        Pearson's Chi-squared test with Yates' continuity correction 
 
data:  contingency_table  
X-squared = 0.5139, df = 1, p-value = 0.4735 
 
 
        Fisher's Exact Test for Count Data 
 
data:  contingency_table  
p-value = 0.174 
alternative hypothesis: true odds ratio is not equal to 1  
95 percent confidence interval: 
  0.1316469 36.8349874  
sample estimates: 
odds ratio  
  5.594729  
 
 
 
 
 
 196 
Warning message: 
In chisq.test(contingency_table) : 
  Chi-squared approximation may be incorrect 
 
V cholerae VFDB 
 
two_way_classification_chi_function (23,165,1,3998) 
     [,1] [,2] 
row1    1   22 
row2  164 3811 
 
        Pearson's Chi-squared test with Yates' continuity correction 
 
data:  contingency_table  
X-squared = 0.223, df = 1, p-value = 0.6367 
 
 
        Fisher's Exact Test for Count Data 
 
data:  contingency_table  
p-value = 0.6217 
alternative hypothesis: true odds ratio is not equal to 1  
95 percent confidence interval: 
 0.02544047 6.61662864  
sample estimates: 
odds ratio  
  1.056276  
 
Warning message: 
In chisq.test(contingency_table) : 
  Chi-squared approximation may be incorrect 
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Appendix B4 
Gene Feature Summary Statistics 
Summary Statistics For Gene Lengths 
 
Descriptive Statistic (Units = Base Pair) 
Bacterial 
Organism 
Gene List 
Type 
Mean Median Maximum Minimum Standard Deviation 
Positive 
Selection 1289 1113 3873 207 744 
Virulence 1190 942 8682 243 998 H pylori 
Genome 958.8 807 8682 39 717 
Positive 
Selection 1281 1038 5322 216 856.5 
Virulence 1280 1026 5322 300 941.3 N meningitidis 
Genome 857.8 717 6048 72 636.9 
Positive 
Selection 1871 1230 9792 426 2003 
Virulence 1230 957 13680 270 1268.5 V cholerae 
Genome 922 783 13680 81 715.93 
  Table B4A : Descriptive statistical summary of gene lengths obtained for genes under positive 
selection, database identified virulence genes and the genomic genes for H pylori, N 
meningitidis and V cholerae. 
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Summary Statistics For %GC Content 
 
Descriptive Statistic (Units = % GC) 
Bacterial 
Organism 
Gene List 
Type 
Mean Median Maximum Minimum Standard Deviation 
Positive 
Selection 39.29 39.48 46.26 29.74 3.01 
Virulence 39.78 39.97 46.89 30.43 3.61 H pylori 
Genome 39.11 39.44 60.61 21.51 3.75 
Positive 
Selection 54.95 55.6 62.24 29.46 4.48 
Virulence 50.07 51.74 60.53 24.54 6.33 N meningitidis 
Genome 51.65 53.4 67.86 17.78 7.09 
Positive 
Selection 48.97 47.04 54.6 34.9 4.05 
Virulence 47.04 48.8 54.39 28.07 5.38 V cholerae 
Genome 47 47.9 56.5 25.6 4.46 
Table B4B : Descriptive statistical summary of %GC content obtained for genes under positive 
selection, database identified virulence genes and the genomic genes for H pylori, N 
meningitidis and V cholerae. 
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Appendix C1 
COG Functional Category Enrichment Statistical Tests  
H. pylori COG Functional Category Enrichment Statistical Tests 
Total number of H. pylori genome genes with COG annotations = 978 
Total number of H. pylori positively selected genes with COG annotations = 178 of 230 genes 
Total number of H. pylori virulence genes with COG annotations = 118 of 153 genes 
 
COG Category 
Number of 
H. pylori 
Database 
Identified 
Virulence 
Genes in 
COG 
Category 
Number of H. 
pylori genome 
genes in  COG 
Category 
P value Adjusted P 
value 
[C] Energy production and conversion 2 67 0.01762 0.4096 
[E] Amino acid transport and 
metabolism 6 80 0.2588 1 
[G] Carbohydrate transport and 
metabolism 3 31 0.8929 1 
[H] Coenzyme transport and 
metabolism 2 58 0.03633 0.21798 
[J] Translation 2 93 0.003517 0.03517 
[K] Transcription 2 33 0.4154 1 
[L] Replication, recombination and 
repair 2 92 0.003827 0.03517 
[M] Cell wall/membrane biogenesis 10 92 0.84 1 
[N] Cell motility 41 48 2.2e-16 2.86e – 15 
[O]Posttranslational modification, 
protein turnover, chaperones 13 58 0.02221 0.15547 
[P] Inorganic ion transport and 
metabolism 15 47 5.068e-05 0.00055748 
[T] Signal transduction mechanisms 5 25 0.2122 1 
[U] Intracellular trafficking and 
secretion 33 55 2.2e-16 2.86e – 15 
Table C1A : Results of a one-way classification Chi-Square tests to determine which COG 
categories are enriched for H. pylori database identified virulence genes. Holm’s method was 
used to correct P values for multiple hypothesis testing. 
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COG Category 
Number of H. 
pylori 
Positively 
Selected Genes 
in COG 
Category 
Number of H. 
pylori genome 
genes in  COG 
Category 
P value Adjusted P 
value 
[C] Energy production and conversion 4 67 0.004867 0.087606 
[D] Cell cycle control, mitosis and 
meiosis 
8 20 0.0178 0.3026 
[E] Amino acid transport and 
metabolism 
18 80 0.3740 1 
[F] Nucleotide transport and 
metabolism 
2 34 0.06832 1 
[G] Carbohydrate transport and 
metabolism 
6 31 0.9464 1 
[H] Coenzyme transport and 
metabolism 
10 58 0.9843 1 
[I] Lipid transport and metabolism 12 38 0.04933 0.7892 
[J] Translation 16 93 0.9041 1 
[K] Transcription 4 33 0.4894 1 
[L] Replication, recombination and 
repair 
14 92 0.524 1 
[M] Cell wall/membrane biogenesis 19 92 0.6182 1 
[N] Cell motility 6 48 0.391 1 
[O]Posttranslational modification, 
protein turnover, chaperones 
9 58 0.711 1 
[P] Inorganic ion transport and 
metabolism 
10 47 0.714 1 
[Q] Secondary metabolites 
biosynthesis, transport and catabolism 
3 12 0.4658 1 
[T] Signal transduction mechanisms 7 25 0.1939 1 
[U] Intracellular trafficking and 
secretion 
7 55 0.3665 1 
[V] Defense mechanisms 7 29 0.5505 1 
Table C1B : Results of a one-way classification Chi-Square tests to determine which COG 
categories are enriched for H. pylori genes under positive selection. Holm’s method was used to 
correct P values for multiple hypothesis testing.  
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COG Category 
Number of H. pylori 
database identified 
virulence genes under 
positive selection 
belonging to COG 
Category 
P value Adjusted P 
value 
[E] Amino acid transport and 
metabolism 
1 0.8788 1 
[J] Translation 2 0.02805 0.25245 
[L] Replication, recombination and 
repair 
1 0.2826 1 
[M] Cell wall/membrane biogenesis 1 0.6812 1 
[N] Cell motility 3 0.03281 0.262 
[O] Posttranslational modification, 
protein turnover, chaperones 
1 0.6676 1 
[P] Inorganic ion transport and 
metabolism 
1 0.1353 0.81180 
[T] Signal transduction mechanisms 1 0.9113 1 
[U] Intracellular trafficking and 
secretion 
2 0.1025 0.71750 
Table C1C : Results of a two-way classification Chi-Square tests to determine which COG 
categories are enriched for H. pylori database identified virulence genes that are under positive 
selection. Holm’s method was used to correct P values for multiple hypothesis testing.  
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N. meningitidis COG Functional Category Enrichment Statistical Tests 
Number of N. meningitidis genome genes with COG annotations = 1356 
Number of N. meningitidis positively selected genes with COG annotations = 199 of 218 genes 
Number of N. meningitidis virulence genes with COG annotations = 47 of 68 genes 
 
COG Category 
Number of N. 
meningitidis 
Database 
Identified 
Virulence Genes 
in COG Category 
Number of N. 
meningitidis 
genome genes in  
COG Category 
P value Adjusted P 
value 
[E] Amino acid transport and 
metabolism 1 129 0.1327 0.5308 
[G] Carbohydrate transport and 
metabolism 2 49 0.8746 1 
[M] Cell wall/membrane 
biogenesis 20 119 7.176e-16 4.3056e – 15 
[N] Cell motility 15 21 2.2e-16 1.76e – 15 
[O]Posttranslational 
modification, protein turnover, 
chaperones 
1 64 0.615 1 
[P] Inorganic ion transport and 
metabolism 6 81 0.09167 0.4583 
[Q] Secondary metabolites 
biosynthesis, transport and 
catabolism 
1 18 0.8723 1 
[U] Intracellular trafficking and 
secretion 20 55 2.2e-16 1.76e – 15 
Table C1D : Results of a one-way classification Chi-Square tests to determine which COG 
categories are enriched for N. meningitidis database identified virulence genes. Holm’s method 
was used to correct P values for multiple hypothesis testing. 
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COG Category 
Number of N. 
meningitidis 
Positively 
Selected Genes 
in COG 
Category 
Number of N. 
meningitidis 
genome genes 
in  COG 
Category 
P value Adjusted P value 
[C] Energy production and conversion 11 105 0.2617 1 
[D] Cell cycle control, mitosis and meiosis 6 24 0.2497 1 
[E] Amino acid transport and metabolism 16 129 0.5248 1 
[F] Nucleotide transport and metabolism 9 39 0.2023 1 
[G] Carbohydrate transport and metabolism 5 49 0.4868 1 
[H] Coenzyme transport and metabolism 15 71 0.1598 1 
[I] Lipid transport and metabolism 5 40 0.8667 1 
[J] Translation 19 122 0.873 1 
[K] Transcription 4 63 0.08358 1 
[L] Replication, recombination and repair 20 152 0.6603 1 
[M] Cell wall/membrane biogenesis 25 119 0.05634 1 
[N] Cell motility 6 21 0.1329 1 
[O]Posttranslational modification, protein 
turnover, chaperones 
8 64 0.7468 1 
[P] Inorganic ion transport and metabolism 11 81 0.9002 1 
[Q] Secondary metabolites biosynthesis, 
transport and catabolism 
2 18 0.9244 1 
[R] General function prediction only 20 167   
[S] Function unknown 12 126   
[T] Signal transduction mechanisms 5 20 0.3191 1 
[U] Intracellular trafficking and secretion 12 55 0.1823 1 
[V] Defense mechanisms 5 15 0.09168 1 
[W] Extracellular structures 1 1 0.1468 1 
Table C1E : Results of a one-way classification Chi-Square tests to determine which COG 
categories are enriched for N. meningitidis genes under positive selection. Holm’s method was 
used to correct P values for multiple hypothesis testing.  
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COG Category 
Number of N. 
meningitidis 
database identified 
virulence genes 
under positive 
selection belonging 
to COG Category 
P value Adjusted P value 
[G] Carbohydrate transport and 
metabolism 1 0.1956 0.5574 
[M] Cell wall/membrane biogenesis 10 0.001423 0.007115 
[N] Cell motility 1 0.001677 0.007115 
[P] Inorganic ion transport and 
metabolism 2 0.1858 0.5574 
[U] Intracellular trafficking and 
secretion 3 0.5025 0.5574 
Table C1F : Results of a two-way classification Chi-Square tests to determine which COG 
categories are enriched for N. meningitidis database identified virulence genes that are under 
positive selection. Holm’s method was used to correct P values for multiple hypothesis testing.  
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V. cholerae COG Functional Category Enrichment Statistical Tests 
Total number of V. cholerae genome genes with COG annotations = 2507 
Total number of V. cholerae positively selected genes with COG annotations = 18 of 23 genes 
Total number of V. cholerae virulence genes with COG annotations = 142 of 169 genes 
 
COG Category 
Number of V. 
cholerae 
Database 
Identified 
Virulence Genes 
in COG 
Category 
Number of 
V. cholerae 
genome 
genes in  
COG 
Category 
P value Adjusted P value 
[D] Cell cycle control, mitosis and 
meiosis 2 35 0.7224 1 
[E] Amino acid transport and 
metabolism 1 250 0.0002615 0.003138 
[G] Carbohydrate transport and 
metabolism 2 143 0.03696 0.3264 
[H] Coenzyme transport and 
metabolism 3 130 0.1322 0.9254 
[I] Lipid transport and metabolism 2 78 0.3398 1 
[K] Transcription 2 216 0.002723 0.029953 
[M] Cell wall/membrane biogenesis 13 160 0.2244 1 
[N] Cell motility 65 133 2.2e-16 3.08e – 15 
[O]Posttranslational modification, 
protein turnover, chaperones 8 124 0.8494 1 
[P] Inorganic ion transport and 
metabolism 14 156 0.09529 0.76232 
[Q] Secondary metabolites 
biosynthesis, transport and catabolism 8 54 0.00983 0.0983 
[T] Signal transduction mechanisms 17 227 0.2728 1 
[U] Intracellular trafficking and 
secretion 38 88 2.2e-16 3.08e – 15 
[V] Defense mechanisms 1 45 0.4949 1 
Table C1G : Results of a one-way classification Chi-Square tests to determine which COG 
categories are enriched for V. cholerae database identified virulence genes. Holm’s method was 
used to correct P values for multiple hypothesis testing. 
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COG Category 
Number of V. 
cholerae 
Positively 
Selected Genes 
in COG 
Category 
Number of V. 
cholerae 
genome genes 
in  COG 
Category 
P value Adjusted P value 
[C] Energy production and conversion 1 168 1 1 
[E] Amino acid transport and metabolism 5 250 0.02739 0.2739 
[F] Nucleotide transport and metabolism 1 64 0.3732 1 
[G] Carbohydrate transport and metabolism 1 143 0.6293 1 
[I] Lipid transport and metabolism 1 78 0.435 1 
[J] Translation 1 158 0.722 1 
[K] Transcription 2 216 0.6642 1 
[M] Cell wall/membrane biogenesis 3 160 0.1029 0.9261 
[P] Inorganic ion transport and metabolism 1 156 0.7099 1 
[T] Signal transduction mechanisms 1 227 0.9148 1 
Table C1H : Results of a one-way classification Chi-Square tests to determine which COG 
categories are enriched for V. cholerae genes under positive selection. Holm’s method was used 
to correct P values for multiple hypothesis testing.  
 
        VC0837, the only V. cholerae database identifed virulence gene under positive selection 
does not belong to a COG’s alphabetical biological process category. 
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Appendix C2 
PSORT Sub-Cellular Localisation Enrichment Statistical Tests  
Chi-Square Tests for Association between PSORT Categories and Genes under 
Positive Selection 
Total Number of H pylori genes annotated by PSORT cutoff > 7.5 = 861 
Total Number of H pylori genes under positive selection annotated by PSORT cutoff > 7.5 = 151 
Total Number of N meningitidis genes annotated by PSORT cutoff > 7.5 = 1103 
Total Number of N meningitidis genes under positive selection annotated by PSORT cutoff > 7.5 = 131 
Total Number of V cholerae genes annotated by PSORT cutoff > 7.5 = 2162 
Total Number of V cholerae genes under positive selection annotated by PSORT cutoff > 7.5 = 14 
Bacterial Organism : H pylori  
 
PSORT Category 
Genome 
Number 
No of genes 
under Positive 
Selection 
P – Value Adjusted P – 
Value 
Cytoplasmic 529 82 0.05853 0.17559 
Cytoplasmic Membrane 238 46 0.4512 0.90240 
Periplasmic 13 1 0.4845 0.90240 
OuterMembrane 69 22 0.001920 0.00768 
ExtraCellular 12 0 Not Tested Not Tested 
Bacterial Organism : N meningitidis  
 
PSORT Category 
Genome 
Number 
No of genes 
under Positive 
Selection 
P – Value Adjusted P – 
Value 
Cytoplasmic 749 94 0.365 0.73 
Cytoplasmic Membrane 274 24 0.08323 0.24969 
Periplasmic 32 2 0.4163 0.73 
OuterMembrane 44 11 0.01213 0.04582 
ExtraCellular 4 0 Not Tested Not Tested 
Bacterial Organism : V cholerae  
 
PSORT Category 
Genome 
Number 
No of genes 
under Positive 
Selection 
P – Value Adjusted P – 
Value 
Cytoplasmic 1303 6 0.2884 0.8652 
Cytoplasmic Membrane 683 6 0.3919 0.8652 
Periplasmic 80 0 Not Tested Not Tested 
OuterMembrane 28 1 0.1673 0.6692 
ExtraCellular 68 1 0.3616 0.8652 
Table C2A : Results of one-way classification Chi-square tests to determine if genes under 
positive selection in H pylori, N meningitidis and V cholerae have statistically significant 
association with a predicted PSORT sub-cellular localisation site. Holm’s method was used to 
adjust P values for multiple hypotheses testing. 
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Chi-Square Tests for Association between PSORT Categories and Database 
Identified Virulence Genes  
Total Number of H pylori genes annotated by PSORT cutoff > 7.5 = 861 
Total Number of H pylori virulence genes annotated by PSORT cutoff > 7.5 = 94 
Total Number of N meningitidis genes annotated by PSORT cutoff > 7.5 = 1103 
Total Number of N meningitidis virulence genes annotated by PSORT cutoff > 7.5 = 33 
Total Number of V cholerae genes annotated by PSORT cutoff > 7.5 = 2162 
Total Number of V cholerae virulence genes annotated by PSORT cutoff > 7.5 = 95 
 
Bacterial Organism : H pylori 
 
PSORT Category Genome 
Number 
No of Database 
Identified 
virulence genes 
P – Value Adjusted P – Value 
Cytoplasmic 529 40 0.0001072 0.0004288 
Cytoplasmic Membrane 238 27 0.8996 1 
Periplasmic 13 1 1 1 
OuterMembrane 69 21 1.798e-07 8.9900e-07 
ExtraCellular 12 5 0.005936 0.0178 
Bacterial Organism : N meningitidis 
 
PSORT Category Genome Number 
No of Database 
Identified 
virulence genes 
P – Value Adjusted P – Value 
Cytoplasmic 749 11 3.627e-05 0.00014508 
Cytoplasmic Membrane 274 8 0.9016 1 
Periplasmic 32 1 1 1 
OuterMembrane 44 12 6.57e-10 3.2850e-09 
ExtraCellular 4 1 0.1146 0.3438 
Bacterial Organism : V cholerae 
PSORT Category Genome 
Number 
No of Database 
Identified 
virulence genes 
P – Value Adjusted P – Value 
Cytoplasmic 1303 36 8.57e-06 2.5710e-05 
Cytoplasmic Membrane 683 32 0.7369 1 
Periplasmic 80 3 1 1 
OuterMembrane 28 10 1.139e-07 5.6950e-07 
ExtraCellular 68 14 6.696e-07 2.6784e-06 
Table C2B : Results of one-way classification Chi-square tests to determine if database 
identified virulence genes for H pylori, N meningitidis and V cholerae have statistically 
significant association with a predicted PSORT sub-cellular localisation site. Holm’s method 
was used to adjust P values for multiple hypotheses testing. 
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Chi-Square Tests for Association between PSORT Categories for Database 
Identified Virulence Genes and Genes under Positive Selection 
Total Number of H pylori genes under positive selection annotated by PSORT cutoff > 7.5 = 
151 
Total Number of H pylori virulence genes annotated by PSORT cutoff > 7.5 = 94 
Total Number of N meningitidis genes under positive selection annotated by PSORT cutoff > 7.5 
= 131 
Total Number of N meningitidis virulence genes annotated by PSORT cutoff > 7.5 = 33 
Total Number of V cholerae genes annotated by PSORT cutoff > 7.5 = 14 
Total Number of V cholerae virulence genes annotated by PSORT cutoff > 7.5 = 95 
 
Bacterial Organism : H pylori 
PSORT Category 
No of genes 
under 
Positive 
Selection 
No of Database 
Identified 
virulence genes 
P – Value Adjusted P – Value 
Cytoplasmic 82 40 (6 genes in common) 0.8917 1 
Cytoplasmic Membrane 46 27 (2 genes in common) 0.1594 0.4782 
Periplasmic 1 1 (0 genes in common)   
OuterMembrane 22 21 (8 genes in common) 0.6516 1 
ExtraCellular 0 5   
Bacterial Organism : N meningitidis 
PSORT Category 
No of genes 
under 
Positive 
Selection 
No of Database 
Identified 
virulence genes 
P – Value Adjusted P – Value 
Cytoplasmic 94 11 (2 genes in common) 0.6372 1 
Cytoplasmic Membrane 24 8 (1 gene in common) 0.5245 1 
Periplasmic 2 1 (0 genes in common)   
OuterMembrane 11 12 (5 genes in common) 0.1387 0.4161 
ExtraCellular 0 1   
Table C2C : Results of a two-way classification Chi-Square tests to determine which PSORT 
sub-cellular localisation sites have a statistically significant  association at the P = 0.05 level for 
H. pylori and N. meningitidis database identified virulence genes that are under positive 
selection. Holm’s method was used to correct P values for multiple hypothesis testing. 
 
The only V cholerae database identified virulence gene that is under positive selection (VC0837) 
has a PSORT score of 2 and belongs to the sub-cellular localisation category unknown. 
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